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6 Aim of the thesis
1 Molecular control of cell proliferation
1.1 Cell proliferation
During the development of a multicellular organism the cells, which all originate from a 
single fertilised egg cell, proliferate, differentiate or undergo apoptosis (programmed cell 
death) to form all the organs and tissues. In an adult organism, however, the great majority of 
cells are quiescent, i.e. non-proliferating. The cells can also increase rapidly in number when 
necessary, for example during wound healing or tissue regeneration. Cellular homeostasis 
depends on the delicate balance between proliferation, differentiation and apoptosis. These 
processes are tightly controlled and defective regulation results in uncontrolled proliferation 
of cells, which can lead to the formation of cancer cells. These cells, which will also be 
referred to as transformed cells, are changed in such a way that they replicate at incorrect 
times and incorrect locations in the body. They seem to appear spontaneously in an organism 
but can also be induced by radiation, carcinogens or viruses that carry transforming genes. In 
order to become transformed they have to escape from the DNA repair mechanism and from 
undergoing apoptosis (Wang and Hsu, 1986; Pardee, 1989; Harrington et al., 1994).
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1.2 Role of growth factors in the regulation of cell proliferation
A central role in the regulation of cell proliferation and differentiation is played by growth 
factors. These are extracellular signalling molecules that can act locally or throughout the 
body by binding to specific receptors on their target cells. Some of them stimulate cell 
proliferation and are therefore called mitogens. Not all cells possess the same growth factor 
receptors and the effect of a growth factor is therefore strongly cell type dependent. This 
provides a fine-tuned activation mechanism by which specific types of cells can be stimulated 
at a specific time and place in the organism.
Some growth factors bind to nuclear receptors, but the majority binds to plasma membrane 
receptors on their target cells. As a result, such receptors become active. In the case of G 
protein-coupled receptors this leads to the subsequent activation of a GTP-binding protein, in 
the case of receptors for cytokines (local mediators for blood-derived cells) to the recruitment 
of cytoplasmic kinases, and in the case of serine/threonine or tyrosine kinase receptors to 
activation of receptor intrinsic kinase activity. G protein-coupled receptors can activate ion 
channels or membrane-bound enzymes such as adenylate cyclase, phospholipase (PL)Cb, and 
cyclic GMP phosphodiesterase. These enzymes can induce various intracellular signal 
transduction pathways, in a cell type dependent manner. Tyrosine kinase receptors are 
autophosphorylated upon growth factor binding. The phosphorylated tyrosines bind several 
substrate molecules including phosphatidylinositol (PI)-3-kinase, PLCg, Shc, and STAT. 
Activation of PI-3-kinase leads to cytoskeletal changes and protection from apoptosis. PLCg, 
similarly as PLCb, cleaves phosphatidylinositol biphosphate (PIP2) into inositol trisphosphate 
and diacylglycerol, of which the latter activates protein kinase C (PKC). Shc binds Grb2 and 
SOS, which is able to activate Ras and a subsequent cascade of serine/threonine kinases: Raf, 
MAPKK, and MAPK (MAP: mitogen-activated protein; K: kinase). This Ras-pathway can 
alternatively be activated by a subclass of G protein-coupled receptors, Gi, by a still unknown 
mechanism, while MAPK can also be activated by PKC. Activation of MAPK leads to the 
subsequent activation of phospholipase A2 (PLA2) and the enhanced transcription of genes 
that are involved in cell proliferation. Tyrosine kinase receptors can also directly activate 
STAT transcription factors, which are involved in the activation of genes leading to the 
induction of cell proliferation. Thus, growth factors activate multiple signal transduction 
pathways that lead to transcriptional activation of specific genes, in combination resulting in 
the induction of cell proliferation.
1.3 Cell cycle
The division of a cell into two genetically identical daughter cells requires a correct DNA 
replication and subsequent segregation of the chromosomes in combination with duplication 
of all cell organelles. The S phase, in which the DNA is duplicated, and the M phase 
(mitosis), in which cells divide, are the two key events in the somatic cell cycle. These phases 
are preceded by two gap phases, which are called G1 and G2 respectively. A schematic 
representation of the cell cycle can be seen in figure 1. During G1, the cells are sensitive to a 
variety of mitogens, growth inhibitors, and differentiation inducers. The presence or absence 
of these factors determines if the cells prepare for S-phase or if  they enter the differentiation 
process, undergo apoptosis, or enter the G0 (quiescent phase). Once they enter the S-phase 
they complete the division cycle, provided that during G2 no errors are found in the duplicated 
DNA. In the case of errors, they undergo apoptosis. The entire process is strictly organised to 
assure the correct arrangement and the accurate completion of each step in the cell cycle. 
Deregulation of the cell cycle is the basis for the formation of tumour cells (Pardee, 1989), 
while cells may undergo apoptosis when they obtain both growth-promoting and growth- 
inhibiting stimuli at the same time, as a result of a so called cell cycle conflict (Day et al.,
1997).
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Figure 1: Schematic representation of the cell cycle.
For explanation see text.
1.4 Cell cycle regulators
The cell cycle machinery is positively controlled by growth factors and negatively by growth- 
inhibiting factors. These factors integrate cell division with environmental and developmental 
stimuli. The sequential assembly of complexes between cyclins and cyclin-dependent kinases 
(cdks) mediates progression of cells through the cell cycle. Different cyclin-cdk complexes 
are active during the various phases of the cell cycle. In short, key regulators of G1 
progression in mammalian cells are the cyclins D 1, D2, and D3, and cyclin E. Cyclin A 
regulates the progression through the S phase, and B-type cyclins that through G2 and M 
phase (reviewed in Sherr, 1994; Karp and Broder, 1995).
Cyclin-cdk complexes are active protein kinases that phosphorylate Ser/Thr-Pro sequences 
in proteins of the cell division machinery and enable the cell to traverse the specific phases of 
the cell cycle. Activation of the cyclin-cdk complex requires phosphorylation of the cdk on a 
specific Thr residue. The G1 cyclin-cdk complexes (cyclin E-cdk2 and cyclin D-cdk4/6) are 
phosphorylated by the cdk-activating kinase (CAK) which is composed of a catalytic subunit 
(cdk7) and cyclin H. The cyclin-cdk complex can additionally contain the proliferating cell 
nuclear antigen (PCNA), which is a subunit of DNA polymerase d and is involved in both 
DNA replication and repair, as well as proteins of the family of cdk inhibitors (CKIs). The 
formation and activation of a cyclin-cdk complex is regulated by oscillations in expression or 
activity of the cyclins and the cdks during cell cycle. Cyclin-cdk complexes can be 
inactivated in several ways. First, cyclin levels can be reduced by turning down their 
transcription or by degradation of the protein. Secondly, the cdk can be inactivated by the 
dephosphorylation of the activating Thr residue, or the phosphorylation on an inactivating Tyr 
residue. Thirdly, the complex can be inhibited by binding to CKIs (section 1.5.2), that bind 
and inactivate the cyclin-cdk complex (reviewed in Peter and Herskowitz, 1994; Sherr, 1994).
1.5 G1 phase regulation
1.5.1 Cyclin-cdk complexes
Mitogenic growth factors promote G0 to G1 transition and G1 phase cell cycle progression by 
increasing the levels of D-type cyclins, cdk4, cdk6 , the CKI p21Cip1, the transcription factor 
E2F-1, and PCNA. The appearing cyclin D-cdk4/6 kinase complexes bind p27kip1, thereby 
decreasing the levels of free p27kip1 and inhibiting cyclin D-cdk activity. Therefore, during 
early G1 no active cyclin D-cdk complexes exist since they just appear when all p27kip1 is 
bound. The cyclin D-cdk complex also contains PCNA and p21Cip1. The stoichiometry of 
p2 1 Cip1 in the cyclin-cdk complex determines whether it acts as an inhibitor or not: complexes 
containing one p21Cip1 are catalytically active while complexes containing multiple p2 1 Cip1 
molecules are inactive. The expression of cyclin E increases during G1 and maximal levels of
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cyclin E-dependent kinase complexes, containing cdk2, p21Cip1 and PCNA, are present at the 
G1-S transition. An important substrate for G1 cdks is the retinoblastoma protein pRb, as well 
as the pRb-related proteins p130 and p107. During early G1 pRb is hypophosphorylated and 
as a consequence it binds to and negatively regulates the activity of transcription factors such 
as E2F. The active G1 cdk complexes phosphorylate and thereby inactivate pRb. The D-type 
cyclins also abrogate the growth-inhibiting activity of pRb directly by preventing E2F 
binding. The phosphorylation of pRb during middle to late G 1 phase results in the release of 
E2F, thereby enabling this factor to activate genes required during S phase such as c-myc and 
cyclin A. Once cells enter S phase, cyclin E is degraded, and cdk2 forms complexes with 
cyclin A, which is synthesised near the G1-S boundary (reviewed in Peeper et al., 1994; Peter 
and Herskowitz, 1994; Sherr, 1994). The major G 1 phase regulatory mechanisms are 
summarised in figure 2 .
1.5.2 Cyclin-dependent kinase inhibitors
As mentioned above, the cyclin-cdk activity is regulated by CKIs. Several growth inhibitors 
have been shown to exert their activity by inducing or activating CKIs. Up to now 2 families 
of mammalian CKIs have been identified.
The first family includes p15INK4B, p16INK4A, p18INK4C, and p19INK4D These proteins are 
only able to bind the cyclin D-cdk4/6 complex. It has been shown that p16 specifically binds 
to cdk4 and thereby blocks the formation of cyclin D-cdk4 complexes. In contrast, p15 
displaces p27kip1 from cyclin D-cdk complexes, thus making the liberated p27kip1 available to 
bind to and to inhibit cyclin E-cdk2 complexes. In addition, p15 competes with the D-type 
cyclins for the binding to cdk4 and cdk6 , thereby inhibiting the cyclin-cdk activity. The 
expression of p15 is increased by the growth-inhibiting factor transforming growth factor 
(TGF) ß (reviewed in Peter and Herskowitz, 1994; Sherr, 1994; Karp and Broder, 1995).
The second family includes p2 1 cip1/waf1/sdi1/cap1 and its murine counterpart p20cap20, as well 
as p27kip1, p28ICK, and p57kip2, which are proteins that can inhibit a broad range of cyclin-cdk 
complexes such as cyclin E-cdk2, cyclin A-cdk2, and cyclin D-cdk4/6. The p21Cip1 protein 
binds to cyclin D-cdk4 and cyclin E-cdk2 complexes during G1 phase. As mentioned 
previously, the stoichiometry of p2 1 Cip1 in the cyclin-cdk complex determines whether it acts 
as an inhibitor or not: complexes containing one p2 1 Cip1 are catalytically active while 
complexes containing multiple p21Cip1 molecules are inactive. In addition, it inhibits DNA 
replication directly by binding to PCNA. Its activity is regulated by transcriptional activation. 
One of the factors that increase p21Cip1 transcription is p53, whose expression increases after 
DNA damage induced for example by ionising radiation. Another transcription factor that 
increases p21Cip1 transcription is the interferon regulatory factor-1 (IRF-1). TGFß induces 
growth inhibition by increasing IRF-1, and as a result p21Cip1 transcription (Miyazaki et al., 
1998). Interestingly, in cells on which TGFß has growth-stimulating activity, p21Cip1 
transcription is decreased as a result of decreased p53 and IRF-1 expression (Miyazaki et al.,
1998). Another member of this CKI family is p27kip1, a factor that inhibits cyclin D-cdk4 and 
cyclin E-cdk2 complexes. Its activity is neither regulated by an increase of transcription, nor 
by an increase of protein synthesis. TGFß inhibits the cdk4 synthesis and thereby reduces the 
cyclin D-cdk4 levels. This results into the release of p27kip1 from the cyclin D-cdk4 complex, 
leading to an increase of the net p27kip1 level and subsequently a decrease of cyclin E-cdk2 
activity. Furthermore, cAMP decreases its turnover while cell-cell contact, rapamicin, and 
lovostatin increase p27kip1 levels via a still unknown mechanism (reviewed in Peter and 
Herskowitz, 1994; Sherr, 1994; Karp and Broder, 1995).
CKIs also play a role in differentiation of cells, a process in which cells withdraw from the 
cell cycle to carry out their specialised function. The accompanying G1 arrest is often caused 
by inactivation of the cyclin D-cdk4 complex as a result of the degradation of cdk4, down-
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regulation of cyclin D expression or inactivation of the complex by p21Cip1. As an additional 
block to S phase entry, expression of cdk2 is down-regulated in some cells. The presence of 
cyclins and cdks in differentiated cells suggests that these proteins may have other, tissue- 
specific functions or are involved in general processes such as cell metabolism. It has also 
been suggested that they are present because they are part of the apoptotic apparatus, which 
may have to be activated at a later stage of development (reviewed by Gao and Zelenka,
1997).
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Figure 2: Regulation of G1 progression.
Addition o f growth factors to G 0 cells induces D-type cyclins, cdk4/6, p21Cip1, E2F, and PCNA, resulting in a 
decrease of p27kip1 levels. pRb is in itially present in the hypophosphorylated form  which binds and inhibits E2F. 
The cyclin D-cdk4/6 com plex binds p27 ip1. Once all free p27 ip1 is bound, the cyclin D-cdk4/6 com plex can 
become phosphorylated and thereby activated, leading to phosphorylation o f pRb and the release o f E2F which 
increases the transcription o f genes required for G 1-S transition. Cyclin A  is first synthesised near the G 1-S 
boundary and accum ulates in com plexes with cdk2 as cyclin E undergoes degradation in S phase. Several factors 
(TGFp, cAMP, and ionising radiation) increase OKI levels (p15, p21Cip1, p27kip1) and as a result induce G 1 arrest.
2 Cell transformation_________________________________________________
2.1 Differences between normal cells and transformed cells
Transformed cells differ in many important characteristics from normal cells. They have 
tumourigenic properties in vivo, but also an indefinite lifespan, a reduced ability to 
differentiate, and a reduced requirement of externally added polypeptide growth factors for 
proliferation. Furthermore, they are able to proliferate under anchorage-independent 
conditions, and have lost density-dependent growth control. The combination of these 
alterations is essential for the fully transformed character of tumour cells (reviewed by Van 
Zoelen, 1991). These various phenotypic characteristics of tumour cells will now be discussed 
in more detail.
• Indefinite lifespan:
The immortalisation of cells is an essential step in oncogenesis. Normal human fibroblasts 
have a limited replicative life span after which they undergo senescence or apoptosis. 
Senescence is the stage of replicative incompetence which is characterised by the repression 
of proliferation-promoting genes such as c-fos, cdc2, and cyclin A, the activation of tumour
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suppressor genes such as pRb and p53, the activation of anti-death genes which prevent cells 
from undergoing apoptosis such as bcl2, and the loss of telomeric DNA (for reviews see 
Wang et al., 1994; Goldstein, 1990). Apoptosis is an essential process in normal maturation of 
an organism but is also activated in the case of DNA damage. Several proto-oncogenes, 
including c-myc, c-fos, c-jun, and bcl-2, and the tumour suppressor genes p53 and pRb are 
involved in the regulation of this process (Harrington et al., 1994; Wang et al., 1994). It has 
been known for a long time that various carcinogens, radiation, the DNA tumour virus 
proteins large T, E1A and E6/7, and oncogenes can immortalise normal cells (Land et al., 
1983; Shay et al., 1991). These immortalising agents influence cellular mechanisms involved 
in the induction of apoptosis and senescence: they induce loss of p53 and pRb activity, the 
activation of anti-apoptotic signal transduction pathways like bcl-2 , and genomic stability 
(Shay et al., 1991; Harrington et al., 1994).
• Reduced ability to differentiate:
Another phenotypic characteristic of transformed cells is the blocking of the differentiation of 
cells. The observation that the v-erbA oncogene encodes a truncated thyroid hormone 
receptor that acts as a differentiation inhibitor for erythroleukemic cells (Damm et al., 1989) 
shows that this is an important aspect of the transformation process. The block in 
differentiation prevents the cells from undergoing terminal differentiation and allows 
continued proliferation of a cell that eventually may acquire additional mutations (Hunter, 
1991). The reduced ability of transformed cells to differentiate can also be considered as an 
imbalance between the probability to enter cellular proliferation and the differentiation 
pathways. Due to the high proliferative activity of transformed cells resulting from autocrine 
growth factor production or oncogene expression, the probability of these cells to enter the 
differentiation pathway may be strongly reduced (Van Zoelen, 1991). Many tumour cells can 
be considered as being blocked in their differentiation.
• Reduced requirement o f  externally added polypeptide growth factors for proliferation:
In addition to ions, amino acids, vitamins, sugars, and in some cases attachment factors such 
as fibronectin, laminin, and collagens, normal cells need the presence of (polypeptide) growth 
factors such as epidermal growth factor (EGF) and platelet-derived growth factor (PDGF) for 
proliferation (Van Zoelen, 1991). Besides their growth-stimulating activity, these factors 
prevent cells from undergoing apoptosis. Tumour cells and chemically or virally-transformed 
cells generally proliferate in the absence of externally added polypeptide growth factors, 
because they are able to secrete growth factors themselves leading to autocrine stimulation of 
the cells (Moses et al., 1981; Kaplan and Ozanne, 1982; Yamakawa et al., 1982; Owen et al., 
1984; Van Zoelen et al., 1987; Hicks et al., 1998). In addition, some tumour cells proceed 
through the G1-S transition in the absence of externally added or secreted growth-stimulating 
factors. This is supposed to result from the activation of proto-oncogenes that provide 
constitutive intracellular growth-promoting signals, or by the inactivation of tumour- 
suppressor genes resulting in loss of responsiveness to growth-inhibiting factors (reviewed by 
Peeper et al., 1994).
• Loss o f  density-dependent growth control:
Non-transformed cells divide until a critical cell density is reached. Therefore, in adult tissues 
most of the cells are assumed to be in a quiescent state as a result of intense cellular contact 
(Van Zoelen, 1991). In vitro, this phenomenon is called density-dependent growth inhibition 
(DDGI). The ability to undergo DDGI is one of the most important differences between the 
growth characteristics of transformed and non-transformed cells in vitro. In order to be able to 
proliferate in vivo, a transformed cell must be able to overcome this growth inhibition. The 
mechanisms described to explain this phenomenon will be discussed in section 3.
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• Ability to proliferate under anchorage-independent conditions:
The majority of deaths from cancer are not due to primary tumours but to secondary tumours 
that arise through metastasis. Therefore, the ability of tumour cells to metastasise lies very 
much at the core of the cancer problem. In order to metastasise, tumour cells first need to get 
released from their neighbour cells, i.e. they need to be able to proliferate in an inappropriate 
environment without cell-cell contact. Non-tumourigenic cells obtained from solid tissues 
need adhesion to a substrate surface in order to proliferate. This phenotype is called 
anchorage dependence. The ability of tumour cells to metastasise is reflected in vitro by 
anchorage-independent growth (AIG). This is the ability of cells to proliferate in the absence 
of adhesion to extracellular matrix proteins. AIG is considered to be one of the best in vitro 
correlates of in vivo tumourigenicity, i.e. the ability of transformed cells to induce tumours in 
nude mice (Shin et al., 1975; Cifone and Fidler, 1980; Schwartz, 1997). The molecular 
mechanisms involved in AIG will be described in section 4.
2.2 Phenotypic transformation
In addition to tumour cells, also certain non-transformed cells can be induced to proliferate 
under anchorage-independent conditions or to undergo loss of DDGI by the addition of 
specific combinations of growth factors (Anzano et al., 1982; Van Zoelen et al., 1988). This 
reversible process is referred to as phenotypic transformation. The investigation of the 
molecules and mechanisms that underlie this process could elucidate the mechanisms 
involved in malignant transformation. Furthermore, phenotypic transformation itself could 
possibly be an important determinant in tumour outgrowth, because polypeptide growth 
factors secreted by transformed cells may also induce proliferation of the surrounding normal 
cells (Van Zoelen et al., 1988). In this thesis these two aspects of phenotypic transformation, 
i.e. the ability of the cells to proliferate under anchorage-independent conditions and the loss 
of DDGI, are extensively described.
3 Mechanisms involved in density-dependent growth inhibition____________
3.1 Introduction
3.1.1 General
As stated before, one of the main differences between the growth characteristics of normal 
versus tumour cells is their density-dependent inhibition of growth. Above a critical cell 
density, cells stop proliferating in spite of the presence of abundant polypeptide growth 
factors. Immediate early genes (c-myc, c-fos, and c-jun) are induced normally by mitogens in 
these dense cultures (Afrakhte et al., 1998), nevertheless the cells are not induced to 
proliferate. Transformed cells, however, are able to proliferate independently of cell density, 
even under confluent conditions. It is very important for cancer research to understand the 
molecular mechanisms involved in the process of DDGI since these mechanisms may play a 
crucial role in the tumourigenic outgrowth of transformed cells (Van Zoelen, 1991).
Several molecular mechanisms have been proposed to explain why normal cells stop 
proliferating above a critical cell density (reviewed by Van Zoelen, 1991). Most likely DDGI 
is controlled by a combination of these processes, in which, depending on the cell type 
studied, certain mechanisms may play a more important role than others. It should be realised 
that the fact that a parameter is regulated by cell density does not automatically mean that this 
parameter is directly involved in the regulation of DDGI. Therefore, a clear distinction should 
be made between parameters that are only regulated by cell density and parameters that 
control DDGI.
13
Chapter 1
3.1.2 Is the induction of DDGI an active or a passive process?
Although growth factor depletion in the medium can result in growth arrest, there is sufficient 
evidence that also in the presence of growth factors cells stop proliferating as soon as a 
critical cell density is reached (reviewed by Lieberman and Glaser, 1981). In addition, it has 
been suggested that DDGI is simply the result of the smaller cell surface area that is exposed 
to the medium in confluent cells when compared to sparse cells, resulting in a restricted 
access of mitogens to the cell surface. The lack of EGF receptor activation in confluent 
human breast epithelial cells, which is supposed to be mediated by prevention of EGF 
receptor activation by extensive cell-cell adhesion (Takahashi and Suzuki, 1996, see above) is 
an example of this mechanism. There are however many reports that exclude this possibility 
(reviewed by Lieberman and Glaser, 1981). From this it can be concluded that in most cases 
the induction of DDGI is an active process.
3.1.3 Mechanisms
The molecular mechanisms that have been proposed to explain why normal cells stop 
proliferating above a critical cell density can be classified into several groups of related 
mechanisms. First we describe (section 3.2) several growth-inhibiting factors which are 
produced at high cell density, including soluble and membrane-bound factors. In section 3.3 
the role of several second messengers is described, including the density of polypeptide 
growth factor receptors, the modulation of the membrane potential, the protein tyrosine 
phosphatase activity, the levels of cyclins and cyclin-dependent kinase inhibitors, and the 
modulation of Na+/H+ antiporter activity and intracellular pH. Next, in section 3.4 the role of 
cell-cell contact and communication via gap junctions, extracellular matrix proteins and their 
receptors, and cell adhesion molecules is described. Finally, some mechanisms which have 
only be postulated for an individual cell line are described in section 3.5. They range from 
cell shape, guanosine triphosphatase-activating protein-like activity, the activity of stress- 
activated protein kinases, cell surface PI-PLC activity, protein disulphide isomerase activity, 
redox state, and DT-diaphorase activity to lipoprotein lipase activity.
3.2 Growth-inhibiting factors
3.2.1 Production of soluble growth inhibitors
Several studies suggest that autocrine growth inhibiting molecules are secreted in the medium 
of dense cultures which overcome stimulatory effects of growth factors and inhibit cell 
proliferation. Various growth-inhibiting factors have been characterised, but only a few are 
secreted specifically by confluent monolayers of non-transformed cells (for reviews see 
Lieberman and Glaser, 1981; Wang and Hsu, 1986).
The first factor characterised in this way is TGFß (Holley et al., 1978), which is a negative 
growth regulator for most cell types, but has growth-stimulating activity for others (reviewed 
by Barnard et al., 1990). However, in studies with BSC-1 cells in which it was initially 
identified as an autocrine growth inhibitor (Holley et al., 1978), acidic conditions were used 
for isolation, a process which is known to activate latent TGFßs artificially, making the 
physiological relevance of this observation questionably (Van Zoelen, 1991). Moreover, 
TGFß is not expected to play a central role in the induction of DDGI in general, because it is 
a ubiquitous protein and has, depending on the cell type studied, growth-inhibiting or 
stimulating activity (Van Zoelen, 1991).
Another factor with autocrine growth-inhibiting activity is secreted fibroblast growth 
regulator (FGR-s) which is secreted by density-inhibited 3T3 cells. The addition of an 
antibody to FGR-s in density-inhibited cultures of these cells leads to increased DNA 
synthesis (Wang and Hsu, 1986). FGR-s was later shown to be related to a mammary-derived 
growth inhibitor (MDGI) belonging to the family of fatty acid binding proteins (Böhmer et
14
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al., 1987).
Mouse 3T3 cells secrete a 45-kDa inhibiting diffusible factor (IDF45, later shown to be 
identical to mouse insulin-like growth factor binding protein-3 (mIGFBP-3)) which is able to 
inhibit stimulation of DNA synthesis induced by serum in chick embryo fibroblasts (Blat et 
al., 1989). Mouse embryo fibroblasts (MEF) secrete IGFBP-3 and the concentration in the 
medium increases with increasing cell density (Blat et al., 1994). It is a bifunctional molecule 
and its inhibiting function appears independent of its known function of binding IGFs. 
Antibodies against IGFBP-3 abolish the inhibition of MEF cell proliferation by medium 
conditioned by cells at high density (Blat et al., 1994). These results show that IGFBP-3 is 
involved in DDGI of these cells but no information is presently available on its mode of 
action. Another member of this family, IGFBP-6 , is also exclusively synthesised at high cell 
density and is growth inhibiting for keratinocytes (Kato et al., 1995) and neuroblastoma cells 
(Babajko et al., 1997). However, in neuroblastoma cells IGFBP-6  is only induced in the 
presence of IGF-I or IGF-II (Babajko et al., 1997), showing that this is not a general 
mechanism.
Murine b-galactosidase binding protein (mGBP), secreted by MEF under serum-free 
conditions, has also growth-inhibiting properties but there seems no correlation between 
mGBP secretion and cell density (Wells and Mallucci, 1991).
3.2.2 Production of membrane-bound growth inhibitors
It has been postulated that the presence of specific cell surface glycoproteins at confluence 
may regulate DDGI (Wieser et al., 1985; 1990; Wieser and Oesch, 1986). The proliferation of 
sparsely seeded human embryonic lung fibroblasts, is inhibited by immobilised plasma 
membrane glycoproteins of density-arrested cultures of the same cells, called contact-inhibins 
(Wieser and Oesch, 1986). The protein responsible for this inhibition is a 60 to 70 kDa 
integral membrane glycoprotein (Wieser and Oesch, 1986) that binds to a 92 kDa plasma 
membrane protein considered to be the contact-inhibin receptor (Gradl et al., 1995). Although 
it is still unclear how activation of this receptor leads to growth inhibition and why 
transformed cells are not inhibited, the widespread expression of contact-inhibin suggests an 
important role in DDGI (Wieser et al., 1990).
3.3 Density-dependent control of intracellular second messengers
3.3.1 Decrease of density of polypeptide growth factor receptors
Another possible mechanism in the control of cellular proliferation of cells at high density is 
the expression regulation of growth factor receptors. It has been shown in a number of both 
normal and malignant cell lines that the density of polypeptide growth factor receptors per 
cell decreases with increasing cell density. This has been demonstrated for EGF, TGFb, 
PDGF, and FGF receptors (Holley et al., 1977; Rizzino et al., 1988; 1990; Veomett et al., 
1989; Hamburger et al., 1991). In addition, in the in situ situation most cells are quiescent and 
have low polypeptide growth factor receptor numbers. It can be imagined that when receptor 
levels drop below a level that is needed to induce sufficiently high levels of second 
messengers in the cell, this could lead to insensitivity to growth factor action and thus to 
DDGI. This suggests that, as a result of the decrease of receptor levels, the cells become 
unresponsive to the action of specific polypeptide growth factors as soon as a critical cell 
density has been reached. Although the mechanism by which this decrease is regulated is not 
well understood, it might play an important role in the regulation of DDGI. Thus not only the 
concentration of specific growth factors, but also the level of growth factor receptors 
determines if a cell will divide or not.
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3.3.2 Modulation of the membrane potential
Another mechanism suggested to be involved in the regulation of DDGI is the modulation of 
the membrane potential (Binggeli and Weinstein, 1986). The membrane potential is 
determined by the concentration gradient for different ions across the plasma membrane on 
one hand, and the permeability for these ions on the other hand. This permeability depends on 
the activation state (open or closed) of the various ion channels. How this is regulated by cell 
density requires further investigation. The plasma membrane potential of eucaryotic cells 
normally ranges from -10 to -90 mV. There is a strong correlation between membrane 
potential and growth status of the cell: Quiescent, non-transformed cells have a membrane 
potential ranging from approximately -40 to -90 mV, whereas proliferating and tumour cells 
have a more depolarised membrane potential. Stimulation of cell proliferation by growth 
factors is often accompanied by a transient membrane depolarisation. However, a reduction of 
membrane potential seems no absolutely necessity for growth since not all growth-stimulating 
factors induce depolarisation (Binggeli and Weinstein, 1986).
3.3.3 Protein tyrosine phosphatases
Protein phosphorylation plays an important role in many cellular processes, including the 
signal transduction pathways leading to cell proliferation. Most of these processes are 
reversibly controlled by phosphorylation and therefore require not only an protein kinases but 
also protein phosphatases (Hunter, 1995). Several observations suggest a role for protein- 
tyrosine phosphatases (PTPases) in DDGI. First, in Swiss 3T3, BALB/c 3T3 and normal 
human diploid fibroblasts, PTPase activity is strongly increased in monolayer cells at high 
cell density (Pallen and Tong, 1991). This suggests that a regulatory mechanism controlling 
PTPase activity may play a role in cell proliferation and growth arrest caused by cell contact. 
Furthermore, the inhibition of PTPase activity by vanadate prevents the induction of DDGI by 
several mitogens in normal rat kidney (NRK) fibroblasts (Rijksen et al., 1993a; 1993b). 
However, depending on the concentration of the mitogen, vanadate can also have an 
inhibiting activity on loss of DDGI. This suggests that several different PTPases are involved 
in density-dependent growth control, some of which are positive and some are negative 
regulators (Rijksen et al., 1993b). Another indication that several different PTPases are 
involved in the regulation of DDGI comes from rat hepatoma cells. In these cells the activity 
of the PTPases PTP1B and LAR is reduced at high cell density, while the SH2-containing 
PTPase activity was found to be increased (Li and Goldstein, 1996). However, PTPase 
activity is also strongly increased in monolayer cells at high cell density in the tumour cell 
line A431 (Mansbridge et al., 1992). As tumour cells do not undergo DDGI, this would 
suggest that this increase is only density-dependently regulated and not causal to DDGI.
3.3.4 Cyclins and cyclin-dependent kinase inhibitors (CKIs)
During contact inhibition of several cell lines including bovine aortic endothelial cells 
(Yoshizumi et al., 1995) and BALB/c-3T3 cells (Yanagisawa et al., 1999) the cyclin A gene 
is downregulated, despite the presence of growth factors. This downregulation results from 
the absence of an active ATF-1-consisting transcription factor complex that activates the 
cyclin A promoter (Yoshizumi et al., 1995). In Mv1Lu mink epithelial cells density-arrest is 
accompanied by the absence of active cyclin E-cdk2 complexes as a result of the presence of 
p27kip1 which binds to and inactivates the kinase complex. The p27kip1 protein is also present 
in proliferating cells, although under these conditions it is sequestered, most likely by cyclin 
D2-cdk4 complexes (Polyak et al., 1994). Furthermore, in these cells density-arrest leads to 
the decreased expression of cyclin D2, cyclin B1 and cdk4 (Wu et al., 1996). Also in density- 
arrested Rat-1 cells cyclin E-cdk2 is inactive because it is part of a 250 kDa complex that 
contains p27kip1 (Steiner et al., 1995). In contact-inhibited 3Y1 rat fibroblasts cyclin D-cdk4 is
16
General introduction
inactive, probably as a consequence of p27kip1 binding (Kato et al., 1997). Cyclin D1 activity 
can also be diminished as a result of a decreased gene expression, as shown in BALB/c-3T3 
cells (Yanagisawa et al., 1999). Recently, it has been shown that DDGI can also result from 
activation of p15 (Yanagisawa et al., 1999) and p16 (Wieser et al., 1999; Yanagisawa et al.,
1999), the latter by inducing inactivation (dissociation) of the cyclin D1-cdk4 complex 
(Wieser et al., 1999). In contrast, p21Cip1 levels are decreased during contact inhibition of 
BALB/c-3T3 cells (Yanagisawa et al., 1999). This decrease of cyclin-cdk activity in dense 
cell cultures, caused by the increase of CKIs or the reduction of cdc25A expression (Afrakhte 
et al., 1998), prevents phosphorylation of pRb and leads to growth arrest. It is disputable if 
these changes in cyclin and CKI activities are causal for the induction of DDGI or are just a 
part of the process of DDGI.
3.3.5 Modulation of Na+/H+ antiporter activity and intracellular pH
The activation of a Na+/H+ antiporter and the resulting rise in intracellular pH (pHi) has been 
shown to play an important role in the induction of cell proliferation by a great number of 
growth factors. The activity of the Na+/H+ antiporter is pHi-dependent. Growth factors 
activate the Na+/H+ exchanger activity, possibly via a PKC dependent mechanism, and 
increase the maximum pHi at which the antiporter can be active, resulting in an increase of 
pHi (reviewed by Moolenaar, 1986). The Na+/H+ antiporter activity (Pouyssegur et al., 1984) 
and pHi (Busa and Nuccitelli, 1984) play a critical role in the control of cell proliferation: a 
reduced pHi inhibits DNA and protein synthesis and cell metabolism. In NRK fibroblasts a 
decrease in pHi is accompanied by a decrease in intercellular communication (Van Zoelen 
and Tertoolen, 1991), suggesting a link between pHi and GJIC. A role for pHi in density- 
arrest has been suggested by the results of Galkina et al. (1992), who showed that in primary 
mouse fibroblasts pHi decreases with increasing cell density. Furthermore, they showed that 
the pHi depends on the number of interactions mediated by integrins, which mediate cell-cell 
and cell-substrate interactions by binding to extracellular matrix proteins. However, in human 
MRC5 fibroblasts pHi is regulated in an opposite manner, being lower in proliferating cells in 
low density than in confluent cultures (Siczkowski and Ng, 1995). Other reports show that 
Na+/H+ antiporter activation is not sufficient to trigger the growth of mammalian cells, and 
has no permissive role on mammalian cell proliferation in general (for review see Grinstein et 
al., 1989). This demonstrates that the importance of this mechanism in the regulation of 
DDGI depends on the cell type of investigation.
3.4 Cell-cell contact and communication
3.4.1 The increase of intercellular communication through gap junctions
Cells in organs and tissues are connected by intercellular channels called gap junctions (GJ). 
GJ are composed of two connexons; one contributed from each communicating cell. Each 
connexon is an assembly of six transmembrane proteins called connexins (Cxs), of which 
many different types exist (Kumar and Gilula, 1996). GJ are permeable junctions that provide 
a way for the exchange of hydrophilic signalling molecules including ions, second 
messengers and other small molecules. Gap juctional intercellular communication (GJIC) is 
strongly decreased in most transformed cells (reviewed in Loewenstein, 1979; Binggeli and 
Weinstein, 1986; Holder et al., 1993). Furthermore, induction of GJIC between normal and 
transformed cells induces growth inhibition of the transformed cells (Mehta et al., 1986). 
Besides, several tumour promoters inhibit GJIC while several inhibitors of carcinogenesis 
were shown to increase GJIC (Budunova and Slaga, 1994). This shows that the increase of 
intercellular communication via GJ could be the cause of the block in cell proliferation at 
high cell density.
Several possible mechanisms have been proposed to describe how this increase of
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intercellular communication could inhibit cell proliferation. The first model suggests that the 
increase in communication enables the diffusion of a growth-inhibiting signal to other cells, 
thus preventing cell division in all coupled cells. In another model, growth-stimulating factors 
may diffuse through all coupled cells. As the number of cells in the system grows, the signals 
dilute into the enlarging cell volume and their concentration eventually falls below the critical 
level for stimulation of cell division (Loewenstein, 1979).
There are many regulators of GJIC (for reviews see Holder et al., 1993; Budunova and 
Slaga, 1994), acting at different levels such as the transcription level of the Cxs, the insertion 
or withdrawal in or out the plasma membrane, and the gating. Of special interest in this 
respect is the observation that components of the extracellular matrix and cell-cell adhesion 
molecules such as cadherins alter Cx gene expression and Cx assembly (described in section
3.4.2 and 3.4.3). The gating is inhibited by growth factors like EGF, PDGF, which bind to 
tyrosine kinase receptors, and lysophosphatidic acid (LPA), which binds to a G-protein 
coupled receptor, as well as factors that induce pHi decrease, PKC activation, and protein 
kinase A activation (Maldonado et al., 1988; Budunova and Slaga, 1994; Moolenaar, 1995a). 
Addition of these factors affects GJIC within seconds, mainly via phosphorylation of the 
various Cxs (reviewed by Budunova and Slaga, 1994).
3.4.2 Induction of extracellular matrix proteins and their receptors
The levels of extracellular matrix (ECM) proteins such as fibronectin, collagen and laminin 
are often decreased in transformed cells (Yamada, 1983; Holder et al., 1993). The receptors 
for ECM proteins are integrins. These transmembrane proteins are primarily responsible for 
the adhesion to proteins of the ECM or to the surface of other cells. The levels of specific 
types of integrins are significantly lower in transformed cells than on normal cells 
(Plantefaber and Hynes, 1989; Fornaro et al., 1999). One of them, b1c integrin, inhibits cell 
proliferation by increasing p27kip1 expression (Fornaro et al., 1999). Integrins also influence 
pHi (see section 3.3.5): the density-dependent increase of integrin levels leads to a decrease of 
pHi that inhibits cell proliferation. Additionally, components of the ECM can regulate GJIC 
(for reviews see Holder et al., 1993; Budunova and Slaga, 1994). Addition of heparins or 
proteoglycans, both present in the extracellular matrix, increases Cx32 expression, Cx 
assembly, and GJIC (reviewed in Budunova and Slaga, 1994). This suggests that ECM 
proteins may play a role in the regulation of DDGI, by inducing GJIC and p27kip1 and 
decrease pHi at high cell density, leading to growth inhibition.
3.4.3 Increase of cell adhesion molecules
Cell adhesion molecules (such as neural (N)-CAM and cadherins) are responsible for cell-cell 
recognition, the initial establishment of the contact between two cells, for the stabilisation of 
primary gap junctional contact spots and for the establishment of selective GJIC between cells 
(reviewed in Holder et al., 1993; Budunova and Slaga, 1994). This suggests that they may 
play an important role in DDGI. In the mouse fibroblast cell line m5S/1M, a cell surface 
glycoprotein has been reported to be expressed only on non-transformed m5S/1M cells. The 
major component of the 140 kDa glycoprotein was identified as N-CAM. The finding that 
immobilised antibodies against N-CAM (mimicking high cell density) strongly inhibit the 
proliferation of subconfluent cells and that antibodies in a soluble form (mimicking low cell 
density) have a growth-stimulating effect on confluent quiescent cultures (Aoki et al., 1991), 
indicates that N-CAM may play an important role in the regulation of DDGI in m5S/1M cells.
Cell adhesion molecules can influence cell proliferation through the regulation of GJIC by 
altering Cx gene expression, thereby influencing Cx assembly. The important role of cell-cell 
interactions in the induction of GJIC is emphasised by the fact that transformed cells and 
surrounding normal cells frequently express the same or a compatible type of Cxs, but do not
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communicate, probably as a consequence of a defective cell-cell recognition by cadherins 
(Budunova and Slaga, 1994).
Furthermore, cell adhesion molecules also influence cell proliferation by regulating growth 
factor receptor accessibility. This plays a role in e.g. human breast epithelial cells where EGF 
induces EGF receptor activation and cell proliferation in cells at low density but not in 
confluent cells (Takahashi and Suzuki, 1996). This lack of growth response is not due to a 
reduction in the number or affinity of the EGF-binding sites. Because expression of the cell 
adhesion molecule E-cadherin is strongly increased in cells at high density and addition of 
antibodies to E-cadherin to confluent cells prior to stimulation with EGF leads to EGF- 
induced cell proliferation, this suggests that in human breast epithelial cells DDGI is achieved 
through prevention of the EGF receptor activation by extensive cell-cell adhesion, mediated 
by excess E-cadherin (Takahashi and Suzuki, 1996). The precise mechanism by which the 
EGF receptor is prevented from being activated by E-cadherin remains to be shown.
The cell-cell contact induced by cell adhesion molecules could furthermore enable 
juxtacrine signalling receptors and membrane-anchored ligands to establish intercellular 
connections (for review see Fagotto and Gumbiner, 1996). Besides their role in the 
establishment of cell-cell contacts, cell adhesion molecules can also participate directly in 
signal transduction. Since they do not possess cytoplasmic sequences with enzymatic or other 
known signal transducing activities, unravelling their putative signalling mechanisms is very 
difficult. This is even more complicated by the fact that cell-cell adhesion also induces 
contact between other signalling proteins. However, in neuronal cells cell adhesion molecules 
act not only as adhesion substrate, but also as cell-surface receptors and as activators of other 
cells, the latter possibly by binding to the FGF (fibroblast growth factor) receptor. In addition, 
several cytoplasmic proteins associated with cell adhesion molecules have been found to 
possess signalling activity (reviewed in Fagotto and Gumbiner, 1996). Each of these 
signalling mechanisms could be responsible for DDGI.
3.5 Additional mechanisms induced in individual cell lines
3.5.1 Changes in cell shape
It has been suggested that changes in cell shape, i.e. increased cell height, induce growth 
inhibition at high cell density (Folkman and Moscona, 1978). However, several arguments 
have been raised against this explanation (reviewed in Lieberman and Glaser, 1981), strongly 
arguing that cell shape does not directly control cell proliferation.
3.5.2 Increased guanosine triphosphatase-activating protein (GAP)-like activity
In confluent NIH 3T3 cells, guanosine triphosphatase-activating protein (GAP)-like activity is 
about four times higher than in cells at low density (Zhang et al., 1992). GAP accelerates the 
intrinsic GTPase activity of Ras, thereby regulating the activity of Ras in a negative manner. 
Since high activity of Ras results in cell transformation of NIH 3T3 cells and can overcome 
DDGI (Zhang et al., 1992), it is likely that the increased GAP-activity in confluent cells is 
relevant to the process of DDGI.
3.5.3 Decrease of stress-activated protein kinases (SAPK)
In mouse fibroblasts the increase of cell density leads to the inhibition of the JNK/SAPK 
pathway resulting in the inactivation of c-Jun, while the MAPK pathway is not influenced.
The inhibition occurs at the same level as or upstream of the small G-proteins cdc42 and 
Rac1. The exact nature of the signal that inactivates this pathway is not known yet. However, 
for its induction the integrity of the intercellular actin microfilament network is essential. This 
mechanism restricts c-Jun activation and mitogenesis in response to mitogenic agents to cells 
that have a disrupted actin microfilament network, for example to cells that border a wounded
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3.5.4 Increase of cell surface PI-PLC
The cell surface PI-specific PLC (csPI-PLC) activity is increased in Swiss 3T3 cells both at 
high cell density (Volwerk et al., 1992) and under serum-deprived conditions (Ting and 
Pagano, 1991). Furthermore, the csPI-PLC activity is only measurable in cell lines that 
undergo growth inhibition at confluence and not in cell lines that are tumourigenic and/or 
cells that do not exhibit growth inhibition in a density-dependent manner. These results 
indicate that the increased activity of csPI-PLC may play a role in DDGI. This implies that 
the resulting increase of DAG and inositol phosphates should regulate cell proliferation in a 
negative manner. However, there is no DAG-induced increase in PKC activity in confluent 
cultures (Ting and Pagano, 1991). In addition, the inositol phosphates generated are released 
to the surrounding medium, while up to now no cell surface inositol phosphate receptor has 
been identified (Hay, 1995). This suggests that the only way by which csPI-PLC could induce 
growth inhibition at cell confluence is via a still unknown cell surface inositol phosphate 
receptor or via a DAG metabolite such as arachidonic acid or the subsequently derived 
eicosanoids (Smith, 1989).
3.5.5 Increase of protein disulphide isomerase (PDI) activity
In normal human foreskin fibroblasts (GM 0868) PDI activity increases as cells become 
confluence and a PDI-inhibitor leads to loss of DDGI. Furthermore, in human fibrosarcoma 
cells (HT 1080) PDI expression is increased by interferon-b (IFN-b), which also restores 
DDGI in these cells (Clive and Greene, 1994). This suggests that PDI is critical to the 
regulation of DDGI in normal fibroblasts. PDI has been found to be involved in the formation 
of correct disulphide bonds and maturation of proteins (Clive and Greene, 1994). 
Transcription factors could probably be targets for these PDI changes since these proteins 
must maintain the correct conformation in order to be active (Hutter et al., 1998).
3.5.6 Redox state
One study suggests a redox-regulated mechanism of cell proliferation in normal cells. The 
redox potential of normal human foreskin fibroblasts (GM 0868), calculated from the levels 
of oxidised (GSSG) and reduced (GSH) glutathione, is -34 mV more reducing in proliferating 
cells than in confluent cultures, while such a difference is not seen in human fibrosarcoma 
cells (HT 1080). Furthermore, the induction of a more reduced redox state in subconfluent 
cells by the addition of GSH synthesis precursors did increase cell proliferation, while the 
induction of a less reducing redox state by the inhibition of GSH synthesis did decrease cell 
proliferation (Hutter et al., 1998). The precise mechanism by which the redox state influences 
cell proliferation has not yet been defined but many biochemical processes that are dependent 
upon correct three-dimensional conformation of proteins, may be influenced and may serve as 
posttranslational regulatory controls. Like PDI, redox changes may have transcription factors 
as target (Hutter et al., 1998). Another explanation for the increase of cell proliferation 
induced by the increase of GSH levels is that this abrogates the production of H2O2 which is 
responsible for the growth factor induced increase of protein tyrosine phosphatase activity. 
The GSH induced decrease of phosphatase activity leads to an increase of protein tyrosine 
phosphorylation and thus to increases cell proliferation (Denu and Tanner, 1998; Lee et al.,
1998).
3.5.7 Increased DT-diaphorase activity
The activity of DT-diaphorase (NAD(P)H:(quinone-acceptor)oxidoreductase) is increased in 
wild-type mouse BALB/c 3T3 cells as they reach confluence and undergo DDGI, and in
area (Lallemand et al., 1998).
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primary cultures of human foreskin fibroblasts with increasing time in culture. Because 
transformed 3T3T fibroblasts did not show this increase, it has been suggested that this 
increase is related to cell-to-cell interaction and other cell surface interactions that effect 
growth control and plays a role in DDGI (Schlager et al., 1993). In line with this model, 
replating of confluent cells at low density resulted in a loss of DT-diaphorase. The increased 
levels of DT-diaphorase are maintained as long as the cells are exposed to high serum 
concentrations. However, they decline if the serum concentration is reduced. The 
physiological significance of this increase is not known, but it has been hypothesised that the 
increase in DT-diaphorase at high cell density is related to the synthesis of a Ca2+ binding 
protein required for DDGI (Schlager et al., 1993).
3.5.8 Lipoprotein lipase
The level of lipoprotein lipase has also been reported to increase sharply when several 3T3 
fibroblast sublines reach confluence. However, this seems to be related to adipose conversion 
rather than to cell density, since in a subline of 3T3 cells that undergoes adipose conversion 
with low frequency the enzyme is not expressed at high cell density (Wise and Green, 1978).
4 Mechanisms involved in anchorage-independent growth________________
4.1 Introduction
As stated in section 2.1, AIG is considered to be the best in vitro correlate of in vivo 
tumourigenicity. In addition to the presence of specific growth factors, non-tumourigenic cells 
obtained from solid tissues need adhesion to a surface in order to proliferate, while most 
tumour cells are able to proliferate in the absence of adhesion (Folkman and Moscona, 1978; 
Allen Hoffmann et al., 1990; Guadagno et al., 1993). The molecular mechanisms involved in 
AIG will be explained in this section.
4.2 Control of G1 phase cell cycle regulators by cell adhesion
In addition to the presence of specific growth factors, also cell adhesion is necessary for G1/S- 
phase progression. The activation of cell cycle regulators such as cyclins and cdks is strongly 
dependent on cell adhesion. This suggests that they play an important role in adhesion- 
dependent cell cycle regulation.
Cell adhesion is necessary for example for the increase of cyclin D1 expression (mRNA 
and protein) induced by mitogenic growth factors (Böhmer et al., 1996; Zhu et al., 1996; 
Radeva et al., 1997). Forced expression of cyclin D1 in non-adherent cells induces pRb 
phosphorylation and entry into S phase, showing that cyclin D1 expression is causal for cell 
cycle progression (Zhu et al., 1996; Resnitzky, 1997). However, in NRK cells cyclin D1 
expression is constitutively high, while these cells do not undergo AIG (Zhu et al., 1996), 
showing that there are more control mechanisms involved in the regulation of AIG.
Furthermore, most normal cells fail to activate the cyclin E-cdk2 complex upon growth 
factor addition under non-adherent conditions. In adherent cells growth factor addition leads 
to the reduction of the levels of the CKI p27kip1, enabling the activation of the cyclin E-cdk2 
complex. However, in non-adherent cells the levels of the CKIs p21Cip1 and p27kip1 are 
increased and the activation of the cyclin E-cdk2 complex is consequently prevented 
(Assoian, 1997; Resnitzky, 1997; Wu and Schonthal, 1997). The transcription of p21Cip1 is 
increased strongly because the gene has two p53-binding sites in its promoter and p53 levels 
are elevated rapidly when cells are cultured under anchorage-independent conditions (Wu and 
Schonthal, 1997). In contrast, in NRK fibroblasts the inhibition of cyclin E-cdk2 activity in 
suspended cells is not mediated by an increase in p21Cip1 and p27kip1 levels, but by a still 
unknown pathway (Carstens et al., 1996). In Rat1 fibroblasts, however, forced expression of 
cyclin E decreases p27kip1 levels but does not induce entry into S phase, suggesting that
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adhesion-dependent cell cycle progression is not mediated by cyclin E but by cyclin D1 
(Resnitzky, 1997).
Also pRb phosphorylation is dependent upon both cell anchorage and growth factors 
(Böhmer et al., 1996; Zhu et al., 1996; Radeva et al., 1997). This can be explained by the fact 
that pRb is phosphorylated by cyclin E-cdk2 and cyclin D-cdk4 complexes which are also 
activated by the combination of adhesion and growth factors. Again, in NRK fibroblasts pRb 
phosphorylation and cyclin E-cdk2 activity are not adhesion-dependent (Zhu et al., 1996).
Another cell cycle regulator whose expression is strongly dependent on adhesion is 
cyclin A (Assoian, 1997; Radeva et al., 1997; Wu and Schonthal, 1997). This is largely a 
consequence of the adhesion-dependent phosphorylation of pRb and p107, which leads to the 
dissociation of the transcription inhibiting E2F-4/p107 complex, subsequently increasing 
cyclin A transcription (Schulze et al., 1995). Also an E2F-independent mechanism, involving 
a CCAAT-binding protein, is involved in the adhesion-dependent expression of cyclin A 
(Krämer et al., 1996). Under anchorage-independent conditions, p21Cip1 levels are elevated 
(induced by increased p53 levels) and as a result cyclin A transcription and activity are 
blocked (Wu and Schonthal, 1997). Furthermore, E2F-1 expression is not increased under 
anchorage-independent conditions, and as a consequence E2F-dependent genes essential for 
cell proliferation can not be induced (Afrakhte et al., 1998).
4.3 Regulation of cell proliferation by anchorage and mitogens
4.3.1 Role of integrins in anchorage dependence
Integrins are primarily responsible for the adhesion to proteins of the extracellular matrix 
(ECM) or to the surface of other cells. Because these interactions are absent under anchorage- 
independent conditions, it is likely that integrins play a role in the regulation of anchorage 
dependent cell proliferation. Integrins are a family of heterodimeric transmembrane proteins 
formed by an a  and a ß subunit. The cytoplasmic domain of the integrin provides a site to 
which the actin cytoskeleton is attached. Besides this structural role, integrins also play an 
active role in cellular signalling. Integrin activation leads to changes in intracellular pH and 
intracellular Ca2+. Furthermore, the tyrosine kinase focal adhesion kinase (FAK) pp125FAK is 
activated. The activated FAK phosphorylates the cytoskeletal proteins paxillin and tensin, 
thereby enabling the binding of other proteins. Thus FAK seems to play an important role in 
cytoskeletal organisation. Autophosphorylation of FAK furthermore creates a binding site for 
the tyrosine kinase pp60src (Src) which leads to activation of Src. The activated Src further 
phosphorylates FAK which leads to binding of PI-3-kinase and Grb2-Sos. This leads to a 
cascade of phosphorylations. Furthermore, integrins activate the GTPase Rho, induce the 
release of lipid mediators such as phosphoinositides, diacylglycerol, and arachidonic acid 
metabolites. They also induce c-fos expression, activate cyclin-cdk complexes, and 
phosphorylate pRb. Thus, to a large extent integrins and growth factors seem to induce 
similar pathways (reviewed by Schaller and Parsons, 1993; Juliano, 1996; Assoian, 1997; 
Schwartz, 1997; Schlaepfer and Hunter, 1998).
4.3.2 Integration of signalling by anchorage and mitogens
Integrin and growth factor pathways collaborate to induce proliferation of non-transformed 
cells (Allen Hoffmann et al., 1990; Guadagno et al., 1993) and in many instances synergistic 
activation has been observed. For example, cell adhesion enhances autophosphorylation of 
tyrosine kinase receptors and increases activation of PKC. Furthermore, growth factor- 
induced PI-3-kinase activation and the activation of MAPKK by Raf (Renshaw et al., 1997) 
depends on cell adhesion. Also the activation of G1 cyclin-cdk complexes and 
phosphorylation of pRb require both cell adhesion and growth factors (reviewed by Schwartz, 
1997). This indicates that, although integrins and growth factors regulate the same signalling
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pathway, they act upon different points in the pathway and both must be present to induce 
MAPK activation and cell proliferation.
Schwartz (1997) postulated a model in which the growth stimulation pathway is separated 
into an integrin and a growth factor-dependent pathway, followed by a convergence point and 
a pathway after convergence. In this model constitutive activation of a step on the integrin 
arm of the pathway before convergence leads to anchorage-independent but serum-dependent 
growth. Constitutive activation of a step on the growth factor arm of the pathway before 
convergence leads to serum-independent but anchorage-dependent growth. Constitutive 
activation of a step after convergence of integrin and growth factor pathways should bypass 
the requirements for both adhesion and growth factors and induce growth factor- and 
anchorage-independent proliferation (Juliano, 1996; Schwartz, 1997). A number of proto­
oncogenes have recently been found to fit in this description. This has lead to the next 
classification: Rho, FAK, Cdc42, c-Abl (Schwartz, 1997), integrin-linked kinase (Radeva et 
al., 1997), and PI-3-kinase (Klippel et al., 1998; Moore et al., 1998) are part of the integrin 
activated pathway, and activation or overexpression of these proteins induces anchorage- 
independent but growth factor-dependent growth. Autocrine expression of growth factors is 
part of the growth factor pathway. Activation of MAP kinase, c-fos expression, cyclin D- and 
cyclin E-cdk activity, and pRb phosphorylation depend on both adhesion and growth factors 
and are therefore localised after the conversion point. Oncogenes such as v-fos and v-src that 
constitutively activate these pathways induce both anchorage and serum independence 
(Schwartz, 1997). The ability of tumour cells to metastasise and to proliferate in inappropriate 
environments, reflected in vitro by AIG, could be seen as a consequence of anchorage- 
independent activation of specific, normally anchorage-dependent pathways. Constitutive 
stimulation of growth factor pathways, for example by the production of autocrine growth 
factors, is supposed to give rise to benign tumours in which the cells are not able to grow 
without anchorage and therefore do not metastasise (Schwartz, 1997).
Recently, some potential candidates for the convergence point have been identified (for 
model see figure 3). First, in NIH 3T3 cells a specific point in the signalling pathway has been 
identified, at which an adhesion-dependent signal is essential for the activation of MAPK and 
induction of cell proliferation: the activation of MAPKK by Raf (Renshaw et al., 1997). This 
suggests that adhesion may promote cell proliferation by facilitating growth factor-induced 
activation of MAPK, leading to its nuclear translocation (Brunet et al., 1999), activation of 
transcription factors such as p62TCF and Elk1 (Gille et al., 1992; Brunet et al., 1999), 
induction of mitogen-induced genes such as c-fos (Gille et al., 1992), induction of cyclin D1 
(Lavoie et al., 1996), and cell cycle re-entry (Pages et al., 1993). However, oncogenic Ras is 
able to induce cell proliferation in the absence of anchorage, showing that this model is far 
too simple to explain all effects of oncogenes. Furthermore, this also shows that very strong 
activation of a pathway may overcome a specific blockade (Renshaw et al., 1997).
The mechanism by which cell adhesion amplifies the activation of MAPKK is currently 
unknown. Proteins in the focal adhesions are not likely to be involved since they are rapidly 
lost upon detachment while the MAPK activity declines more slowly (Renshaw et al., 1997). 
Furthermore, blocking of FAK activation does not block MAPK activation (Lin et al., 1997a). 
Also a direct role for the small G-proteins Rac, Rho, and Cdc42 is unlikely (reviewed by 
Juliano, 1996). Possibly the regulation of scaffolding proteins that control the proximity of 
Raf and MAPKK, or as yet unidentified protein kinases or phosphatases that may regulate 
MAPKK activity are involved (Renshaw et al., 1997). A possibly candidate could be the 
recently isolated serine/threonine kinase that interacts directly with integrin a  or b subunit 
cytoplasmic domains (Hannigan et al., 1996). Second, in NIH 3T3 cells, there exists an 
anchorage-dependent step between Ras and Raf in the signalling cascade initiated by 
mitogens (Lin et al., 1997b). Third, in CCL39 lung fibroblasts MAPK activation is not a 
limiting factor for G1 to S phase transition in the absence of anchorage. Thus at least one
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adhesion-mediated signalling event distinct from MAPK activation is required for maximal 
cell proliferation. This suggests that there must be a conversion point prior to cyclin D1 
induction and hyperphosphorylation of pRb (Le Gall et al., 1998). This shows that there exist 
various convergence points, depending on the cell type.
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Figure 3: Model for the co-operative control 
of G1 phase cell cycle progression by growth 
factors and adhesion.
In th is model the m ajor sites o f growth factor (Gf) 
and adhesion action during cell cycle progression 
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4.4 Mechanisms involved in the induction of AIG by growth factors
4.4.1 Introduction
Several mechanisms have been supposed to play a role in the induction of AIG in 
nontransformed cells by growth factors. In parallel with DDGI, AIG is most likely controlled 
by a combination of these processes, in which, depending on the cell type studied, certain 
mechanisms may play a more important role than others.
4.4.2 Induction of extracellular matrix proteins
Cell anchorage to substratum is mediated largely by the interaction of cell-surface integrins 
with the extracellular matrix (ECM). The steady-state level of the ECM protein fibronectin is 
decreased upon loss of attachment (Dalton et al., 1992). As ECM proteins provide anchorage 
for cells under anchorage-independent conditions, increased expression induced by growth 
factors could lead to the induction of AIG. Indeed, TGFb and PDGF-BB both induce AIG and 
increase fibronectin expression in several cell types (Ignotz and Massague, 1986; Allen 
Hoffmann et al., 1990). However, not all factors that induce AIG increase fibronectin gene 
expression (Thompson et al., 1988b; Rijksen et al., 1993b), showing that the production of 
ECM proteins is not obligatory for AIG. The induction of AIG by TGFb can be mimicked by 
fibronectin in NRK fibroblasts (Ignotz and Massague, 1986), in contrast to the induction of 
AIG of human embryonic skin fibroblasts by PDGF-BB (Allen Hoffmann et al., 1990). 
However, fibronectin is unable to replace TGFb in inducing AIG of EGF-treated NRK cells 
in the absence of serum growth factors (Allen Hoffmann et al., 1986 and E.J.J. van Zoelen,
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unpublished data). Since fibronectin isolates often contain TGFb, it can not be excluded that 
much of the fibronectin effects should be considered as secondary to TGFb action. On the 
other hand, AIG induced by TGFb and PDGF-BB is specifically blocked by inhibitors of 
fibronectin binding to its cell surface receptor (Ignotz and Massague, 1986; Allen Hoffmann 
et al., 1990), suggesting that fibronectin plays a role in TGFb action. However, these results 
only show that fibronectin production is necessary for AIG. TGFb also induces some 
collagen-related matrix proteins in a variety of cell lines (Ignotz and Massague, 1986). 
Together, this shows that interaction of cells with extracellular adhesion receptors is 
necessary but not sufficient for induction of cell proliferation under anchorage-independent 
conditions.
4.4.3 Induction of cyclin activity
As stated in section 4.2, cell adhesion is necessary for the increase of cyclin D1 expression, 
activation of cyclin E-cdk2, pRb phosphorylation, and cyclin A expression. This suggests that 
in order to induce AIG, growth factors must compensate for these adhesion-dependent 
mechanisms. It has been shown that TGFb indeed increases cyclin A levels only under 
conditions that NRK fibroblasts undergo AIG, i.e. in the presence of EGF (Zhu et al., 2000).
4.4.4 Connective tissue growth factor
Connective tissue growth factor (CTGF) is known as a secreted downstream mediator of 
TGFb action on fibroblasts and other connective tissue cells, where it stimulates cell 
proliferation and ECM synthesis. This suggests that CTGF could play a role in the induction 
of AIG. In NRK fibroblasts CTGF does not induce AIG directly but the synthesis and action 
of CTGF are believed to be essential for TGFb-induced AIG (Kothapalli et al., 1997).
4.4.5 Inositol polyphosphate 5-phosphatase
Inositol polyphosphate 5-phosphatase hydrolyses the second messenger molecules 
Ins(1,4,5)P3, which induces the release of calcium from intracellular stores, and 
Ins(1,3,4,5)P4, which is implicated in gating calcium at the plasma membrane. A decrease of 
inositol polyphosphate 5-phosphatase activity induced by antisense-transfection leads to 
chronically elevated Ins(1,4,5)P3, and Ins(1,3,4,5)P4, and intracellular calcium concentrations. 
As suggested by the fact that decreased levels of inositol polyphosphate 5-phosphatase 
activity have been found in some tumours, the antisense-transfection leads to cellular 
transformation of NRK cells, i.e. these cells are able to proliferate under anchorage- 
independent conditions and induce tumours in nude mice (Speed et al., 1996). This suggests 
that Ins(1,4,5)P3, Ins(1,3,4,5)P4, and intracellular calcium concentrations are involved in the 
regulation of AIG. However, these cells still undergo DDGI, although at higher cell density 
(Speed et al., 1996). This makes its role in DDGI unclear.
4.4.6 Intracellular pH
In several non-transformed, anchorage-dependent fibroblast cell lines it has been shown that 
the pHi depends on the culturing conditions; the pHi is lower when cells they are cultured as 
non-adherent, round cells than when they are cultured as spread cells. On the other hand, in 
several transformed cells the pHi is the same under both culturing conditions. This suggests 
that normal cells need to adhere to have a sufficiently high pHi and as a consequence that AIG 
is only possible when pHi is increased (Schwartz et al., 1989).
In adherent cells the pHi depends on the number of interactions mediated by integrins 
(Galkina et al., 1992). Provided that pHi is also regulated by integrin levels in non-adherent 
cells, this suggests that under anchorage-independent conditions integrin levels are too low to 
elevate pHi sufficiently. This predicts that the integrin levels should be decreased in
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anchorage-independently cultured cells. Indeed, the cell-surface expression of the major 
integrin, a5^1, is decreased in anchorage-independent fibroblasts as a result of a high 
turnover (Dalton et al., 1995). In addition, adhesion of bovine capillary endothelial cells to 
ECM proteins such as fibronectin, fibrinogen, laminin, etc. which occurs by a variety of 
different integrins, actually induces an elevation of pHi (Schwartz et al., 1991). Together, 
these results suggest that cells are not able to proliferate under anchorage-independent 
conditions because of a lack of integrin expression, resulting into a decreased pHi. The cells 
can undergo AIG by increasing their integrin expression, leading to an increase of pHi. It is 
not known if an increase of pHi is absolutely necessary to induce AIG. On the other hand, an 
artificially induced increase of pHi is generally not sufficient to induce cell proliferation 
(Grinstein et al., 1989).
4.4.7 Activation of protein tyrosine phosphatases (PTPases)
Tyrosine phosphatase activity is strongly increased when A431 cells are grown in spheroids 
(Mansbridge et al., 1992). Inhibition of PTPases leads to the induction of AIG in NRK 
fibroblasts (Rijksen et al., 1993b). This suggests that the activation of PTPases under 
anchorage-independent conditions plays a role in the inhibition of cell proliferation. Perhaps 
growth factors can only induce AIG when they are able to activate PTPases to a sufficiently 
high level.
5 The role of growth factors in loss of DDGI and AIG_____________________
5.1 Normal rat kidney cells as a model system for the regulation of cell proliferation
An attractive model system to study the mechanisms involved in (loss of) DDGI and AIG is 
the normal rat kidney (NRK) fibroblast cell line. These cells are widely used since these two 
aspects can be studied in one cell line. An additional advantage is the fact that all the 
experiments used to study AIG and (loss of) DDGI can be carried out under completely 
serum-free conditions. NRK fibroblasts are immortalised cells that have a normal phenotype 
and are strictly dependent on externally added growth factors for proliferation. When made 
quiescent by serum-deprivation at submaximum density, they are mitogenically still 
responsive to a variety of growth factors including epidermal growth factor (EGF). Cultured 
in the presence of EGF as the only growth-stimulating hormone, these cells have a normal 
phenotype: they undergo DDGI (Figure 4C) and are unable to grow under anchorage- 
independent conditions (Figure 4A). In the additional presence of TGF b or retinoic acid 
(RA), however, they become phenotypically transformed (Anzano et al., 1982; Van Zoelen et 
al., 1988; 1994) resulting in release from density-arrest (Figure 4D) and the ability to 
proliferate under anchorage-independent conditions (Figure 4B).
5.2 Cell proliferation assays on NRK cells
5.2.1 Introduction
In order to study the effects of growth factors on NRK cell proliferation in monolayer, 
thymidine incorporation assays are being used. There are several different assays to study the 
various aspects of cell proliferation: the induction of cell proliferation, the prevention of 
DDGI, or the induction of loss of DDGI.
In figure 5 a schematic presentation of the utilised growth stimulation assays is given. As 
can be seen, the cells are first grown in serum-containing medium until confluence. 
Subsequently, the cells are incubated for 3 days under serum-free conditions, after which they 
are called quiescent cells. The various different assays starting with such quiescent cells are 
described below. In short, addition of EGF to these quiescent cells induces one round of cell 
division (mitogenic activation), leading to DDGI. Addition of EGF and TGFb to quiescent 
cells or addition of TGFb to cells which have undergone DDGI leads in both cases to
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phenotypic transformation. In all assays, insulin is added as a progression factor to prevent 
apoptosis (Kim et al., 1995).
Figure 4: Phenotypic transformation of NRK cells induced by EGF and TGFp (Van Zoelen, 1991).
The cells were cultured in soft agar (sem isolid m edium) in the presence of (A) 5 ^g/m l insulin and 2 ng/ml EGF, or 
(B) 5 ^g/m l insulin, 2 ng/ml EGF and 1 ng/ml TGFp. Colonies were photographed 14 days after inoculation.
Cells in m onolayer culture were grown to confluence in serum -conta ining medium, made quiescent by the addition 
of growth factor-inactivated serum -conta ining medium and subsequently stim ulated with (C) 5 ^g/m l insulin and 2 
ng/ml EGF or (D) 5 ^g/m l insulin, 2 ng/ml EGF and 1 ng/ml TGFp. Cultures were photographed after 72 hours of 
incubation in these latter media.
Subconfluent
Serum 
-----►
Confluent Quiescent
Serum 
free 
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Prevention EGF + 
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Figure 5: Mitogenic activation and loss of DDGI of NRK cells induced by growth factors.
Cells are grown to confluence in serum -containing medium. W hen they are confluent, they are incubated 72 hours 
in serum -free medium to obtain qu iescent cells. W hen these qu iescent cells are treated with EGF, they divide 
once after which they undergo density-dependent growth inhibition (DDGI). W hen these density-arrested cells are 
treated with a transform ing fac to r such as TGFp, they undergo loss of DDGI. This m eans tha t they are able to 
divide again and thus form  ce llu lar multilayers. W hen quiescent cells are treated with EGF in the additional 
presence of TGFp, the cells do not undergo DDGI and form cellu lar multilayers.
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5.2.2 Mitogenic activation
Quiescent cells can be directly used to test the mitogenic activity of growth factors in the 
following ways (Van Zoelen et al., 1986). Cells are stimulated for 22 hours with growth 
factors and the rate of thymidine incorporation into cellular DNA is determined either during 
2 -hours time pulses (figure 6a) or in a cumulative manner during the entire stimulation period 
(see Chapter 5 figure 1). The advantage of the first assay is that differences in time course for 
mitogenic stimulation between individual growth factors is measured. The second assay is 
less time consuming.
5.2.3 Induction of DDGI by EGF
When the time course of thymidine incorporation after addition of EGF is measured for a 
longer period than 22 hours, NRK cells undergo one round of duplication, resulting in 
progression through the S-phase between 9 and 22 hours after growth factor addition (see 
figure 6a). Subsequently the rate of thymidine incorporation decreases and returns to 
background levels, in spite of the continuous presence of EGF (Van Zoelen et al., 1988). 
Fluorescence-activated cell-sorting experiments show that upon EGF treatment (in the 
presence of insulin) the cells are triggered to enter one cell cycle and that cells are unable to 
proceed through an additional cell cycle (Van Zoelen et al., 1988). However, in non-confluent 
cultures EGF is able to induce cell proliferation during multiple cell cycles. Together, these 
results have previously led to the conclusion that 45 hours after treatment of confluent NRK 
cultures with EGF a fraction of the cells has undergone one additional cell cycle, after which 
the cells have become density-arrested as a result of the high cell density (Van Zoelen, 1991).
Density-arrested cells, obtained by treating quiescent, serum-deprived NRK cells for 48 
hours with EGF in the presence of insulin, can subsequently be used for studies on loss of 
DDGI.
5.2.4 Phenotypic transformation: Prevention of DDGI
Another way to study the ability of growth factors to induce phenotypic transformation is by 
measuring the prevention of DDGI, as follows. When quiescent cells are stimulated with EGF 
in the additional presence of TGFb, the cells undergo a round of duplication, similar to cells 
treated with solely EGF (figure 6a). However, after this round of duplication, the rate of 
thymidine incorporation remains at an elevated level upon further incubation, because the 
cells undergo additional rounds of duplication as a result of phenotypic transformation (Van 
Zoelen et al., 1988). In figure 6a it can be seen that at 45 hours after the addition of EGF and 
TGFb the level of thymidine incorporation is maximal. Obviously, when measuring 
thymidine incorporation between 43 and 45 hours phenotypically transformed NRK cells are 
characterised by a high rate of thymidine incorporation, while a low incorporation rate is 
observed in density-arrested cells (Van Zoelen, 1991). This phenomena is used to assay the 
prevention of DDGI. In this type of assay the thymidine incorporation is measured in a 
2-hours time pulse 45 hour after growth factor addition in the presence of EGF to quiescent 
cells (Van Zoelen et al., 1988). This assay is presented schematically in figure 6c (43-45 h 
pulse). Of course, prevention of DDGI can also be determined during multiple 2-hours time 
pulses (see figure 6a). All the above mentioned assays are presented schematically in figure 
6c.
5.2.5 Phenotypic transformation: Induction of loss of DDGI
In this assay (Van Zoelen, 1991), above obtained density-arrested cells are incubated with 
additional, possibly transforming factors. Subsequently thymidine incorporation is determined 
in either 2 -hours time pulses (see results in figure 6b) to study the kinetics, or in a cumulative 
manner between 2 and 19 hours (see Chapter 2 figure 1).
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Figure 6: Mitogenic activation and loss of DDGI of NRK cells induced by growth factors.
a. Mitogenic activation, DDGI and prevention o f DDGI. Cells were grown to confluence in serum -containing 
medium, incubated 72 hours in serum -free m edium  to obtain qu iescent cells, and stim ulated with the 
indicated growth factors (in the presence o f Insulin) at t=0. [3H]thym idine incorporation was determ ined during 
a 2-hours tim e pulse, and data were presented relative to uptake in unstim ulated controls (Van Zoelen et al., 
1988).
b. Loss o f DDGI. Q uiescent cells were treated with EGF and insulin fo r 48 hours. These density inhibited cells 
were stim ulated with the indicated growth factors at t=0. [3H]thym idine incorporation was determ ined during a 
2-hours tim e pulse, and data were presented relative to uptake in unstim ulated contro ls (Van Zoelen, 1991).
c. Schematic presentation o f the described growth stimulation assays.
5.3 Model for DDGI and phenotypic transformation of NRK cells
As described in section 3, several molecular mechanisms have been proposed to explain why 
normal cells stop proliferating above a critical cell density. Most likely DDGI is controlled by 
a combination of these processes, in which, depending on the cell type, certain mechanisms 
may play a more important role than others. In NRK fibroblasts several mechanisms have 
been shown to play a role in DDGI, including tyrosine phosphatase activity, intercellular 
communication, membrane potential, and the density of receptors for growth factors to which 
cells can respond (reviewed in Van Zoelen, 1991). However, the density-dependent 
modulation of EGF receptor densities is supposed to be the most appropriate mechanism to 
describe DDGI of EGF-treated NRK cells (Van Zoelen, 1991). In this model, as shown in 
figure 7, EGF receptor levels decrease at high cell density to such a level that the cells 
become unresponsive to the stimulating activity of EGF, resulting in DDGI. The cells can
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undergo phenotypic transformation by an increase of EGF receptor numbers, as induced by 
factors such as RA and TGFp, thus enhancing the growth-stimulating signals induced by EGF 
(Figure 7A), or alternatively by the activation of parallel growth-stimulating pathways by 
factors such as PDGF and lysophosphatidic acid (LPA; Figure 7B).
EGF TGFp EGF PDGF/LPA
V J \ /
Or
M____
Figure 7: Model for growth factor-induced loss of density-dependent inhibition of growth of NRK cells 
(Van Zoelen, 1991).
NRK cells cultured in the presence o f EGF and insulin become density inhibited at high densities because the 
EGF-induced growth-stim ulating signals (indicated by the single arrow from  the EGF receptor) are insufficient for 
induction o f cell proliferation. Density-arrested NRK cells can be restim ulated to proliferate by the addition of 
factors (such as TGFp or RA) tha t increase the EGF receptor number, thus enhancing the level o f growth- 
stim ulating signals induced by EGF (A), or alternatively by addition o f factors (such as PDGF and LPA) tha t act in 
parallel w ith EGF, in such way that the growth-stim ulating signals o f the two factors com bined are suffic ient to 
induce proliferation (B).
5.4 AIG of NRK cells
Under anchorage-independent conditions NRK cells are blocked within the cell cycle shortly 
before progression from G1 to S phase (Guadagno and Assoian, 1991; Han et al., 1993). The 
mechanisms that have been proposed to play a role in the induction of AIG of NRK cells are 
the induction of extracellular matrix proteins and the activation of protein tyrosine 
phosphatases (reviewed in Van Zoelen, 1991). In NRK fibroblasts, a strong parallel has been 
observed between the growth factor requirements for induction of DDGI and AIG (Van 
Zoelen et al., 1988; Lahaye et al., 1999). This suggests that probably the same mechanisms 
underlie these two aspects of phenotypic transformation, and raises the possibility that the 
EGF receptor levels are also involved in AIG. This aspect will be studied in this thesis.
5.5 Effect of bradykinin on loss of DDGI of NRK fibroblasts
Previous reports from our laboratory show that bradykinin (BK), a nonapeptide with a variety 
of physiological and pharmacological activities (Roberts, 1989), has a strong inhibiting effect 
on the RA- and TGFb-induced loss of DDGI of NRK cells (Afink et al., 1994; Van Zoelen et 
al., 1994). Northern analyses and 125I-EGF binding studies show that this inhibition is 
parallelled by a repression of the increase of EGF receptor expression by RA and TGFp (Van 
Zoelen et al., 1994). Upon prolonged incubation, however, BK has growth stimulatory effects 
by itself and enhances the proliferating effects of RA and TGFp.
The inhibiting effect of BK cannot be correlated to the levels of arachidonic acid release, 
degradation of inositol-containing phospholipids, or modulation of PKC activity (Afink et al., 
1994; Van Zoelen et al., 1994), since prostaglandin F2a (PGF2a) and LPA induce similar 
second messengers and do not mimic this growth inhibition. However, the inhibiting effect of 
BK can be inhibited by prostaglandin G/H synthase (PGH) inhibitors, suggesting that one or 
more PGH synthase products mediate the inhibiting effect of BK (Afink et al., 1994). It is 
known that several products of the metabolic conversion of AA by PGH synthase can be 
potent inhibitors of cell growth (reviewed by Fukushima, 1992). However, none of the well
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characterised PGH synthase products such as the prostaglandins A2, D2, Ei, E2, F2a, I2, and 
the thromboxane A2 agonist U46619 were able to mimic the inhibiting activity of BK on the 
RA-induced transformation of NRK cells (Afink et al., 1994).
6 Aim of the thesis___________________________________________________
As shown before in our laboratory (Afink et al., 1994), BK has initially a strong inhibiting 
effect on the RA- and TGFb-induced loss of DDGI of NRK cells. It was shown that a PGH 
synthase product most likely mediated the inhibiting effect of BK. However, its identity was 
still unknown. In this thesis we tried to identify the unknown PGH synthase product. In 
C hapter 2 we showed that externally added PGJ2 can mimic the inhibiting effect of 
bradykinin on the loss of density-arrest induced by RA, suggesting that PGJ2 is a possible 
candidate for being the bradykinin-induced growth-inhibiting prostaglandin. However, from 
direct analysis of AA products produced by the treated NRK cells, no evidence for production 
of PgJ2 was obtained (C hapter 6).
As described above, it has been postulated that NRK cells become density-arrested as a 
result of a decrease of the EGF receptor level below a threshold level that makes these cells 
unresponsive to stimulation by EGF (Van Zoelen, 1991). Confluent cultures of NRK cells, 
made quiescent by serum-deprivation, can still be induced to undergo one additional cell 
cycle by EGF, before reaching quiescence as a result of density arrest (Van Zoelen et al., 
1988). Assuming that EGF receptor levels are decreased below a critical level in density- 
arrested cells, we hypothesised that already in serum-deprived quiescent cells EGF receptor 
levels must have been decreased to such a level that they limit EGF-induced mitogenesis. In 
C hapter 3 of this thesis we investigated the role of EGF receptor levels in the regulation of 
mitogenic activation of NRK fibroblasts and were able to confirm this hypothesis.
Loss of DDGI and AIG are both aspects of phenotypic transformation. A strong parallel 
has been observed between the growth factor requirements for induction of DDGI and AIG in 
these cells (Van Zoelen et al., 1988), suggesting that probably the same mechanism underlies 
these two aspects of phenotypic transformation. This raises the possibility that the EGF 
receptor levels are also involved in AIG. In C hapter 4 of this thesis we investigated the role 
of EGF receptor levels in the regulation of AIG of NRK fibroblasts. We showed that EGF 
receptor levels are also decreased in cells cultured under anchorage-independent conditions. 
Furthermore, we showed that agents that stimulate AIG of NRK cells, also upregulate EGF 
receptor levels. From this we concluded that in NRK cells EGF receptor levels regulate not 
only DDGI, but also mitogenic activation and induction of AIG; i.e. that the same mechanism 
underlies these two aspects of phenotypic transformation and mitogenic activation.
Intriguingly, while PGF2a, LPA, and BK were shown to induce similar second messengers, 
they exhibit different effects on NRK cell proliferation (Afink et al., 1994). We investigated 
this phenomenon into more detail and included ET-1, another activator of G-protein-coupled 
receptors, in our studies. The results are presented in C hapter 5 and show that ET-1 and the 
other three agents induce comparable second messenger systems but have all a clearly 
different effect on cell proliferation. The possible explanations for these differences are 
discussed in this Chapter.
In C hapter 6 (General discussion) the role of EGF receptor levels in the regulation of cell 
proliferation of NRK cells is discussed. Next, the importance of this model in NRK 
fibroblasts is critically considered. Finally, additional results on the BK-induced inhibitor are 
presented. The results presented in this thesis increase the insight on the regulation of DDGI 
and AIG in NRK cells.
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Effect of bradykinin on loss of density-dependent 
growth inhibition of normal rat kidney cells
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Published in: Cellular and Molecular Biology 40: 717-721, 1994
Abstract
Normal rat kidney fibroblasts, density-arrested in the presence of epidermal growth factor 
(EGF), can be restimulated to proliferate in a synchronous way and acquire a transformed 
phenotype following treatment with additional growth factors like retinoic acid (RA) and 
transforming growth factor (TGF) b. It was found that bradykinin has a strong inhibitory 
effect on growth stimulation induced by these factors, an effect which cannot be mimicked by 
prostaglandin (PG)F2a. The growth-inhibiting effect can be blocked by inhibitors of cyclo- 
oxygenase activity, indicating that the relevant second messenger is most likely a 
prostaglandin. Externally added PGJ2, at a concentration of 10 |iM, can mimic the inhibitory 
effect of bradykinin on the loss of density-arrest induced by RA suggesting that PGJ2 is a 
possible candidate for being the bradykinin induced growth-inhibiting prostaglandin.
Introduction
Normal rat kidney (NRK) fibroblasts have a normal phenotype and undergo density- 
dependent growth inhibition when cultured in the presence of epidermal growth factor (EGF) 
as the only growth-stimulating polypeptide. These density-arrested cells can acquire a 
transformed phenotype, characterized by loss of density-dependent growth inhibition, and can 
be restimulated to proliferate in a synchronous way following treatment with additional 
growth factors like retinoic acid (RA) and transforming growth factor (TGF) b in the presence 
of EGF (Van Zoelen et al., 1988). RA and TGFb exert their mitogenic activities in an indirect 
way by elevating EGF receptor levels (Van Zoelen et al., 1994).
Within the first 20 hours after the addition of the growth factors to density-arrested cells, 
bradykinin, a nonapeptide with a variety of physiological and pharmacological activities 
(Roberts, 1989), was found to have a strong inhibitory effect on growth stimulation induced 
by RA and TGFb. The observed growth inhibition induced by bradykinin was shown to be 
paralleled by a repression of the up-regulation of EGF receptor expression by RA and TGFb 
(Van Zoelen et al., 1994). At later time points, however, bradykinin has been shown to have 
growth stimulatory effects by itself and to enhance the proliferating effects of RA and TGFb. 
The inhibitory effect of bradykinin cannot be correlated with degradation of inositol- 
containing phospholipids, the level of arachidonic acid release, the production of cAMP or 
modulation of protein kinase C activity (Van Zoelen et al., 1994). The relevant second 
messenger has been shown to be most likely a prostaglandin but externally added 
prostaglandins such as PGA2, PGD2, PGE1, PGE2, PGF2a and PGI2 were unable to mimic the 
effects of bradykinin. In this paper we show that PGJ2, at a concentration of 10 mM, inhibits 
the growth-stimulation induced by RA, suggesting that the growth-inhibiting prostaglandin 
might be PGJ2.
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Growth-stimulation assays
NRK fibroblasts (clone 49F) were plated at a density of 12.500 cells/cm2, grown to 
confluence in serum-containing medium for 4 days, and subsequently cultured in serum-free 
medium for 3 days, as described by Van Zoelen et al. (1988). These cells were then density- 
arrested by incubation in 5 ng/ml EGF and 5 |ig/ml insulin for an additional 48 h (Van Zoelen 
et al., 1988). Density-arrested cells were re-stimulated to proliferate by treatment with 
additional growth factors, and incorporation of [3H]thymidine (0.5 |iCi/ml added; Amersham) 
was measured cumulatively between the indicated times after growth factor addition (Van 
Zoelen et al., 1994).
Materials
TGFb1 was isolated from human platelets as described by Van de Eijnden-Van Raaij et al. 
(Van den Eijnden-Van Raaij et al., 1988). [D-Arg0, Hyp3, Thi5,8, D-Phe7]-bradykinin, 
flurbiprofen, indomethacin, metyrapone (MDPP), nordihydroguaiaretic acid (NDGA), PGA2, 
PGD2, PGE2, PGF2a, PGJ2 and RA were from Sigma. Bradykinin was from Boehringer. 
[3H]Thymidine was from Amersham. PGE1 and PGI2 were a kind gift of G. Rijksen 
(Department of Hematology, University Hospital Utrecht).
Results
Effect of bradykinin on growth factor-induced loss of density-inhibition of NRK cells cannot be 
mimicked by PGF2a
Bradykinin was found to have a strong inhibitory effect on growth stimulation induced by RA 
within the first 20 hours after the addition of the growth factors to density-arrested cells (Van 
Zoelen et al., 1994). In figure 1 it is shown that the growth stimulatory effect of TGFb is also 
inhihibited by bradykinin. Bradykinin is known to activate phospholipase C and A2 upon 
receptor activation (Roberts, 1989), but our data on NRK cells show that bradykinin is a 
relatively poor inducer of inositol polyphosphate formation and [3H]arachidonic acid release. 
Furthermore we showed that in these cells PGF2a is far more potent than bradykinin in 
inducing these second messenger pathways (Van Zoelen et al., 1994; Afink et al, 1994) but, 
as is shown in figure 1, it is unable to mimic the growth inhibiting effect of bradykinin. When 
added in combination with PGF2a bradykinin also has a strong inhibitory effect on growth 
stimulation induced by RA (data not shown). From these results it can be concluded that the 
growth inhibiting effect of bradykinin cannot be correlated with the levels of inositol 
polyphosphate formation and [3H]arachidonic acid release.
The bradykinin effect is B2-receptor-mediated and can be blocked by inhibitors of cyclo- 
oxygenase activity
Figure 2 shows that the bradykinin B2-receptor antagonist ([D-Arg0, Hyp3, Thi5,8, D-Phe7]- 
bradykinin) and indomethacin (Indo) or flurbiprofen (Flur) can reverse the bradykinin- 
induced growth inhibition of NRK cells. It can be concluded from these results that the 
biological effects of BK are B2-receptor mediated and can be blocked by inhibitors of cyclo- 
oxygenase activity (Indo and Flur) but not by inhibitors of lipoxygenase and epoxygenase 
such as NDGA and MDPP. These inhibitors of cyclo-oxygenase activity also blocked the 
effects of bradykinin when added together with inhibitors of lipoxygenase and epoxygenase 
indicating that the inhibition of the cyclo-oxygenase activity does not enhance the formation 
of an inhibiting lipoxygenase or epoxygenase product (data not shown).
Materials and methods
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Figure 1: Effect of bradykinin on 
growth factor-induced loss of 
density-inhibition of NRK cells.
NRK cells density-arrested by 
_ incubation with 5 ng/ml EGF and 5 
|jg /m l insulin for 48 h in serum -free 
B K  m edium  were incubated with 2 
ng/ml TGFp, 50 ng/ml RA or 
PGF2a without stim ulus (Cont), in the
presence or absence o f 1 jM  BK 
or 10 jM  PGF2a. The incorporation 
o f [3H]-thym idine was determ ined 
between 4 and 19 hours after 
growth factor addition. Values 
represent the mean ± s.e.m. of 
trip licate determ inations from  a 
representative experiment.
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Figure 2: Reversal of bradykinin-induced growth inhibition of NRK cells by bradykinin B2-receptor 
antagonist ([D-Arg0, Hyp3, Thi5,8, D-Phe7]-bradykinin) and indomethacin.
Density-arrested cells were incubated with the indicated growth factors at the concentrations described in figure 1. 
W hen indicated the cells were treated for 3 hours with 1 pM Indo, 1 pM Flur, 1 pM NDGA or 1 pM M DPP before 
the addition of growth factors. Experim ents with 5 pM BK-antagonist were carried out in the presence of 0.1 pM 
bradykinin. The [3H]-thym idine incorporation was determ ined between 4 and 19 hours after the addition o f the 
growth factors. Values represent the mean ± s.e.m. o f trip licate determ inations from  a representative experiment.
Figure 3: Inhibition of RA- 
induced growth stimulation by 
bradykinin, PGA2, PGD2, PGE1, 
PGE2, PGI2 and PGJ2.
Density-arrested cells were 
incubated w ithout stim ulus (Cont) or 
w ith 50 ng/ml RA in the additional 
presence or absence o f 1 pM BK or 
10 pM PGA2, PG D2, PG E1, p g e 2, 
PGI2 and PGJ2. Incorporation of 
[3H]-thym idine was determ ined 
between 4 and 19 hours after 
growth factor addition. Values 
represent the mean ± s.e.m. of 
trip licate determ inations from  a 
representative experiment.
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Effects of externally added prostaglandins on the growth-stimulatory effects of RA
It can be concluded from figure 2 that the relevant second messenger is most likely a 
prostaglandin. Figure 3 shows that externally added prostaglandins such as PGA2, PGD2, 
PGEi, PGE2 and PGI2 at concentrations of 10 |iM were unable to mimic the effects of 
bradykinin and that PGJ2 at a concentration of 10 |iM has an inhibitory effect on the loss of 
density-arrest induced by RA suggesting that PGJ2 is a possible candidate for being the 
bradykinin induced growth-inhibiting prostaglandin. From dose-response curves can be 
concluded that the half-maximum concentration for the inhibition by PGJ2 is 5-7 |iM (data not 
shown).
Discussion
NRK fibroblasts undergo density-dependent growth inhibition when cultured in the presence 
of EGF. These density-arrested cells can be restimulated to proliferate and acquire a 
transformed phenotype following treatment with additional growth factors such as RA and 
TGFß (Van Zoelen et al., 1988).
Bradykinin has a strong inhibitory effect on growth stimulation induced by those growth 
factors, but has no effect on the proliferation of these cells by itself (Van Zoelen et al., 1994). 
PGF2a is far more potent than bradykinin in activating phospholipase C and A2 upon receptor 
activation in NRK cells (Van Zoelen et al., 1994; Afink et al, 1994) but, as shown in figure 1, 
it is unable to mimic the growth-inhibiting effect of bradykinin. It has also be shown (figure 
2) that the bradykinin effect is B2-receptor-mediated and can be blocked by inhibitors of 
cyclo-oxygenase activity suggesting that the relevant second messenger is most likely a 
prostaglandin.
McAllister et al. (1993a) showed that the bradykinin-induced inhibition of DNA-synthesis 
induced by EGF or PDGF in human gingival fibroblasts is mediated by PGE2. Our results 
show that in NRK cells externally added prostaglandins such as PGA2, PGD2, PGE1, PGE2, 
PGF2a and PGI2 were unable to mimic the effects of bradykinin. The same results were 
obtained when these prostaglandins were added together with bradykinin to cells treated for 3 
hours with 1 |iM Indo (data not shown). We showed that PGJ2 inhibits the growth-stimulation 
induced by RA. It also abolishes the reversal of the growth-inhibition by bradykinin, induced 
by indomethacin (data not shown). All these data combined suggest that the growth-inhibiting 
prostaglandin induced by bradykinin in NRK cells might be PGJ2. PGJ2 is a known inhibitor 
of cell progression (reviewed by Fukushima, 1992) and it is a good candidate for being the 
growth-inhibiting prostaglandin induced by bradykinin.
Present experiments aim to proof that PGJ2 is the growth-inhibiting prostaglandin 
specifically induced by bradykinin and not by PGF2a. Also the precise mechanism of the 
PGJ2-dependent inhibition by bradykinin will be the subject of further investigations. PGJ2 is 
known to elevate the synthesis of heat shock protein (HSP) 70 in human K562 
erythroleukemia cells (Santoro et al., 1989). Another point of interest will be the possible 
regulation of Ras-GAP and the neurofibromatosis-1 gene product by PGJ2 which has been 
shown to be regulated in vitro by PGA2, PGF1a, PGF2a, and PGE2 (Han et al., 1991).
The observed growth inhibition induced by bradykinin was shown to be paralleled by a 
repression of the up-regulation of EGF receptor expression by RA and TGFß (Van Zoelen et 
al., 1994). The up-regulation of growth factor receptors in NRK cells is probably the most 
appropriate mechanism for controlling density-dependent growth arrest (Rizzino et al., 1990; 
Van Zoelen et al., 1994). Further experiments will have to be carried out to indicate if PGJ2 
can mimic the effect of bradykinin on receptor up-regulation.
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Abstract
Normal rat kidney (NRK) fibroblasts are immortalised cells that are strictly dependent on 
externally added growth factors for proliferation. When cultured in the presence of epidermal 
growth factor (EGF) as the only growth stimulating hormone, these cells have a normal 
phenotype and undergo density-dependent growth inhibition. It has been postulated that this 
density-arrest results from a decrease of EGF receptor levels below a threshold level which 
makes these cells unresponsive to stimulation by EGF. In the present study we show that 
NRK cells, made quiescent by serum-deprivation at submaximum density, are mitogenically 
still responsive to EGF, but show enhanced mitogenic stimulation after 8 hours pre-treatment 
with either transforming growth factor ß (TGFß) or retinoic acid (RA), while prostaglandin 
F2a (PGF2a) and bradykinin (BK) enhance the mitogenic stimulation by EGF only slightly 
under these conditions. Addition of TGFß or RA results in an increase of both 125I-EGF- 
binding capacity and EGF receptor mRNA levels. Using flow cytometric analysis we show 
that pre-treatment with TGFß or RA increases the percentage of cells entering the cell cycle 
as a function of time. Furthermore, pre-treatment of the cells with TGFß or RA increases the 
rate of mitogen-activated protein kinase (MAPK) phosphorylation by EGF. PGF2a and BK 
also increase EGF receptor levels, but only with delayed kinetics. These results show that 
already in serum-deprived quiescent NRK cells EGF receptor levels limit EGF-induced 
mitogenic stimulation. This observation provides further evidence for the regulating role of 
the EGF receptor in density-dependent growth control of NRK cells.
Introduction
Normal rat kidney (NRK) fibroblasts have been widely used as a model system to study the 
molecular mechanisms of density-dependent growth control. These immortalised cells are 
strictly dependent on externally added growth factors for proliferation. When made quiescent 
by serum-deprivation at submaximum density, they are mitogenically still responsive to EGF. 
When cultured under these conditions in the presence of epidermal growth factor (EGF) as 
the only growth stimulating hormone, they have a normal phenotype and undergo density- 
dependent growth inhibition. In the additional presence of transforming growth factor ß 
(TGFß) or retinoic acid (RA), however, these cells become phenotypically transformed and 
can be released from density-arrest (Anzano et al., 1982; Van Zoelen et al., 1988; 1994).
Density-dependent growth inhibition is one of the main differences between the growth 
characteristics of normal versus tumour cells. Various molecular mechanisms have been 
proposed to explain why normal cells stop proliferating above a critical cell density. These 
include the production of autocrine growth inhibitors, modulation of the membrane potential
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and the ability to undergo intercellular communication, alterations in cell surface 
glycoproteins (reviewed by Van Zoelen, 1991), enhanced tyrosine phosphatase activity 
(Rijksen et al., 1993a, b), and activation of cyclin-dependent kinase inhibitors (reviewed by 
Peeper et al., 1994; Polyak et al., 1994). Furthermore it has been shown in a number of non­
transformed cell lines (Holley et al., 1978; Rizzino et al., 1988; 1990; Hamburger et al., 1991) 
that the density of polypeptide growth factor receptors decreases with increasing cell density. 
As a consequence normal cells may become unresponsive to the action of specific 
polypeptide growth factors as soon as a critical cell density has been reached.
In the case of NRK cells, modulation of EGF receptor densities seems to be the most 
appropriate mechanism for describing density-dependent growth inhibition. It has been shown 
that EGF binding decreases with increasing cell density in NRK cells (Rizzino et al., 1988; 
1990). TGFß and RA are potent inducers of phenotypic transformation in these cells (Van 
Zoelen et al., 1988) and both have been shown to increase EGF receptor gene transcription 
(Thompson et al., 1988; Thompson and Rosner, 1989; Hou et al., 1994) and, in a dose- 
dependent manner, also EGF receptor numbers (Assoian et al., 1984; 1985; Roberts et al., 
1984). Roberts et al. (1984) have shown that the increased EGF binding accompanying RA 
treatment of NRK cells correlates with increased responsiveness of the cells to EGF, 
suggesting that the EGF receptor number controls the response of these cells to EGF. These 
results have led to a model in which EGF receptor levels regulate density-dependent growth 
inhibition in NRK cells (Van Zoelen, 1991). In this model EGF receptor levels decrease at 
high cell density to such a level that the cells become unresponsive to the stimulating activity 
of EGF, resulting in density-dependent growth inhibition. Growth factors that increase EGF 
receptor number (TGFß and RA) enhance the level of growth-stimulating signals induced by 
EGF, and induce phenotypic transformation of the cells in the presence of EGF.
Confluent cultures of NRK cells, made quiescent by serum-deprivation, can still be 
induced to undergo one additional cell cycle by EGF, before reaching quiescence as a result 
of density arrest (Van Zoelen et al., 1988). Assuming that EGF receptor levels are decreased 
below a critical level in density-arrested cells, we hypothesised that already in serum- 
deprived quiescent cells EGF receptor levels must have been decreased to such a level that 
they limit EGF-induced mitogenesis. To confirm this we studied the effects of pre-treatment 
of serum-deprived quiescent NRK cells with factors that increase EGF receptor numbers and 
tested if they were able to enhance EGF-induced mitogenic stimulation. Besides TGFß and 
RA we also studied the effects of prostaglandin F2a (PGF2a), bradykinin (BK), and phorbol
12-myristate 13-acetate (PMA). The first two of these have been shown to induce 
proliferation of density-arrested NRK cells in an EGF-dependent manner (Afink et al., 1994), 
while PMA has been shown to be a poor inducer of phenotypic transformation of NRK cells 
(Van Zoelen et al., 1994).
The present studies show that pre-treatment of quiescent NRK cells with these modulating 
agents induces a time-dependent increase in EGF receptor levels, which is paralleled by 
enhanced mitogenic stimulation by EGF and enhanced EGF-induced phosphorylation of MAP 
kinase. From these data it is concluded that EGF receptor levels play a regulating role in 
growth control of NRK cells.
Materials and methods
Phenotypic transformation assay
NRK cells (clone 49F) were grown to confluency in serum-containing medium and were 
subsequently made quiescent by incubation in serum-free medium for three days (Van Zoelen 
et al., 1988). Incorporation of [3H]-thymidine (0.5 |iCi/ml added) was measured between 43 
and 45 hours after stimulation of serum-deprived, quiescent NRK cells with the indicated 
factors in the presence of 5 |ig/ml insulin (Van Zoelen et al., 1988).
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Growth-stimulation assays
NRK cells were grown to confluency in serum-containing medium and were subsequently 
made quiescent by incubation in serum-free medium for three days. These cells were pre­
treated for 8 hours with the indicated factors unless stated otherwise. Subsequently the 
medium was replaced by fresh serum-free medium (Van Zoelen et al., 1988) and the cells 
were restimulated to proliferate by the addition of 5 ng/ml EGF and 5 |ig/ml insulin. 
Incorporation of [3H]-thymidine (0.5 |iCi/ml added) was measured between 1 and 16 hours 
after the addition of EGF.
mRNA expression
EGF receptor mRNA levels were monitored semi-quantitatively using the “primer-dropping” 
RT-PCR method (Wong et al., 1994), as follows:
RNA extraction:
Quiescent cells (9.6 cm2 wells) were stimulated for 8 hours with growth factors after which 
RNA was extracted using the method described by Chomczynski and Sacchi (1987). The 
RNA concentrations were determined by measuring the absorbance at 260 nm.
Reverse transcription reactions:
Each 20 |il cDNA synthesis reaction contained 2 |ig of total RNA, 1x first strand buffer 
(Gibco-BRL), 2 mM each of deoxynucleotide triphosphates (dATP, dGTP, dCTP, dTTP, 
Pharmacia), 10 mM of DTT (Gibco-BRL), 20 units placental ribonuclease inhibitor 
(RNAguard, Pharmacia), 200 units of MuLV-reverse transcriptase (Superscript II, Pharmacia) 
and 30 |iM of oligo(dT)12. Reaction mixtures were preincubated for 5 min at 20°C prior to 
cDNA synthesis. The reverse transcription reactions were carried out for 90 minutes at 41°C, 
and the samples were subsequently heated for 5 min at 95°C to terminate the reverse 
transcription reaction. Subsequently samples were cooled to 4°C or stored at -20°C until use. 
PCR reactions:
Multiplex PCRs were started in a 20 |il reaction volume containing 0.5 |il of RT reaction 
product as template DNA (corresponding to cDNA synthesised from 50 ng of total RNA),
1.3x PCR buffer (Gibco-BRL), 2 mM MgCl2, 200 |iM of each deoxynucleotide and 17 pmol 
of each 5’ and 3’ EGF receptor primers (also designated the starter primer pair). To each tube 
0.625 units of Taq DNA polymerase (Gibco-BRL) were added during the first denaturation 
step. The DNA was amplified for 31 cycles in which each PCR cycle consisted of a 
denaturation step at 94°C for 30 seconds, a primer-annealing step at 60°C for 1 min, and a 
polymerisation step at 72°C for 30 seconds. During the 12th denaturation step 17 pmol of 
each 5’ and 3’ GAPDH primer (secondary primers) were added in 5 |il reaction mixture 
containing 1.3x PCR buffer, 2 mM MgCl2 and 200 |iM of each deoxynucleotide. PCR 
amplifications were performed in a Perkin Elmer thermal cycler. Aliquots of PCR reaction 
products (approximately 4 |il), equalised to give equivalent signals from the GAPDH mRNA, 
were electrophoresed through 2% agarose gels containing 0.5 |ig/ml of ethidium bromide. 
Gels were illuminated with UV light, photographed using “The Imager” (Appligene) and 
analysed by computerised densitometric scanning of the images using the “Image Quant” 
program. The intensities of the ethidium bromide fluorescence signals were determined from 
the area under the curve for each peak.
Primers:
Primers used for the amplification of:
(a) Rat EGF receptor cDNA: (forward primer) 5’-CCTCAGGGACTGCGAGAAC-3’, 
(reverse primer) 5’-AGCCACCTCCTGGATGGTC-3’ (PCR product size = 251 bp);
(b) Rat GAPDH cDNA: (forward primer) 5’-TCACCACCATGGAGAAGGC-3’, (reverse 
primer) 5’-GGATGACCTTGCCCACAGC-3’ (PCR product size = 359 bp).
Primer pairs for detecting rat EGF receptor cDNA were based on the PCR primer 
sequences used by Leung et al. (1991) and sequences obtained from Gen Bank for rat EGF
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receptor. Primer pairs for detecting rat GAPDH cDNA were based on the PCR primer 
sequences used by El-Husseini et al. (1994) and sequences obtained from Gen Bank for rat 
GAPDH.
EGF-binding studies
NRK cells grown to confluency in 6 -well dishes were made quiescent by incubation in 
serum-free medium for three days. The factors to be tested were added during 8 hours after 
which the medium was changed for 0.5 ml of binding buffer (Dulbecco’s modified Eagle’s 
medium, supplemented with 0.1 % BSA and 50 mM Bes, pH 6 .8) containing 4 ng/ml 
125I-EGF (generous gift from Dr. T. Benraad, Department of Endocrinology, University of 
Nijmegen). Non-specific binding was determined by a parallel treatment with a 100-fold 
excess of unlabelled EGF. The cells were incubated for 1 hour at room temperature after 
which they were washed three times with phosphate-buffered saline (PBS) containing 0.1 % 
BSA, three times with PBS and subsequently extracted with 1 % Triton X-100, prior to 
g-counting.
MAPK-phosphorylation
NRK cells were grown to confluency in 6 -well dishes (9.6 cm2) in serum-containing medium 
and were subsequently made quiescent by incubation in serum-free medium for three days. 
After pre-treating the cells for 8 hours with modulating factors, the time-dependent 
phosphorylation of MAPK by 5 ng/ml EGF was measured. At the indicated time points after 
stimulation the medium was aspired and the cells were washed once with ice-cold 
magnesium- and calcium-free phosphate-buffered saline and rapidly lysed in 150 |il of sample 
buffer (10% glycerol; 60 mM Tris.HCl, pH 6 .8 ; 2% SDS; 0.3 M b-mercaptoethanol; 
bromophenol blue). The lysates were sheared and boiled for 10 minutes. Aliquots of 20 |il 
were analysed by gelelectrophoresis on a 12.5% SDS-polyacrylamide gel. Proteins were 
transferred to nitro-cellulose and the blots were probed with a polyclonal antibody directed 
against MAPK (Burgering et al., 1993). Probed proteins were detected by horse radish 
peroxidase-linked second antibodies (Nordic, Tilburg) and visualized by POD Western 
Blotting chemiluminescence substrate (Boehringer Mannheim). The bands representing the 
phosphorylated MAPK and the unphosphorylated MAPK were scanned using a BioRad 
GS-700 Imaging Densitometer and analysed by computerised densitometric scanning of the 
images using the “Image Quant” program. Subsequently the amount of phosphorylated 
MAPK was expressed as a percentage of total MAPK.
Fluorescence analysis
Flow cytometric analysis:
For flow cytometric (FCM) analysis, serum-deprived quiescent NRK cells were pre-treated 
for 8 hours with the growth factors indicated, after which 10 |iM iodo-desoxyuridine (IdU; 
Sigma) was added together with EGF. At the indicated time points the cells were trypsinised, 
and fixed by the addition of a 20-fold excess of 70% ethanol. After this the cells were washed 
with magnesium-, calcium- and potassium-free phosphate-buffered saline, and treated with 
pepsin in 2N HCl, followed by a neutralisation step using sodium tetraborate, as described by 
Van Erp et al. (1988). Subsequently cells were incubated with a monoclonal antibody specific 
for IdU in the additional presence of 0.5% Tween-20, followed by an incubation with 
fluorescein-labelled rabbit-anti-mouse immunoglobulins (both from Dakopatts, Copenhagen, 
Denmark), and with the DNA-specific stain propidium iodide (Sigma) in the presence of 
RNAse. Cell cycle distribution was analysed on a flow cytometer 50H (Ortho Instruments, 
Westwood, CA) at an excitation wavelength of 488 nm, and emission at 515-530 nm for 
fluorescein and > 630 nm for propidium iodide (Van Erp et al., 1988). DNA histograms were 
analysed by the method of Baisch et al. (1975).
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Confocal laser scanning microscopy:
For the experiments using the confocal laser scanning microscope, cells were grown on 
gelatine-coated glass, fixed in acetone, and subsequently treated as mentioned above, using 
pepsin-free 4N HCl and omitting the trypsinisation step. Specimens were embedded in 
moviol, analysed on a BioRad MRC 600 CLSM microscope at an excitation wavelength of 
488 nm, and emission at 525-555 nm for fluorescein, and > 600 nm for propidium iodine, and 
subsequently photographed from the line screen.
Materials
Transforming growth factor b  (TGFbO was isolated from human platelets as described (Van 
den Eijnden-Van Raaij et al., 1988). Bradykinin, retinoic acid (RA), phorbol 12-myristate
13-acetate (PMA), and prostaglandin F2a (PGF2a ) were from Sigma, and [3H]-thymidine from 
Amersham.
Results
TGFp, RA, PGF2a, and BK prevent NRK cells from undergoing density-dependent growth 
inhibition
In order to investigate the mitogenic effects of the modulating factors tested and their ability 
to prevent NRK cells from undergoing density-arrest, [3H]-thymidine incorporation into 
quiescent NRK cells was measured between 43 and 45 hours after stimulation by these factors 
both in the absence and presence of EGF. Van Zoelen et al. (1988) have shown that cells 
which have become density-arrested do no longer incorporate [3H]-thymidine under these 
conditions.
Figure 1: TGFp, RA, PGF2a, and BK 
prevent NRK cells from undergoing 
density-dependent growth inhibition.
Serum -deprived, qu iescent NRK cells 
were treated for 45 hours w ith 1 ng/ml 
TGFb, 50 ng/ml RA, 1 pM PGF2a, 1 pM 
BK, 50 ng/ml PMA, or no addition 
(Cont), in the presence o f 5 pg/m l insulin 
and in the presence (+) or absence (-) of 
5 ng/ml EGF. Cum ulative [3H]-thym idine 
(TdR) incorporation was measured 
43-45 hour after stimulation. Indicated 
standard errors o f the mean are based 
on trip licate experiments.
EGF
The results presented in figure 1 show that in the presence of EGF as the only growth 
stimulating hormone, cells indeed undergo density-dependent growth arrest. In the additional 
presence of TGFb, RA, PGF2a or BK the cells have been prevented from undergoing density- 
dependent growth arrest and undergo phenotypic transformation. RA and TGFb induce 
phenotypic transformation strongly while PGF2a and BK have approximately half the 
stimulating activity of RA and TGFb under these conditions. PMA does not prevent cells 
from undergoing density-arrest. From these results it can be concluded that upon prolonged 
stimulation TGFb, RA, PGF2a and BK all prevent EGF-treated cells from undergoing density- 
dependent growth arrest. Since these modulating factors induce phenotypic transformation in 
an EGF dependent manner, we have subsequently tested the effects of these factors on EGF 
receptor levels.
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Effect of phenotypic transformation inducing agents on EGF-induced cell proliferation
In order to test if  EGF receptor levels limit EGF-induced proliferation in NRK cells made 
quiescent by serum deprivation, cells were pre-treated for 8 hours with the above factors. 
Subsequently the factors were removed followed by incubation for 16 hours in EGF- 
containing medium during which thymidine incorporation was measured.
The data in figure 2 show that none of these modulating agents has significant growth 
stimulatory activity in the absence of EGF. Pre-treatment with PGF2a, BK and PMA for 8 
hours increases EGF-induced proliferation only slightly, but strongly enhanced proliferation 
occurs following TGFb and RA pre-treatment. The increase of EGF-induced proliferation is 
not the result of a non-specific induction of cell proliferation by these modulating agents, 
since platelet-derived growth factor-BB (PDGF-BB)-induced mitogenic activation of NRK 
cells is not enhanced upon preincubation with TGFb or RA (data not shown). These results 
show that pre-treatment of quiescent NRK cells with factors that induce phenotypic 
transformation such as RA and TGFb, increases mitogenic activity of EGF. This demonstrates 
that there is a correlation between the ability of modulating factors to prevent cells from 
undergoing density-dependent growth inhibition and the ability to increase the mitogenic 
activation of NRK cells by EGF.
Figure 2: Effect of modulating agents on the 
EGF-induced thymidine incorporation levels 
in NRK cells.
Serum -deprived, quiescent NRK cells were 
pretreated fo r 8 hours with 1 ng/ml TGFb, 50 
ng/ml RA, 1 pM PGF2a, 1 pM BK, 50 ng/ml PMA, 
or no addition (Cont). Subsequently the m edium 
was replaced by fresh serum -free medium and 5 
ng/ml EGF was added (+) or not (-), both in the 
presence o f 5 pg/m l insulin, and cum ulative 
[3H]-thym idine (TdR) incorporation was 
measured between 1 and 16 hours after 
stimulation. Indicated standard errors o f the 
mean are based on trip licate experiments.
Effect of phenotypic transformation inducing agents on EGF receptor mRNA levels and 
125I-EGF binding to NRK cells
In order to directly investigate if the modulating agents tested enhance EGF receptor 
expression, the effects of these factors on EGF receptor mRNA levels were determined in 
NRK cells after treatment for 8 hours with these factors. Figure 3 shows that TGFb and RA 
strongly increase the EGF receptor mRNA levels after 8 hours, in contrast to PGF2a and BK 
which only have a very weak stimulating effect. PMA has even an inhibitory effect.
To verify if  this increase in EGF receptor mRNA levels also leads to an increase in EGF 
receptor numbers we determined 125I-EGF binding ability. The addition of TGFb, RA, PGF2a, 
BK and PMA to cultures of quiescent NRK cells resulted in an initial decrease of the 
125I-EGF binding in agreement with previous data (Assoian et al., 1984; Assoian, 1985; Earp 
et al., 1988). However, as can be seen in figure 4, after 8 hours of stimulation an apparent 
increase of 125I-EGF binding was observed after treatment with TGFb or RA. Stimulation 
with PGF2a, BK or PMA for 8 hours resulted in restored 125I-EGF binding. Because of the 
low numbers of EGF receptors in NRK cells (approximately 3000 receptors per cell (Van 
Zoelen et al., 1986)) receptor affinities are difficult to quantify in terms of a Scatchard plot. 
However, the initial decrease of the 125I-EGF binding did not seem to be caused by a shift in 
receptor affinity because a similar decrease was also observed in the presence of saturating 
concentrations (20 ng/ml) of 125I-EGF.
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Figure 3: Effect of modulating agents on 
the EGF receptor mRNA levels.
S e ru m -d e p rive d , q u ie sce n t N R K  ce lls  w e re  
trea te d  fo r 8 hou rs  w ith  1 ng /m l TG Fß, SG 
ng /m l RA, 1 pM  P G F 2a, 1 pM  BK, SG ng/m l 
PM A, S ng /m l EG F, o r no add ition  (C ont). 
E G F  re ce p to r m R N A  leve ls  w e re  m easured  
s e m i-q u a n tita tive ly  using th e  “ p rim e r- 
d ro p p in g ” R T -P C R  m ethod  and p lo tted  as 
fo ld  s tim u la tio n  re la tive  to  un trea ted  cells. 
Ind ica ted  s ta n da rd  e rro rs  o f th e  m ean are 
based on tr ip lica te  expe rim en ts .
C o n t T G F ß R A  P G F 2a B K  P M A  E G F
Figure 4: Effect of modulating agents on 
the 125I-EGF binding to NRK cells.
S e ru m -d e p rive d , q u ie sce n t N R K  ce lls  w e re  
trea te d  fo r 8 hou rs  w ith  1 ng /m l TG Fß, SG 
ng /m l RA, 1 pM  P G F 2a, 1 pM  BK, SG ng/m l 
PM A, o r no add ition  (C ont). 12SI-E G F  (4 
ng /m l) b ind ing  w a s  de te rm in e d  and co rrec ted  
fo r  n o n -sp e c ific  b ind ing  (ob ta in e d  by the  
a d d itio na l tre a tm e n t w ith  a 1GG-fold exce ss  o f 
u n labe lled  EG F), and p lo tted  as fo ld 
s tim u la tio n  re la tive  to  un trea ted  ce lls. 
Ind ica ted  s tanda rd  e rro rs  are  based on 
d u p lica te  expe rim en ts .
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Effect of phenotypic transformation inducing agents on EGF-induced MAPK phosphorylation
The previous results show that TGFb and RA increase 125I-EGF binding while PGF2a, BK 
and PMA have no effect. In order to determine if increased EGF receptor levels are paralleled 
by enhanced activation of intracellular second messengers we measured the activation of 
MAPK. Binding of EGF to its receptor results in an induction of both the RAS and 
phospholipase-C pathways which each lead to the activation of MAPK. This activation is 
accompanied by phosphorylation which can be quantified by Western blotting (Burgering et 
al., 1993). Figure 5 shows that in quiescent NRK cells MAPK is non-phosphorylated, and can 
be fully induced into the activated, phosphorylated state upon 4 minutes of treatment with 
EGF. The data show that in cells pre-treated for 8 hours with RA and TGFb near complete 
phosphorylation was already achieved after 2 min of incubation with EGF, while after 8 hours 
treatment with BK, PGF2a, or PMA the EGF-induced MAPK phosphorylation was not 
affected. Treatment with TGFb, RA, PGF2a, BK and PMA alone did not affect MAPK- 
phosphorylation measured after incubation for 8 hours. These data show that increased EGF 
receptor levels induced by RA and TGFb are paralleled by enhanced activation of 
intracellular second messengers. The rate by which EGF induces the phosphorylation of 
MAP-kinase correlates with the number of EGF receptors. However, there seems no 
correlation between the kinetics of the phosphorylation of MAP-kinase and the extend of the 
EGF-induced mitogenesis.
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Figure 5: Effect of modulating agents on 
EGF-induced MAPK phosphorylation in 
NRK cells.
Serum -deprived, qu iescent NRK cells were 
treated for 8 hours w ith 1 ng/ml TGFb, 50 
ng/ml RA, 1 pM PGF2a, 1 pM BK, 50 ng/ml 
PMA, or no addition (Cont). Subsequently 
the cells were incubated w ith 5 ng/ml EGF at 
37°C for the indicated periods o f time. The 
cells were lysed at 4°C in reducing sample 
buffer and the lysates were analysed by 
SDS-PAGE. Proteins were transferred to 
nitrocellulose and M APK was visualized with 
anti-M APK antibody followed by an 
incubation with a horse radish peroxidase- 
linked second antibody. Chem olum inesence 
was used for v isualization. M APK 
phosphorylation was expressed as a 
percentage of the total MAPK. Indicated 
standard errors are based on duplicate 
experiments.
Effect of prolonged incubation with modulating agents on EGF-induced cell proliferation and 
on 125I-EGF binding to NRK cells
We showed that pre-treatment of NRK cells for 8 hours with the modulating agents TGFb or 
RA strongly increases EGF-induced thymidine incorporation, EGF receptor mRNA levels, 
125I-EGF-binding, and the rate of mitogen-activated protein kinase (MAPK) phosphorylation 
by EGF. However pre-treatment of cells for 8 hours with PGF2a or BK increases EGF 
receptor mRNA levels and EGF-induced thymidine incorporation in NRK cells only slightly, 
with no apparent effect on 125I-EGF-binding and EGF-induced MAPK phosphorylation. The 
kinetics of phenotypic transformation induced by TGFb, RA, PGF2a, and BK show that 
PGF2a and BK induce phenotypic transformation with delayed kinetics when compared to RA 
and TGFb (Van Zoelen, 1991; Afink et al., 1994). These results suggest that PGF2a and BK 
may also enhance EGF receptor expression with delayed kinetics. We therefore measured the 
effect of incubation for 24 hour with these modulating agents on 125I-EGF-binding and on 
EGF-induced cell proliferation.
The data in figure 6 show that pre-treatment with PGF2a or BK for 24 hours increased 
EGF-induced proliferation much stronger than after 8 hours pre-incubation (figure 2), while 
TGFb and RA pre-treatment induced maximum levels of proliferation after both pre­
incubation periods.
To verify if  this increase in EGF-induced mitogenesis is paralleled by an increase in EGF 
receptor levels, we measured 125I-EGF binding after prolonged pre-treatment. In figure 7 it 
can be seen that stimulation for 24 hours with PGF2a and BK resulted in a more than 2 fold 
stimulation of 125I-EGF binding capacity, indicating that the EGF receptor number increases 
slower than after treatment with TGFb or RA. PMA did not increase 125I-EGF binding any 
further.
Kinetics of cell cycle entry by EGF is modulated by TGFp, RA, PMA, and BK
The differences in thymidine incorporation levels observed after pre-treatment of NRK cells 
with TGFb, RA, PGF2a, BK, and PMA (figure 2 and 6) can be considered to reflect the 
percentage of cells recruited to enter S-phase following EGF treatment. This is demonstrated 
in more detail in figure 8 , where the fraction of cells remaining in the G1/G0-phase has been 
determined as a function of time after EGF stimulation, using flow cytometric (FCM) 
analysis. It has been shown that, in a first approximation, cells leave the G1/G0-phase 
exponentially, the slopes of the linearities obtained reflecting the probability of cells entering 
the S-phase (Pardee et al., 1978). Under all conditions tested the first cells enter the S-phase
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after 7 hours of incubation with EGF. However, following pre-treatment with TGFß, 50% of 
the cells have left the G1/G0-phase within 10 hours of incubation, while without pre-treatment 
it takes nearly 13 hours before 50% of the cells have entered the S-phase. Since pre-treatment 
with TGFß and RA enhances EGF receptor densities in NRK cells dose-dependent, EGF 
receptor levels appear to determine directly the probability by which EGF subsequently 
induces these cells to proliferate. These data show that the percentage of cells induced to 
proliferate by EGF in a confluent culture made quiescent by serum-deprivation depends on 
EGF receptor levels, and can therefore be controlled by treatment with agents that increase 
EGF-receptor number such as TGFß, RA, PGF2a and BK.
Figure 6: Effect of 24 hour incubation with 
modulating agents on EGF-induced 
thymidine incorporation levels in NRK cells.
Serum -deprived, qu iescent NRK cells were 
pretreated for 24 hours with 1 ng/ml TGFß, 50 
ng/ml RA, 1 pM PGF2a, 1 pM BK, 50 ng/ml 
PMA, or no addition (Cont). Subsequently the 
m edium  was replaced by fresh serum -free 
m edium  and 5 ng/ml EGF was added (+) or not 
(-), both in the presence o f 5 pg/m l insulin, and 
cum ulative [3H]-thym idine (TdR) incorporation 
was m easured between 1 and 16 hours after 
stimulation. Indicated standard errors o f the 
mean are based on trip licate experiments.
+ EGF
Figure 7: Effect of 24 hour incubation with 
modulating agents on the 125I-EGF binding 
to NRK cells.
Serum -deprived, qu iescent NRK cells were 
treated for 24 hours w ith 1 ng/ml TGFß, SG 
ng/ml RA, 1 pM PGF2a, 1 pM BK, SG ng/ml 
PMA, or no addition (Cont). 12SI-EGF (4 ng/ml) 
binding was determ ined and corrected fo r non­
specific binding (obtained by the additional 
treatm ent with a 1GG-fold excess o f unlabelled 
EGF), and plotted as fold stim ulation relative to 
untreated cells. Indicated standard errors of 
the mean are based on duplicate experiments.
Figure 8: Effect of TGFß, RA, PMA, and BK 
on the percentage of cells recruited to 
proliferate following EGF treatment.
Serum -deprived, qu iescent NRK cells were 
pretreated for 8 hours w ith 1 ng/ml TGFß (O), 
50 ng/ml RA (■), 50 ng/ml PM A (x), or no 
addition ( • ) ,  all in the presence o f 5 pg/ml 
insulin. Following incubation w ith 5 ng/ml EGF, 
FCM analysis was carried out at the indicated 
tim e points to quantify the percentage o f cells 
w ith diploid DNA content in the G1/G 0-phase 
(w ithout IdU incorporation). Indicated standard 
errors o f the mean are based on trip licate 
experiments.
tim e after stim ulation (hrs)
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Recruitment of NRK cells by EGF to S-phase is TGFp dependent
The effect of TGFp pre-treatment on the efficiency of the recruitment of NRK cells from 
G1/G0- to S-phase upon treatment with EGF is illustrated in figure 9 using confocal laser 
scanning microscopic analysis. The lower half of each photograph represents fluorescence 
from the nuclei present, stained with propidium iodide. The upper half represents 
fluorescence from the same nuclei which during the incubation period have incorporated 
iodo-deoxy-uridine (IdU) following cellular S-phase progression. In untreated cells and cells 
incubated with insulin and TGFp, only a background percentage of cells have incorporated 
IdU as a result of S-phase progression. In cells stimulated by EGF for 16 hours without pre­
treatment roughly 50% of the nuclei are IdU positive, while in EGF-stimulated cells pre­
treated with TGFb more than 90% of the cells have been induced to enter S-phase. These data 
show that basically all NRK cells in these cultures can be induced to proliferate by EGF, but 
that the recruitment for individual cells is controlled by agents that modulate EGF receptor 
density.
C Figure 9: The effect of TGFp pre-treatment on the recruitment of NRK cells from G1/G0- to S-phase.
Serum-deprived, quiescent NRK cells were 
stimulated as follows:
A: no pretreatment, no EGF added;
B: no pretreatment, stimulation by 5 ng/ml EGF;
C: pretreatment with 1 ng/ml TGFp, no EGF added;
D: pretreatment with 1 ng/ml TGFp, stimulation by 5 
ng/ml EGF.
Pretreatment was carried out 8 hours before EGF 
addition, in the presence of 5 |jg/ml insulin. IdU was 
added together with EGF, following incubation for 16 
hours. For the four conditions tested, the upper panel 
shows fluorescence from IdU positive nuclei, while
D the lower panel shows fluorescence from the same field using propidium iodide as general nuclear 
staining. Magnification: 1500x.
Discussion
We have hypothesised that NRK cells become density-arrested in the presence of EGF, as 
soon as EGF receptor density has dropped below a critical level. As a prerequisite this should 
imply that at submaximum cell density EGF-induced signalling is limited by the number of 
EGF receptors. To confirm this hypothesis we examined in serum-deprived quiescent NRK 
cells if factors, that are known to enhance EGF receptor levels in these cells, increase EGF- 
induced mitogenesis. TGFb and RA are known to induce phenotypic transformation of NRK 
cells in an EGF-dependent manner and to increase the number of EGF receptors per cell 
(Assoian et al., 1984; Van Zoelen et al., 1994) while PMA has no effect on EGF receptor 
numbers (Kraft, 1986). In the present study we confirmed that besides TGFb and RA, also 
PGF2a and BK prevent NRK cells from undergoing density-dependent growth inhibition in 
the presence of EGF as a result of phenotypic transformation.
9 0  • •
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According to the model proposed by Van Zoelen (1991), modulating factors that induce 
phenotypic transformation of NRK cells in an EGF dependent manner should increase EGF 
receptor numbers. In this study we showed that pre-treatment of quiescent NRK cells for 8 
hours with TGFb or RA, and for 24 hours with PGF2a or BK did increase EGF-induced 
mitogenic activation. Furthermore we showed that TGFb and RA strongly increased EGF 
receptor mRNA levels and 125I-EGF binding within 8 hours, in agreement with previous 
studies (Assoian et al., 1984; Roberts et al., 1984; Assoian, 1985; Thompson et al., 1988; 
Thompson and Rosner, 1989; Hou et al., 1994), and also increased EGF-induced second 
messenger formation (MAPK phosphorylation). In contrast, addition of PGF2a or BK required 
24 hours to detect significantly increased 125I-EGF binding. The kinetics of EGF receptor 
increase by PGF2a or BK correlate very well with the kinetics of phenotypic transformation 
induced by these agents (Van Zoelen, 1991; Afink et al., 1994), which are delayed when 
compared to RA and TGFb. PMA decreased EGF receptor mRNA levels and EGF-induced 
MAPK phosphorylation weakly, and did have no effect on 125I-EGF binding, in agreement 
with the observation of Kraft (1986) that PMA has no effect on EGF receptor number in NRK 
cells. Earp et al. (1988) have shown that growth factors that stimulate PtdIns(4,5)P2 
hydrolysis increase EGF receptor mRNA levels and EGF receptor protein synthesis in WB 
cells within 3 hours. PGF2a and BK are both inducers of PtdIns(4,5)P2 hydrolysis in NRK 
cells (Afink et al., 1994; Van Zoelen et al., 1994), but do increase EGF receptor numbers only 
after 24 hours of stimulation in NRK cells. PGF2a is a stronger inducer of PtdIns(4,5)P2 
hydrolysis than BK in NRK cells (Afink et al., 1994), but does not increase EGF receptor 
numbers more strongly than BK, suggesting that there is no direct correlation between the 
level of PtdIns(4,5)P2 hydrolysis and the increase in EGF receptor numbers. The current 
effects of BK seem unrelated to its observed inhibitory effect on loss of density-dependent 
growth inhibition upon short time incubation (Afink et al., 1994).
In many cell types EGF itself is able to enhance the EGF receptor mRNA levels (Clark et 
al., 1985; Earp et al., 1988; Thompson and Rosner, 1989), receptor protein levels (Earp et al.,
1988), and receptor gene promoter activity (Hudson et al., 1989), acting on both the 
transcriptional (Hudson et al., 1989; Thompson and Rosner, 1989) and posttranscriptional 
(Clark et al., 1985) level. The results from Thompson and Rosner (1989) show that in NRK 
cells EGF enhances the EGF receptor mRNA level only slightly by increased transcription. 
However, in density-inhibited NRK cells, EGF seems no longer able to enhance the number 
of EGF receptors to a sufficiently high level (Van Zoelen et al., 1994). The present study 
shows that also in serum-deprived, quiescent NRK cells EGF is not able to enhance the EGF 
receptor mRNA level. Only very high EGF concentrations (50 ng/ml) induce a slight increase 
of EGF receptor mRNA, in agreement with the results from Thompson and Rosner (1989). 
However, even at that high concentration EGF does not enhance the number of EGF receptors 
to a sufficiently high level that can prevent cells from undergoing density arrest (data not 
shown).
The decrease of EGF receptor levels at high cell density is not universal. In BSC-1, KB, 
A-549, A-431, NRK-49F, WI-38, and CCD-18LU cells EGF receptor levels are decreased at 
high cell density (Rizzino et al., 1990), but in human glial cells EGF receptor levels have 
been shown to be upregulated at high cell density (Westermark, 1977). If a decrease of EGF 
receptor levels at high cell-density results in growth arrest, it should be expected that 
upregulation of EGF receptor expression levels results in increased proliferation. Hongo et al. 
(1992) proved that an increase in EGF receptor levels enhances EGF-induced mitogenesis 
only in cells with low EGF receptor levels, by showing the relationship between the ability of 
TGFb to increase EGF receptor numbers and the EGF-induced mitogenesis in different types 
of rabbit corneal cells with different EGF receptor numbers. Besides EGF binding, also the 
PDGF, fibroblast growth factor (FGF) and TGFb binding decrease with increasing cell
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density in NRK cells (Rizzino et al., 1988; 1990), but cell density does not seem to regulate 
all growth factor receptors co-ordinately. The binding of TGFß, PDGF, and fibroblast growth 
factor (FGF) decreases stepwise with increasing cell density while the EGF binding is sharply 
reduced at high cell densities, but not at intermediate cell densities (Rizzino et al., 1990). This 
different regulation o f the EGF receptor binding in NRK cells supports the previously 
mentioned idea that the decrease o f  EGF receptor levels in these cells regulates density- 
dependent growth inhibition in NRK cells and suggests that the decrease o f  the other 
receptors plays a minor role. Furthermore it has been shown that a decrease of PDGF or 
insulin-like growth factor-II binding at high cell density plays a minor role in the regulation 
of density-dependent growth inhibition in NRK cells because neither RA nor TGFß increase 
PDGF binding to NRK cells (Van Zoelen et al., 1986) or increase PDGF-BB-induced 
mitogenic activation of the cells (data not shown), while TGFß does not increase the number 
of receptors for insulin-like growth factor-II (Assioan et al., 1984).
TGFß induces loss of density-dependent growth inhibition and anchorage-independent 
proliferation, two aspects of phenotypic transformation, in NRK cells. Besides the mechanism 
by which TGFß induces loss of density-dependent growth inhibition of NRK cells in the 
presence o f EGF by increasing EGF receptor numbers and enhancing the level o f  growth- 
stimulating signals induced by EGF (Van Zoelen, 1991), it has been proposed that the 
induction o f extracellular matrix proteins such as fibronectin plays an important role in the 
induction of anchorage-independent proliferation by TGFß (Ignotz and Massague, 1986).
This seems to explain the effects of TGFß on anchorage-independent proliferation quite well 
because the production o f matrix proteins by cells grown in agar could provide an anchorage 
for their daughter cells. It is difficult to imagine, however, how this mechanism could play a 
role in the loss o f  density-dependent growth inhibition o f NRK cells, since these cells are 
already anchored and form cellular monolayers with high endogenous fibronectin levels (Van 
Zoelen, unpublished results). Furthermore, RA does not seem to enhance the fibronectin gene 
expression in NRK cells (Thompson et al., 1988; Thompson and Rosner, 1989) but does 
induce phenotypic transformation, indicating that cells can undergo phenotypic 
transformation in the absence of increased fibronectin gene expression.
In conclusion we have shown in the present study that the recruitment o f  serum-deprived, 
quiescent NRK cells by EGF to enter the cell cycle is enhanced by agents that increase EGF 
receptor levels. From these results it can be concluded that already in serum-deprived 
quiescent NRK cells EGF receptor levels are limiting for EGF-induced mitogenesis. This 
provides further evidence for the regulating role o f  the EGF receptor in density-dependent 
growth control of NRK cells.
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Abstract
Epidermal growth factor (EGF) receptor levels are known to play a central role in density- 
dependent growth regulation of normal rat kidney (NRK) fibroblasts. Here we show that EGF 
receptor expression is strongly decreased when NRK cells are cultured under anchorage- 
independent conditions, and that expression is returned to original levels upon cell re­
adherence. Agents that stimulate anchorage-independent growth (AIG) of NRK cells in the 
presence of EGF are shown to upregulate both EGF receptor promoter activity and 125I-EGF 
binding capacity. These data show that two aspects of phenotypic transformation of NRK 
cells, namely density-arrest and AIG, can both directly be correlated to EGF receptor levels.
Introduction
Cell cycle progression of non-transformed fibroblasts is regulated by extracellular signals 
provided by polypeptide growth factors and cell adhesion. In contrast, most tumour cells can 
proliferate in the absence of externally added growth factors and without cell anchorage. In a 
number of non-transformed cell lines, polypeptide growth factors are able to induce 
phenotypic transformation (Ozanne et al., 1982), resulting in loss of density-dependent 
growth inhibition (DDGI) and induction of anchorage-independent growth (AIG). AIG is 
regarded to be the best in vitro correlate for tumorigenic behaviour of cells in vivo (Shin et al., 
1975; Cifone and Fidler, 1980), but the mechanisms underlying AIG are still largely 
unknown. Several mechanisms have been proposed to play a role in the induction of AIG, 
including increased production of extracellular matrix proteins such as fibronectin (Ignotz and 
Massague, 1986; Thompson et al., 1988), an increase in intracellular pH (Schwartz et al.,
1989), induction of cyclin A (Guadagno et al., 1993) and cyclin D1 (Zhu et al., 1996) 
expression, activation of cyclin E-cdk2 (Zhu et al., 1996), activation of a connective tissue 
growth factor (CTGF)-dependent signalling pathway (Kothapalli et al., 1997), and modulation 
of protein-tyrosine phosphatase activity (Rijksen et al., 1993b; Galaktionov et al., 1995).
NRK fibroblasts have been widely used as a model system to study the role of growth 
factors in phenotypic transformation. When cultured in the presence of epidermal growth 
factor (EGF) as the only growth-stimulating hormone, these immortalized cells have a normal 
phenotype and undergo DDGI. In the additional presence of modulating factors such as 
retinoic acid (RA) or transforming growth factor-ß (TGF-ß), which by themselves are not 
mitogenic for these cells, density-arrested NRK cells become responsive again to the growth 
stimulatory effect of EGF, resulting in loss of DDGI (Anzano et al., 1982; Van Zoelen et al., 
1988; Van Zoelen, 1991; Lahaye et al., 1998). It has been established that the number of EGF 
receptors in NRK cells decreases with increasing cell density. Therefore, we have postulated
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that EGF-treated NRK fibroblasts become density-arrested as a result of a reduction in EGF 
receptor levels below a critical level from which they can be released by addition of such 
factors as RA and TGF-b that increase EGF receptor numbers (Van Zoelen, 1991; Lahaye et 
al., 1998).
In normal rat kidney (NRK) fibroblasts, a strong parallel has been observed between the 
growth factor requirements for induction of DDGI and AIG (Van Zoelen et al., 1988; Lahaye 
et al., 1999). Furthermore, mutant NRK cells have been described in which transforming- 
deficiency is coupled to an inability to proliferate under anchorage-independent conditions, 
suggesting that the same mechanisms may underlie these two aspects of transformation 
(Kume et al., 1992). However, the role of EGF receptor densities in induction of AIG of NRK 
cells has not been studied directly. In the present study, we show that EGF receptor levels are 
strongly decreased under anchorage-independent conditions and upregulated again when cells 
are allowed to re-adhere. Agents that induce EGF-dependent AIG in NRK cells are shown to 
upregulate EGF receptor expression in these non-adhered cells. These data indicate that EGF 
receptor levels may not only control DDGI of NRK cells, but also their ability to grow under 
anchorage-independent conditions.
Materials and methods 
Cell cultures
Adherent cells: NRK cells (clone 49F) were plated at a density of 1.0x104 cells/cm2, and 
grown to confluence in Dulbecco’s modified Eagle’s medium (DMEM), supplemented with 
10% (v/v) newborn calf serum (NCS). Confluent cells were subsequently made quiescent by 
incubation in serum-free medium (SF) consisting of a 1:1 mixture of DMEM and Ham’s F-12 
medium, supplemented with 30 nM Na2SeO3 and 10 |ig/ml human transferrin for three days 
(Van Zoelen et al., 1988).
Anchorage-independent growth. Tissue culture plates were coated with poly (2-hydroxyethyl- 
methacrylate), abbreviated as poly(HEMA), in ethanol as described (Fukazawa et al., 1995). 
One day before each experiment, confluent NRK cell cultures were trypsinized and replated 
at 50% confluency in order to obtain single cells in a subconfluent, proliferating culture. The 
next day, cells were trypsinized again and seeded in SF medium supplemented with 5 |ig/ml 
insulin, 0.2% bovine serum albumin (BSA), and 10% (v/v) growth factor-inactivated foetal 
calf serum (SFS medium) (Van Zoelen et al., 1986).
MTT assay for anchorage-independent growth
A total of 1.5x104 cells were seeded in 130 |il per well of SFS medium in 96-well tissue 
culture plates coated with poly(HEMA). Subsequently, growth factors to be tested were added 
to the cells in 20 |il binding buffer (DMEM supplemented with 0.1% BSA and 50 mM Bes, 
pH 6 .8 ; see (Van Zoelen et al., 1986)). After incubation for 5 days, 15 |il MTT ((3-(4,5- 
dimethylthiazol-2yl)-2,5-diphenyltetrazolium bromide), 5 mg/ml) in phosphate-buffered 
saline (PBS) was added and incubated for 4 hours. The produced MTT formazan was 
solubilized by addition of 100 |il of SDS solution (20% (w/v) sodiumdodecyl sulphate in 0.1 
M HAc), and the absorbance was measured after 24 hours at 570 nm, relative to the 
absorbance at 690 nm, using a microplate reader (Fukazawa et al., 1995).
EGF receptor promoter activity
Vectors: EGF receptor gene promoter activity: Luciferase reporter gene vector pSVOALD5’ 
containing the 5’ region of the human EGF receptor gene (-1100 to -19 relative to the ATG 
translation site) (Hudson et al., 1989), was kindly provided by Dr G.N. Gill (University of 
California, San Diego). PDGF a-receptor gene promoter activity: Luciferase reporter gene 
vector (pSLA4) containing the -441 to +118 region of the human platelet-derived growth 
factor a-receptor (PDGFaR) gene promoter (-441/+118LUC) (Afink et al., 1995). To allow
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for selection of stable transfectants, a neomycin resistance-encoding vector (pcDNA I/ NEO, 
Invitrogen) was cotransfected.
Transfections'. NRK cells were seeded at a density of 4.0x104 cells/cm2 in 80 cm2 tissue 
culture dishes, one day prior to transfection. Plasmid DNA was transfected using the calcium 
phosphate precipitate method (Sambrook et al. 1989). Subsequently, the cells were incubated 
for 3 days in DMEM + 10% NCS, after which 700 |ig/ml geneticin was added to start the 
selection of the transfected cells. The surviving cells were trypsinized and cultured in the 
presence of geneticin (300 |ig/ml) for 3 weeks.
Assay o f  luciferase activity: The stably transfected cells were cultured under the same 
experimental conditions as described above for the parental cells. Luciferase activity was 
assayed in a LKB 1250 luminometer, using the Promega luciferase assay kit. Luciferase 
activity was corrected for cell numbers by measuring protein concentrations according to the 
Lowry method using BSA as standard.
mRNA expression
EGF receptor mRNA expression was monitored semi-quantitatively by the “primer-dropping” 
RT-PCR method which allows to distinguish changes in gene expression of less than twofold 
to greater than 75-fold (Wong et al., 1994). Optimal cycle numbers were determined as 
described (Wong et al., 1994). Under these conditions competitive interference was absent 
and twofold changes in the abundance of PCR products were detected over a span of 4-5 
cycles, making this method suitable to monitor EGF receptor mRNA expression (Lahaye et 
al., 1998).
EGF-binding studies in non-adherent cells
A total of 0.5x106 cells were seeded in 1 ml SFS medium in 24-well tissue culture plates 
(adherent) or in 24-well tissue culture plates coated with poly(HEMA) (non-adherent) and 
treated for 48 hours with the indicated factors. After washing the cells three times with 
binding buffer, the medium was changed for 0.5 ml of binding buffer now containing in 
addition 4 ng/ml murine 125I-EGF (a gift from Dr. T. Benraad, Department of Endocrinology, 
University of Nijmegen). Non-specific binding was determined by a parallel treatment with a 
100-fold excess of unlabelled EGF. The cells were incubated for 1 hour at room temperature 
after which they were washed three times with PBS containing 0.1% BSA, three times with 
PBS and subsequently extracted with 1% (v/v) Triton X-100, prior to g-counting (Van Zoelen 
et al., 1994). 125I-EGF binding was corrected for cell numbers by measuring protein 
concentrations according to the Lowry method using BSA as standard.
Materials
Transforming growth factor b 1 (TGF^1) was from R&D Systems. Bradykinin (BK), 
lysophosphatidic acid (LPA), prostaglandin F2a (PGF2a), retinoic acid (RA), transferrin,
MTT, and BSA were from Sigma. Endothelin-1 (ET-1) was from Peninsula Laboratories 
Europe. DMEM and Ham’s F-12 medium were from Gibco, NCS from Hyclone, and 
poly(HEMA) from Aldrich-Chemie, Germany.
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Results
125EGF receptor mRNA, EGF receptor promoter activity and I-EGF binding are decreased in 
anchorage-independent cultures of NRK cells
Figure 1 shows EGF receptor mRNA levels, measured be the “primer-dropping” RT-PCR 
method, in NRK cells that have been cultured for 3 days on poly(HEMA)-coated dishes. The 
data indicate a 2.5 fold reduction in mRNA levels in anchorage-independent cells when 
compared to quiescent monolayer cells. When cells were grown on poly(HEMA)-coated 
dishes in the presence of EGF and RA, a combination of factors that induces AIG of NRK 
cells, no such reduction in EGF receptor mRNA levels was observed.
In order to study if the above reduction in mRNA levels under anchorage-independent 
conditions is due to a repression of transcriptional activity, the activity of an EGF receptor 
promoter construct linked to luciferase was studied after stable transfection into NRK cells. 
Figure 2 shows that basal EGF receptor promoter activity decreased in a time-dependent 
manner after substrate release, resulting in approximately 10% of its original value after 72 
hours of incubation. Re-adherence of the same cells resulted in a time-dependent restoration 
of EGF receptor promoter activity, demonstrating that the reduction in activity upon substrate 
release is not due to cell death. Moreover, a similar reporter construct based on the platelet- 
derived growth factor a-receptor promoter was much less affected by cell adherence, 
indicating that the effects observed do not result from a general inhibition of macromolecule 
biosynthesis.
Quiescent
monolayer Poly-HEMA
^  t , RA Control + 
EGF time after seeding (hours)
Figure 1: Effect of cell anchorage on EGF 
receptor mRNA levels in NRK cells
NRK cells were cultured for 3 days on 
poly(HEM A)-coated dishes in SFS m edium  (poly- 
HEMA) in the absence (Control) or presence of 
50 ng/ml RA and 5 ng/ml EGF (RA+EGF), or 
were cultured as m onolayer cells and incubated 
in SF m edium for 3 days (Q uiescent monolayer). 
Indicated standard errors o f the mean are based 
on at least five experiments.
Figure 2: Influence of anchorage-independent 
culturing of NRK cells and subsequent re-adherence 
on EGF receptor promoter activity
EGF receptor (continuous line) or PD G Fa receptor 
(dashed line) prom oter-activity m easured as a function of 
tim e after seeding the (stably transfected) cells on 
poly(HEM A)-coated dishes in SFS medium. A fte r 3 days, 
the non-adherent NRK cells were allowed to reattach in 
the sam e m edium  and luciferase activity was measured 
for another 3 days. Indicated standard errors of the 
mean are based on trip licate experiments.
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In figure 3 it is shown that this decrease of EGF receptor promoter activity is parallelled by a 
decrease of 125I-EGF binding. These data show that EGF receptor expression levels are 
strongly affected by cell adherence. Similar effects on EGF receptor expression have been 
obtained by Mansbridge et al. (1994) who showed a strongly decreased binding of 125I-EGF to 
A431 cells when grown in spheroids, in contrast to those of Ness et al. (1994) who observed 
an increase in EGF receptor mRNA levels in glioma cells cultured without anchorage.
Adherent
oo ■0to G)
Figure 3: Effect of anchorage-independent culturing and 
phenotypic transformation-inducing agents on EGF 
binding in NRK cells.
NRK cells were seeded on culture dishes (adherent) or on 
poly(HEMA)-coated dishes (non-adherent), the latter in the 
presence of 1 pM PG F2a, 50 ng/ml RA, or 1 ng/ml TGFp, or 
without additional factors (control) in S F S  medium. After 
incubation for 2 days, 125I-EGF (4 ng/ml) binding was 
determined and corrected for non-specific binding. Data are 
expressed relative to the number of cells determined by 
protein analysis. Indicated standard errors are based on 
duplicate experiments.
Non-adherent
Induction of anchorage-independent growth of NRK cells is parallelled by increased EGF 
receptor promoter activity and increased 125I-EGF binding
Besides RA and TGFb, several other factors have been shown to induce phenotypic 
transformation of NRK cells in the presence of EGF, including bradykinin (BK), 
prostaglandin F2a (PGF2a), endothelin-1 (ET-1), and lysophosphatidic acid (LPA) (Roberts et 
al., 1984; Kusuhara et al., 1992; Afink et al., 1994; Van Zoelen et al., 1994). When tested on 
quiescent monolayer cells and density-arrested cells, these various factors have been shown to 
enhance EGF receptor levels (Lahaye et al., 1998). In order to study if these factors are also 
able to enhance EGF receptor expression in anchorage-independent cells, we used the above 
cells stably transfected with the EGF receptor promoter linked to luciferase. Figure 4 shows a 
comparison between the ability of these factors to induce AIG of NRK cells and their ability 
to enhance EGF promoter activity in anchorage-independent cultures of these cells. The data 
presented show that ET-1, TGFb, and PGF2a strongly increase both EGF-dependent AIG and 
EGF receptor promoter activity, while BK, LPA, and RA have only a minor effect in both 
assays. Similar results were obtained when colony formation in soft agar was measured 
instead of proliferation on poly(HEMA)-coated dishes (data not shown). Also in anchorage- 
independent cells which were first cultured for 48 hours in the absence of growth factors,
EGF receptor promoter activity and AIG could still be induced upon subsequent growth factor 
treatment (data not shown), indicating these growth factors can up-regulate EGF receptor 
promoter activity even after the initial decrease observed upon loss of anchorage. 125I-EGF 
binding studies show (figure 3) that particularly PGF2a and TGFb strongly enhance the 
number of EGF receptors in anchorage-independent NRK cells, in parallel with their activity 
on EGF receptor promoter activity (figure 4A). RA was less active in both assays, but clearly
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more potent in the binding assay than in the promoter assay. The same disconnection between 
the induction of EGF receptor promoter activity and AIG can be seen in the case of 
stimulation with LPA. This discrepancy will be discussed.
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Figure 4: Effect of phenotypic transformation-inducing agents on EGF receptor promoter activity in 
anchorage-independent NRK cells compared to their ability to induce anchorage-independent 
proliferation.
A: EGF receptor promoter activity. NRK cells were seeded on poly(HEMA)-coated dishes in the presence of 1 pM 
BK, 1 pM PG F2a, 0.1 pM ET-1, 100 pM LPA, 50 ng/ml RA, 1 ng/ml TGFp, 5 ng/ml EGF, or in the absence of 
factors (Cont) in S F S  medium. After incubation for 2 days, EGF receptor promoter activity was measured and 
corrected for cell numbers. Indicated standard errors of the mean are based on triplicate experiments.
B: Anchorage-independent proliferation. NRK cells were seeded on poly(HEMA)-coated dishes in the presence of
5 ng/ml EGF and the indicated factors, or in the complete absence of factors (Cont) in S F S  medium. After 
incubation for 5 days, cell numbers were measured using the MTT assay. Indicated standard errors of the mean 
are based on quadruplicate experiments.
Discussion
NRK fibroblasts are unique in that their proliferation is strongly stimulated by EGF, while 
this growth factor is unable to induce a transformed phenotype in these cells. In our previous 
studies we have shown (Lahaye et al., 1998) that pre-treatment of quiescent NRK cells with 
agents that enhance EGF receptor levels increases the mitogenic potential of EGF in these 
cells, indicating that the number of EGF receptors limits the mitogenic activity of this growth 
factor. Moreover, addition of such factors to confluent monolayer cultures is essential to 
induce phenotypic transformation of EGF-treated NRK cells, by preventing them from 
becoming density-arrested. In the present study we have shown that, similar to culturing at 
high cell density, also anchorage-independent culturing of NRK cells results in a strong 
reduction of EGF receptor expression levels. As a consequence, treatment of anchorage- 
independent cells with EGF alone is insufficient to induce these cells to proliferate. However, 
treatment of these cells with the modulating factors that are known to increase EGF receptor 
expression in monolayer cells results in anchorage-independent growth of EGF-treated cells. 
This shows that the growth factor requirements for loss of density-dependent growth 
inhibition and anchorage-independent growth of NRK cells are very similar and that in both 
cases EGF-induced proliferation very likely relies on sufficiently high EGF receptor levels.
In this study, we have used NRK cells stably transfected with the 5’-region of the human
EGF receptor promoter activity
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EGF receptor gene linked to luciferase to study the effects of modulating factors on EGF 
receptor promoter activity. Previous studies have indicated that this promoter construct is 
sensitive to stimulation by EGF itself, phorbol 12-myristate 13-acetate (PMA), (Bu)2cAMP, 
dexamethasone (Hudson et al., 1989), and TGFb (Thompson et al., 1988; Hou et al., 1994). 
Retinoic acid (RA) has been shown to have both activating (Hudson et al., 1989) and 
repressing (Zheng et al., 1992) activity on the EGF receptor promoter, while expression 
studies have indicated that agents which induce PtdIns(4,5)P2 hydrolysis in rat liver epithelial 
cells are able to increase EGF receptor mRNA levels in these cells (Earp et al., 1988). We 
have previously shown that ET-1 and PGF2a are both very strong inducers of PtdIns(4,5)P2 
hydrolysis in substrate-attached NRK cells, while BK and LPA have only poor activity 
(Lahaye et al., 1999). These results correlate very well with our current results on induction of 
EGF receptor promoter activity in anchorage-independent cells.
Our present binding studies with radiolabeled EGF have indicated that RA not only 
upregulates EGF receptor mRNA and protein levels in monolayer NRK cells (Roberts et al., 
1984; Thompson and Rosner, 1989; Lahaye et al., 1998) but also in anchorage-independent 
cells (figure 3). This increase of 125I-EGF binding is parallelled by induction of AIG (figure 
4B), but not necessarily by a comparable increase of EGF receptor promoter activity (figure 
4A). This could be due to the fact that important RA-inducible elements for positive 
regulation of EGF receptor expression in NRK cells are lacking in the promoter construct 
tested here, as indicated in earlier studies (Maekawa et al., 1989). Nevertheless, in adherent 
NRK cells, EGF receptor promoter activity is strongly increased by RA (Lahaye et al., 1999). 
This does not exclude the possibility however that important RA-inducible elements for 
positive regulation of EGF receptor expression in non-adherent NRK cells are lacking in the 
promoter construct tested here. The strong increase of EGF receptor mRNA levels by RA in 
the presence of EGF (figure 1) underlines this statement. The same contrast between 
induction of EGF receptor promoter activity and AIG was seen when the cells were 
stimulated with LPA, indicating that the correlation between EGF receptor levels and EGF 
receptor promoter activity is only observed whith specific stimuly, in paticular TGFb and 
PtdIns(4,5)P2 hydrolysing agents such as ET-1 and PGF2a.
Our present 125I-EGF binding studies show that the decrease of EGF receptor mRNA levels 
and promoter activity is parallelled by a decrease of 125I-EGF binding, while factors that 
induce AIG also increase 125I-EGF binding. Most likely these binding studies tend to 
underestimate the effects of the modulating agents tested on EGF receptor expression, since 
anchorage-independent NRK cells have a tendency to form clusters that have a limited 
penetration of EGF (Mansbridge et al., 1992). In our experience and that of others (reviewed 
in Van Zoelen, 1991) it is difficult, however, to quantitatively determine EGF receptor levels 
in NRK cells by other techniques, e.g. using immunological techniques, because of the very 
low receptor numbers present.
Our data show that EGF itself is able to increase EGF receptor promoter activity in NRK 
cells to a level which is comparable to that induced by PGF2a. In many cell types, including 
monolayer NRK cells (Thompson and Rosner, 1989), EGF is able to enhance EGF receptor 
mRNA levels (Clark et al., 1985; Earp et al., 1988; Thompson and Rosner, 1989), receptor 
protein levels (Earp et al., 1988), and receptor gene promoter activity (Hudson et al., 1989), 
acting on both the transcriptional (Hudson et al., 1989; Thompson and Rosner, 1989) and 
post-transcriptional (Clark et al., 1985) level. However, EGF by itself is neither able to induce 
anchorage-independent proliferation of NRK cells, nor to induce proliferation of density- 
arrested cells. This shows that an increase of EGF receptor numbers alone may not 
necessarily be sufficient to induce AIG of NRK cells and that additional signalling pathways 
may be involved. Nevertheless, the present data strongly suggest that an increase of EGF 
receptor numbers is a prerequisite for the induction of anchorage-independent growth.
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Several other mechanisms have been proposed to play a role in the induction of AIG of NRK 
cells. The induction of extracellular matrix proteins such as fibronectin has been shown to 
accompany the induction of AIG by TGFß (Ignotz and Massague, 1986; Thompson et al., 
1988). However, not all phenotypic transformation-inducing factors increase fibronectin gene 
expression (Thompson et al., 1988; Rijksen et al., 1993b), showing that that the production of 
extracellular matrix proteins is not obligatory for AIG. Furthermore, fibronectin is unable to 
replace TGFß in inducing AIG of EGF-treated NRK cells (Allen Hoffmann et al., 1986; E.J.J. 
van Zoelen, unpublished data). Another mechanism proposed is the modulation of protein- 
tyrosine phosphatase (PTPase) activity, since inhibition of PTPases leads to induction of AIG 
(Rijksen et al., 1993b) and overexpression of the tyrosine- and threonine-specific cdc25 
phosphatase is involved in the induction of AIG (Galaktionov et al., 1995). Furthermore, a 
connective tissue growth factor (CTGF)-dependent signalling pathway seems to be involved 
in TGFß-induced AIG of NRK cells (Kothapalli et al., 1997). Other studies show that the 
expression of cyclin A plays an important role in the regulation of AIG in NRK cells. The 
expression is suppressed when NRK cells are suspended while ectopic expression of cyclin A 
bypasses the adhesion requirement (Guadagno et al., 1993). The regulation of cyclin A 
expression by adhesion is mediated at the transcriptional level (Krämer et al., 1996), 
suggesting that proteins that are present prior to the appearance of cyclin A during cell cycle 
progression are targets of the adhesion signal (Carstens et al., 1996). Unlike observations on 
other cell types (Böhmer et al., 1996; Zhu et al., 1996), cyclin D1 levels or activity of the 
cyclin E/cdk2 complex do not appear to play a role in the induction of AIG of NRK cells 
(Zhu et al., 1996). It should be realized, however, that most of the studies mentioned on AIG 
of NRK cells have been carried out in the presence of serum-containing media with its variety 
of growth factors. Our previous studies on density-dependent growth arrest of NRK cells and 
our current ones on AIG have all been carried out under growth factor-defined culture 
conditions, to allow studies on the effects of EGF as the only growth-stimulating hormone 
present.
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Abstract
In the present study, we compared the effects of endothelin (ET)-1 on cell proliferation and 
second messenger induction in normal rat kidney (NRK) fibroblasts, with those of other 
activators of G protein-coupled receptors such as prostaglandin (PG)-F2a, bradykinin (BK), 
and lysophosphatidic acid (LPA). LPA is mitogenic by itself, while the other factors require 
the presence of epidermal growth factor (EGF). In density-arrested NRK cells, ET-1 and LPA 
induce phenotypic transformation rapidly, with similar kinetics as retinoic acid (RA) and 
transforming growth factor (TGF)-b, while BK and PGF2a only do so with delayed kinetics. 
ET-1 and PGF2a are strong inducers of anchorage-independent growth, with a similar level of 
induction as TGFb, in contrast to LPA and BK. When investigating second messenger 
generation, we found that ET-1 is the strongest activator of arachidonic acid release and 
phosphatidyl-inositol diphosphate hydrolysis. Only in the case of ET-1 the cell depolarization 
is not reversible upon removal of the factor. Similar, only the ET-1-induced transient 
enhancement of intracellular calcium concentration is parallelled by both homologous and 
heterologous desensitization. Concluding, these data show that ET-1 is a potent inducer of 
second messengers and phenotypic transformation in NRK cells, with characteristics that 
clearly differ from those of other activators of G protein-coupled receptors, most likely as a 
result of prolonged receptor activation.
Introduction
Endothelin-1 (ET-1) has originally been identified as a potent vasoconstrictor synthesized by 
endothelial cells, but later studies have indicated that it has a wide range of additional 
physiological and pathophysiological activities (for reviews see Simonson and Dunn, 1990; 
Sokolovsky, 1991; Hay et al., 1993). ET-1 belongs to a family of 21-amino-acid peptides that 
bind to receptors that belong to the seven transmembrane domain superfamily of G protein­
coupled receptors, designated the ETA and ETB receptors.
Depending on the cell type studied, ET-1 has been described to activate Gq resulting in 
activation of phospholipase C (Takuwa et al., 1989; MacNulty et al., 1990; Plevin et al., 1991; 
Van der Bend et al., 1992), to activate Gi leading to inhibition of adenylate cyclase (Takuwa 
et al., 1989; Hilal Dandan et al., 1992; Lin and Chuang, 1993) or to activate Gs thereby 
activating adenylate cyclase (Eguchi et al., 1993). Moreover, it has been shown that ET-1 is 
able to increase protein tyrosine kinase activity (Cazaubon et al., 1993; Simonson and 
Herman, 1993; Saville et al., 1994), and to activate the phospholipases A2 (Simonson and
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Dunn, 1990) and D (MacNulty et al., 1990; Van der Bend et al., 1992) as well as ERK1 and 
ERK2 (Yoshimasa et al., 1992; Cazaubon et al., 1993).
With respect to cell proliferation, both positive (Takuwa et al., 1989; MacNulty et al.,
1990; Simonson and Herman, 1993) and negative (Mallat et al., 1995) effects of ET-1 have 
been described. Also in the case of normal rat kidney (NRK) cells, ET-1 has been shown to 
have growth modulating activity (Yeh et al., 1991; Kusuhara et al., 1992). In these cells ET-1 
mainly binds to the ETA receptor (Yumet et al., 1995), resulting in an increase in [Ca2+]i 
(Kusuhara et al., 1992; Suzaki et al., 1997), the degradation of inositol-containing 
phospholipids (Suzaki et al., 1997), the expression of c-jun, jun B, and c-fos mRNA in a time- 
dependent manner, and an upregulation of EGF (epidermal growth factor) receptor density 
(Yumet et al., 1995). Recent data have shown that ET-1 is also able to induce anchorage- 
independent growth of NRK cells in an EGF-dependent manner (Kusuhara et al., 1992).
NRK cells are immortalized fibroblasts that have widely been used as a model system for 
studying growth factor-induced phenotypic transformation, including loss of density- 
dependent growth control and induction of anchorage-independent growth. We have 
postulated (Van Zoelen, 1991) that NRK cells become density-arrested when cultured in the 
presence of EGF as the only growth-stimulating factor, because above a specific cell density 
the number of EGF receptors drops below the critical level that is required for EGF-induced 
growth stimulation. Proliferation can be restored by addition of parallel-acting growth factors 
such as platelet-derived growth factor (PDGF) resulting in phenotypic transformation. 
Alternatively, growth regulating stimuli such as transforming growth factor b (TGFb) or 
retinoic acid (RA) can be added, which by themselves have no growth-stimulating activity for 
NRK cells, but are able to enhance EGF receptor levels, making these density-arrested cells 
responsive again to EGF.
In recent studies we have shown that also a number of ligands for G protein-coupled 
receptors (for reviews see Roberts, 1989; Moolenaar, 1995b; Negishi et al., 1995), including 
prostaglandin F2a (PGF2a), bradykinin (BK) and lysophosphatidic acid (LPA) are able to 
induce phenotypic transformation of NRK cells in an EGF-dependent manner (Afink et al., 
1994; Van Zoelen et al., 1994). Interestingly, the kinetics by which these three factors induce 
loss of density-dependent growth inhibition differ strongly (Afink et al., 1994; Van Zoelen et 
al., 1994), although they have all been shown to enhance EGF receptor numbers (Lahaye et 
al., 1998). No direct correlation was found between the levels of induction of known second 
messengers by these three factors and their biological effects towards NRK cells. The 
observation that ET-1 induces anchorage-independent growth of NRK fibroblasts (Kusuhara 
et al., 1992) prompted us to compare the biological effects of ET-1 with those of PGF2a, BK 
and LPA in this respect. The present data show that ET-1 is a very potent inducer of all 
aspects of phenotypic transformation in NRK cells, with characteristics that are clearly 
different however from those of the other above ligands of G protein-coupled receptors.
Materials and methods 
Cell cultures
NRK cells (clone 49F) were plated at a density of 1.0x104 cells/cm2, and grown for 96 hours 
in 24-well tissue culture dishes until confluence in Dulbecco’s modified Eagle’s medium 
(DMEM; Gibco Life Technologies, Breda), supplemented with 10% newborn calf serum 
(Hyclone, Logan, Utah). Confluent cells were subsequently made quiescent by incubation in 
serum-free medium (SF) consisting of a 1:1 mixture of DMEM and Ham’s F-12 medium, 
supplemented with 30 nM Na2SeO3 and 10 |ig/ml human transferrin (Sigma, St. Louis, MO) 
for three days (Van Zoelen et al., 1988).
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Growth-stimulation assays
Quiescent cells were stimulated for 22 hours with the indicated factors in the presence or 
absence of 5 ng/ml EGF, together with 5 |ig/ml insulin. Incorporation of [3H]-thymidine (0.5 
|iCi/ml added; Amersham International) was measured between 1 and 22 hours after the 
addition of EGF, as described (Van Zoelen et al., 1986).
Pre-treatment assays
Alternatively, quiescent NRK cells were pre-treated for 8 hours with the indicated factors. 
Subsequently the medium was replaced by fresh SF medium without factors and the cells 
were restimulated to proliferate by the addition of 5 ng/ml EGF and 5 |ig/ml insulin. 
Incorporation of [3H]-thymidine (0.5 |iCi/ml added) was measured between 1 and 16 hours 
after the addition of EGF (Lahaye et al., 1998).
Prevention of density-dependent growth inhibition
Quiescent NRK cells were stimulated for 45 hours with the indicated factors in the presence 
of 5 |ig/ml insulin and incorporation of [3H]-thymidine (0.5 |iCi/ml added) was measured 
between 43 and 45 hours after stimulation (Van Zoelen et al., 1988).
Restimulation of density-arrested cells
Quiescent NRK cells were stimulated for 48 hours with 5 ng/ml EGF and 5 |ig/ml insulin to 
undergo an additional cell cycle after which the cells become quiescent as a result of density- 
arrest. Density-arrested cells thus obtained were restimulated to proliferate by addition of the 
indicated factors. The capacity of these growth factors to induce phenotypic transformation 
was determined by the measurement of [3H]-thymidine incorporation (0.5 |iCi/ml added), 
either in a cumulative manner between 2 and 19 hours after the addition of the factors, or in 
successive 2-hours pulse intervals between 10 and 30 hours after the addition of the factors.
MTT assay for anchorage-independent growth
Tissue culture 96-well plates were coated with poly (2-hydroxyethyl/methacrylate), 
abbreviated as poly(HEMA), in ethanol (Aldrich-Chemie, Deisenhofen, Germany) as 
described by Fukazawa et al. (1995). One day before each experiment, confluent NRK cell 
cultures were trypsinized and replated at 50% confluence in order to obtain a subconfluent, 
proliferating culture. The next day, cells were trypsinized again and seeded in an amount of 
1.5x104 cells in a volume of 130 |il per well in SF medium supplemented with 5 |ig/ml 
insulin, 0.2 % bovine serum albumin (BSA) and 10% growth factor-inactivated fetal calf 
serum (Van Zoelen et al., 1986). Subsequently, growth factors to be tested were added to the 
cells in 20 |il binding buffer (DMEM supplemented with 0.1 % BSA and 50 mM Bes, pH 6.8; 
see Van Zoelen et al., 1986). After incubation for 7 days, 15 |il MTT (5 mg/ml in phosphate- 
buffered saline (PBS)) was added and the cells were incubated for 4 hours. The produced 
MTT formazan was solubilized by addition of 100 |il of SDS solution (20% sodiumdodecyl 
sulphate in 0.1 M HAc), and the absorbance was measured after 24 hours at 570 nm, relative 
to the absorbance at 690 nm, using a microplate reader (Fukazawa et al., 1995).
EGF-binding studies
Density-arrested NRK cells in 6-well tissue culture dishes (9.6 cm2) were treated for 24 hours 
with the indicated factors. After washing the cells three times with binding buffer, the 
medium was changed for 0.5 ml of binding buffer now containing 4 ng/ml murine 125I-EGF 
(gift from Dr. T. Benraad, Department of Endocrinology, University of Nijmegen). Non­
specific binding was determined by a parallel treatment with a 100-fold excess of unlabelled 
EGF. The cells were incubated for 1 hour at room temperature after which they were washed 
three times with PBS containing 0.1 % BSA, three times with PBS and subsequently 
extracted with 1 % Triton X-100, prior to g-counting (Van Zoelen et al., 1994).
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Intracellular Ca measurements
For calcium measurements, cells were grown on gelatin-coated glass coverslips and cultured 
as described above. Density-arrested cells were loaded for 30 min with 2 |iM Fura-2AM 
(Molecular Probes, Eugene, OR) in bicarbonate-buffered SF medium at 37°C. Subsequently 
the cells were washed and incubated in Hepes/bicarbonate-buffered saline (in mM: 145 NaCl, 
5 KCl, 1 MgCl2, 1 CaCl2, 10 glucose, 15 Hepes, 17.6 NaHCO3) at 25°C. Intracellular calcium 
measurements were performed using a spectrofluorometer (SPF-500 Aminco) at an excitation 
wavelength of 340 nm (4 nm bandwidth) and an emission wavelength of 480 nm (8 nm 
bandwidth). Growth factors were added directly to the incubation medium (Afink et al.,
1994).
Membrane potential measurements
During whole cell patch clamp studies, cells were perfused at a rate of 1-2 ml per min with 
bicarbonate-buffered SF medium (5% CO2) at room temperature. SF-medium contains the 
following concentrations of inorganic salts (in mM): 109.5 NaCl, 5.4 KCl, 1.8 CaCl2, 0.81 
MgCl2, 44.0 NaHCO3, and 1.0 NaH2PO4. Current clamp methods were used to measure 
membrane potential. Pipettes were filled with a high K+, Tris-buffered solution (in mM: 25 
NaCl, 120 KCl, 1 CaCl2, 1 MgCl2, 10 Tris, 3.5 EGTA, pH 7.4). An EPC-7 patch clamp 
amplifier (List, Darmstadt, Germany) and CED software (Cambridge Electronic Design 
Limited, Cambridge, UK) were used to acquire data. Acquisition was obtained at a rate of 1 
Hz (De Roos et al., 1997b).
[ H]-arachidonic acid release
Density-arrested NRK cells in 6-well dishes were labeled with 0.25 |iCi/ml [3H]-arachidonic 
acid (120 Ci/mmol, NEN Life Science Products International) for 16 hours. After labeling, 
the medium was replaced by 2 ml serum-free medium with additional 0.1% fatty acid free 
BSA (Sigma). During the following 3 hours the medium was replaced every hour to remove 
unincorporated label. Factors to be tested were added for 1 hour after which total radioactivity 
released into 0.5 ml of the culture medium was determined by liquid scintillation analysis 
(Afink et al., 1994).
Inositol phosphate determination
Confluent NRK cultures were labeled with [3H]-inositol (Amersham) as described by Afink et 
al. (Afink et al., 1994). After the cells had been grown to density-arrest, they were stimulated 
for 30 min with the indicated factors, and the formed inositol phosphates were determined 
following anion-exchange chromatography (Tilly et al., 1987; Afink et al., 1994).
Materials
Transforming growth factor b  (TGFbO was from R&D Systems Europe (Abingdon, U.K.). 
Bradykinin (BK), lysophosphatidic acid (LPA), prostaglandin F2a (PGF2a), retinoic acid (RA) 
and MTT were from Sigma. Endothelin-1 (ET-1) was from Peninsula Laboratories Europe 
(Merseyside, U.K.).
2+
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Results
ET-1 has no mitogenic activity by itself but enhances EGF-induced proliferation
In order to investigate the mitogenic activity of ET-1 for NRK cells we measured if ET-1 was 
able to stimulate serum-free quiescent cells to proliferate and compared its ability with that of 
LPA, BK and PGF2a. Fig. 1a shows that BK and ET-1 have no significant growth stimulatory 
activity, while in contrast PGF2a is slightly mitogenic and LPA is almost as strong a mitogen 
as EGF. The results of stimulation with LPA, BK, and PGF2a are in accordance with those of 
Afink et al. (Afink et al., 1994).
We previously showed that EGF receptor levels limit EGF-induced proliferation in NRK 
cells made quiescent by serum deprivation and that pre-treatment with factors that increase 
EGF receptor levels increases EGF-induced proliferation (Lahaye et al., 1998). In the present 
study the cells were pre-treated for 8 hours with ET-1, LPA, BK, PGF2a, RA, or TGFb; 
subsequently the factors were removed and the cells were incubated in EGF-containing 
medium for 16 hours during which thymidine incorporation was measured. Pre-treatment for
8 hours with ET, BK, PGF2a, RA, and TGFp without subsequent addition of EGF did not 
result in significant growth stimulation; only LPA had strong stimulatory activity under these 
conditions (data not shown). The data in Fig. 1b show that pre-treatment with ET-1, LPA,
BK, or PGF2a increased EGF-induced proliferation, although to a lesser extent than following 
TGFb and RA pre-treatment. From these results it can be concluded that ET-1 has no 
mitogenic activity towards NRK cells but increases EGF-induced proliferation, indicating that 
the lack of mitogenic activity is not the result of the absence of specific ET-1 receptors.
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Figure 1: Mitogenic activity of ET-1; comparison with LPA, BK, PGF2a, RA, and TGFp.
A: Serum-deprived, quiescent NRK cells were treated for 22 hours with 0.1 pM ET-1, 100 pM LPA, 1 pM BK, 1 pM 
PG F2a, 5 ng/ml EGF, or no addition (Cont), in the presence of 5 pg/ml insulin. Cumulative [3H]-thymidine (TdR) 
incorporation was measured between 2 and 22 hours after growth factor addition.
B: Quiescent NRK cells were pre-treated for 8 hours with 0.1 pM ET-1, 100 pM LPA, 1 pM BK, 1 pM PGF2a, 50 
ng/ml RA, 1 ng/ml TGFp, or no addition (Cont). Subsequently the medium was replaced by fresh serum-free 
medium and 5 ng/ml e G f  and 5 pg/ml insulin were added. Cumulative [3H]-thymidine (TdR) incorporation was 
measured between 1 and 16 hours after stimulation.
Indicated standard errors of the mean are based on triplicate experiments.
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ET-1 induces phenotypic transformation of NRK cells
Kusuhara et al. (1992) showed that ET-1 is able to stimulate anchorage-independent cell 
growth of NRK cells in the presence of EGF, indicating that ET-1 has transforming activity. 
Two other aspects of phenotypic transformation of NRK cells are the loss of density- 
dependent growth inhibition and the prevention of density-dependent growth arrest. To study 
the ability of ET-1 to induce loss of density-dependent growth inhibition, NRK cells were 
made growth-arrested by incubation with EGF, and cumulative thymidine incorporation was 
subsequently measured during the first 19 hours following addition of the modulating factors 
indicated. Fig. 2a shows that ET-1 is able to restimulate density-arrested NRK cells to almost 
the same extent as RA or TGFb. The effect induced by ET-1 was also similar to that of LPA, 
but significantly stronger than that of BK or PGF2a.
We also examined if ET-1 could prevent cells from undergoing density-arrest, by 
measuring [3H]-thymidine incorporation into quiescent NRK cells between 43 and 45 hours 
after stimulation with various factors, both in the absence and presence of EGF, according to 
the protocol of Van Zoelen et al. (1988). Fig. 2b shows that in the presence of EGF alone, 
cells undergo density-dependent growth arrest, while in the additional presence of ET-1, LPA, 
BK, PGF2a, RA, or TGFb the cells are prevented from undergoing density-dependent growth 
arrest and keep proliferating. RA and TGFb prevent density-arrest strongly, while ET-1, BK, 
LPA, and PGF2a show lower activity in this assay. In the absence of EGF, only LPA had 
significant stimulating activity. From these results, it can be concluded that ET-1, similar to 
LPA, BK, and PGF2a, prevents EGF-treated cells from undergoing density-dependent growth 
arrest. These results confirm that ET-1 is a strong inducer of phenotypic transformation in 
NRK cells.
100
O C, <S, 'Q >  O <2. 'O 'P
^ % *s> ^
Figure 2: ET-1 induces phenotypic transformation of NRK cells.
A: Restimulation o f density-arrested cells: Density-arrested NRK cells were restimulated to proliferate by addition 
of 0.1 |jM ET-1, 100 jM  LPA, 1 jM  BK, 1 jM  PGF2a, 50 ng/ml RA, 1 ng/ml TGFp, or no addition (Cont). 
Cumulative [3H]-thymidine (TdR) incorporation was measured between 2 and 19 hours after growth factor 
addition.
B: Prevention of density-dependent growth inhibition: Quiescent NRK cells were treated for 45 hours with 0.1 jM  
ET-1, 100 jM  LPA, 1 jM  BK, 1 jM  PGF2a, 50 ng/ml RA, 1 ng/ml TGFp, or no addition (Cont), in the presence of 5 
jg/ml insulin and in the presence (hatched bars) or absence (open bars) of 5 ng/ml EGF. Cumulative 
[3H]-thymidine (TdR) incorporation was measured 43-45 hour after stimulation.
Indicated standard errors of the mean are based on triplicate experiments.
62
Phenotypic transformation of NRK cells by ET-1
ET-1 is a potent inducer of anchorage-independent cell growth of NRK cells
Because ET-1 can induce soft agar growth of NRK cells in serum containing medium 
(Kusuhara et al., 1992), we wondered if ET-1 can also induce cell proliferation on 
poly(HEMA)-coated dishes (Fukazawa et al., 1995) in the absence of serum growth factors in 
the presence of growth-factor defined medium. As can be seen in Fig. 3, ET-1 is a potent 
inducer of anchorage-independent cell growth of NRK cells in the presence of EGF, and 
stimulates proliferation to almost the same extent as PGF2a and TGFp. LPA and BK induce 
anchorage-independent cell growth to a much lesser extent under these conditions. In the 
absence of EGF, only PGF2a and TGFp show some ability to induce anchorage-independent 
cell growth. These results show that ET-1 is particularly a strong inducer of this aspect of 
phenotypic transformation of NRK cells.
Figure 3: ET-1 induces anchorage- 
independent cell growth of NRK 
cells.
NRK cells were seeded on 
poly(HEMA)-coated dishes in the 
presence of 0.1 pM ET-1, 100 pM LPA, 
1 pM BK, 1 pM PGF2a, 50 ng/ml RA, or 
1 ng/ml TGFp, in the presence of 5 
pg/ml insulin and in the presence 
(hatched bars) or absence (open bars) 
of 5 ng/ml EGF. After incubation for 7 
days, the extent of MTT reduction 
during 4 hours was measured and 
plotted as fold stimulation relative to 
untreated cells. Indicated standard 
errors of the mean are based on 
quadruplicate experiments.
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Kinetics of ET-1-induced phenotypic transformation of NRK cells
The previous results show that ET-1 is a poor mitogen for NRK cells, but a strong inducer of 
phenotypic transformation. Afink et al. (1994) showed that LPA induces loss of density-arrest 
of NRK cells with faster kinetics than BK and PGF2a. Because ET-1 resembles LPA in its 
ability to overcome density-arrest (Fig. 2a), we compared the kinetics by which ET-1 
restimulates density-arrested NRK cells with the other factors by measuring [3H]-thymidine 
incorporation during 2 hours pulses.
Figure 4: Kinetics of ET-1-induced 
phenotypic transformation of NRK 
cells.
Density-arrested NRK cells were 
restimulated to proliferate by addition of
0.1 pM ET-1, 100 pM LPA, 1 pM BK,
1 pM PG F 2a, 50 ng/ml RA, or 1 ng/ml 
TGFp. [3H]-thymidine (TdR) 
incorporation was measured in 
successive 2-hours pulse intervals 
between 10 and 30 hours after the 
addition of the factors and plotted as fold 
stimulation relative to untreated cells.
10 12 14 16 18 20 22 24 26 28 30 
Time after growth factor addition (hours)
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Fig. 4 shows that the kinetics of the ET-1- and LPA-induced loss of density-arrest are 
comparable with those of RA and TGFb, but clearly faster than those of BK and PGF2a, 
suggesting that the mechanisms by which ET-1- and LPA induce phenotypic transformation 
differ from those of BK and PGF2a. This difference in kinetics explains in part the low 
stimulation levels observed after stimulation by BK or PGF2a for 19 hours, as shown in Fig. 
2a.
Effect of ET-1 on 125I-EGF binding to NRK cells
We showed previously that factors that induce phenotypic transformation of NRK cells in an 
EGF-dependent manner are also able to increase EGF receptor numbers in these cells. 
Furthermore, we showed that EGF receptor levels limit EGF-induced proliferation in NRK 
cells made quiescent by serum deprivation, and that pre-treatment with factors that increase 
EGF receptor levels results in EGF-induced proliferation (Lahaye et al., 1998). ET-1 
increases the EGF-induced mitogenic activation of NRK cells (Fig. 1b) and induces 
phenotypic transformation only in the presence of EGF (Fig. 2) which suggests that the fast 
induction of phenotypic transformation by ET-1 could probably result from an increase of 
EGF-receptor numbers per cell.
It is well-established that an increase of 125I-EGF binding by TGFb or inositol-lipid 
degrading stimuli can be preceded by an initial decrease (Assoian et al., 1984; Assoian, 1985; 
Earp et al., 1988; Lahaye et al., 1998) which is abolished after approximately 4 to 8 hours 
(Assoian et al., 1984; Assoian, 1985; Lahaye et al., 1998). Fig. 5 demonstrates that 8 hours 
after the addition of ET-1, LPA, or BK, the 125I-EGF binding is not significantly different 
from the starting level, while 8 hours after the addition of PGF2a a decrease is indeed 
observed. At this time point, the RA- and TGF^-induced 125I-EGF binding is already strongly 
increased. Incubation of density-arrested NRK cells for 24 hours, however, with ET-1, LPA, 
BK, or PGF2a results in a significant increase in binding although both TGFb and RA remain 
much more potent stimulators of EGF binding. Concluding it can be stated that phenotypic 
transformation is induced by these factors only in the presence of EGF and that this 
phenotypic transformation is accompanied by an increase in the EGF receptor numbers, 
suggesting that such increase is a prerequisite for phenotypic transformation.
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Figure 5: Effect of ET-1 on 125I-EGF binding to NRK cells.
Serum-deprived, quiescent NRK cells were treated for 8 hours (open bars) or 24 hours (hatched bars) with 0.1 pM 
ET-1, 100 pM LPA, 1 pM BK, 1 pM PGF2a, 50 ng/ml RA, 1 ng/ml TGFp, or no addition (Cont). 125I-EGF (4 ng/ml) 
binding was determined and corrected for non-specific binding (obtained by the additional treatment with a 
100-fold excess of unlabelled EGF), and plotted as fold stimulation relative to untreated cells. Indicated standard 
errors of the mean are based on at least sextuplicate experiments.
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ET-1 is a strong inducer of Ca2+-release
To find a possible cause for the differences in the kinetics by which ET-1, LPA, BK and 
PGF2a induce phenotypic transformation of NRK cells, we investigated the production of 
second messengers after stimulation with these factors. In NRK cells, ET-1 has been shown to 
bind to ETa receptors (Yumet et al., 1995) resulting in an increase in [Ca2+]¡(Kusuhara et al., 
1992; Suzaki et al., 1997). In Fig. 6a it is shown that ET-1, LPA, BK and PGF2a all induce a 
transient increase in intracellular Ca2+ with comparable kinetics. However, Fig. 6b shows that 
upon repetitive addition of various ligands, ET-1 not only induces homologous 
desensitization, but also heterologous desensitization towards BK (and LPA or PGF2a; data 
not shown). In contrast, BK induces only homologous desensitization but no heterologous 
desensitization towards ET-1. PGF2a and LPA behaved similar as BK, in that they induced 
homologous but no heterologous desensitization (data not shown). Another striking feature of 
ET-1 which is not shared by the three other ligands of G protein-coupled receptors is the 
sustained increase in intracellular Ca2+ it induces. This phenomenon has also been observed in 
Swiss 3T3 fibroblasts (Ohnishi et al., 1989), and most likely results from the quasi­
irreversible nature of endothelin binding to its receptor, causing a prolonged activation of its 
G protein-linked signaling pathways (Hilal Dandan et al., 1997). These data show that with 
respect to the ability to induce cellular Ca2+ responses (mobilization) ET-1 behaves 
differently from the other three ligands.
BK PgF2a
Figure 6: ET-1 induces Ca2+-mobilization in NRK cells.
A: Typical Ca2+-responses to the addition of 0.1 ET-1 (1), 100 LPA (2), 1 BK (3) or 1 PGF2a (4) to 
density-arrested NRK cells.
B: Ca2+-responses to a second dose of ET-1 (1) or BK (2) and to the subsequent addition of BK (1) or ET-1 (2). 
Ca2+ levels are represented as Fura2 fluorescence intensities. Each trace is representative of at least 5 similar 
experiments.
ET-1 induces prolonged membrane depolarization
The effect of ET-1 on membrane potential was investigated using whole-cell patch clamp 
measurements in the current clamp mode. The cells were continuously perfused and the 
agonists were included in the perfusion medium during the indicated time periods 
(approximately 5 min). Fig. 7 shows that ET-1, LPA, BK and PGF2a caused a rapid
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depolarization of the membrane in density-arrested NRK cells. This correlates with the results 
of De Roos et al. (1997b) on BK- and PGF2a-induced depolarization as a result of the opening 
of a calcium-dependent chloride channel. Upon removal of the ligands, however, a rapid 
repolarization was observed in the case of LPA, BK and PGF2a, but not in the case of ET-1. 
These observations are in line with the notion that ET-1 may bind its receptor in a quasi­
irreversible manner, resulting in prolonged receptor activation (Hilal Dandan et al., 1994; 
1997).
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Figure 7: ET-1 induces prolonged membrane depolarization in monolayers of NRK cells.
Typical depolarization in response to 0.1 pM ET-1, 100 pM LPA, 1 pM BK, or 1 pM PGF2a measured in the current 
clamp mode of the whole cell patch clamp configuration. Cells were continuously perfused and the agonists were 
included in the perfusion medium during the indicated time. Each trace is representative of at least 5 similar 
experiments.
ET-1 is a strong inducer of [ H]-arachidonic acid release and phosphatidyl-inositol diphosphate 
hydrolysis
Activation of G protein-coupled receptors may result in the induction of arachidonic acid 
(AA) release and hydrolysis of phosphatidyl-inositol diphosphate (PtdIns(4,5)P2). Fig. 8a 
shows that after 1 hour of stimulation LPA and BK stimulate AA-release only weakly, while 
PGF2a and particularly ET-1 are stronger inducers. Fig. 8b shows that ET-1 is also by far the 
strongest inducer of PtdIns(4,5)P2 hydrolysis in these cells, with twofold higher induction 
than PGF2a. Although ET-1 and PGF2a induce PtdIns(4,5)P2 hydrolysis much stronger than 
BK and LPA, the data of Fig.6a show that this does not necessarily have to result in a more 
efficient Ca2+-release (see Fig. 6a). Although our present and previous (Afink et al., 1994) 
results show that there is no direct correlation between the levels of second messenger 
generation and the ability of ligands to induce phenotypic transformation, the results 
presented in Figs. 6-8 indicate show that of all ligands tested ET-1 is by far the strongest 
inducer of second messengers in NRK cells.
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Figure 8: ET-1 is a strong inducer of [3H]-arachidonic acid (AA) release and PtdIns(4,5)P2 hydrolysis.
A: AA-release: Density-arrested, [3H]-arachidonic acid labeled NRK cells were stimulated for 1 hour with 0.1 pM 
ET-1, 100 pM LPA, 1 pM BK, or 1 pM PGF2a, after which total radioactivity released into 0.5 ml of the culture 
medium was determined by liquid scintillation analysis and plotted as fold stimulation relative to untreated cells. 
Indicated standard errors of the mean are based on at least quintuplicate experiments.
B: Ptdlns(4,5)P2 hydrolysis: Density-arrested, 3H-inositol labeled NRK cells were stimulated for 30 min with 0.1 pM 
ET-1, 100 pM LPA, 1 pM BK, or 1 pM PGF2a, after which the inositol phosphates were determined and plotted as 
fold stimulation relative to untreated cells. Indicated standard errors of the mean are based on triplicate 
experiments.
Discussion
In the present study, we have shown that ET-1 is a strong transforming factor for NRK cells 
with characteristics different from those of the other G protein-coupled receptor activating 
factors investigated. To summarize, ET-1 has no mitogenic activity in the absence of other 
growth factors, it increases EGF-induced proliferation, it induces phenotypic transformation 
in an EGF-dependent manner and with fast kinetics, it increases 125I-EGF binding to NRK 
cells, it is a strong inducer of AA-release and PtdIns(4,5)P2 hydrolysis, and it induces a Ca2+ 
transient and a rapid depolarization of the membrane. Typically, the addition of ET-1 leads to 
a prolonged depolarization of the membrane and prevents Ca2+-mobilization by the other 
ligands of G protein-coupled receptors. ET-1, as well as PGF2a, LPA and BK, induces a 
transient increase in intracellular Ca2+ in Swiss 3T3 fibroblasts, despite the fact that these 
cells already exhibit a depolarized membrane (around -30 mV) compared to NRK cells 
(Theuvenet et al., unpublished). This makes unlikely that the prolonged depolarization of 
NRK cells is responsible for the homologous and heterologous desensitization of cellular Ca2+ 
responses by ET-1.
When the characteristics of ET-1 are compared with those of PGF2a, LPA, and BK, it can 
be seen that only LPA is mitogenic in the absence of other growth factors. All of these factors 
induce phenotypic transformation, a Ca2+ transient and a rapid depolarization of the 
membrane, and increase 125I-EGF binding to NRK cells. However, BK and PGF2a induce 
phenotypic transformation with delayed kinetics and LPA and ET-1 with fast kinetics. There 
are also large differences in the levels of second messengers induced: ET-1 and PGF2a induce 
very strong PtdIns(4,5)P2 hydrolysis and are both strong inducers of AA-release, while LPA 
and BK do so with much less potency. Only ET-1 induces a prolonged depolarization of the 
membrane and only the transient enhancement of intracellular calcium concentration by ET-1
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is parallelled by heterologous desensitization.
Various cell types have been tested and those studies show that ET-1 can activate Gq 
(Takuwa et al., 1989; MacNulty et al., 1990; Plevin et al., 1991; Van der Bend et al., 1992),
Gi (Takuwa et al., 1989; Hilal Dandan et al., 1992; Lin and Chuang, 1993) and Gs (Eguchi et 
al., 1993). In comparison, PGF2a has been shown to activate Gq, leading to the activation of 
the phospholipase Cp pathway (Nakao et al., 1993; Watanabe et al., 1994; Negishi et al.,
1995), and the increase of protein tyrosine kinase activity (Ben-Av et al., 1993; Watanabe et 
al., 1994). BK activates Gq (Bareis et al., 1983; Burch and Kyle, 1992) and Gs (Bareis et al., 
1983) resulting in the activation of adenylate cyclase. LPA activates Gq (Moolenaar, 1995b), 
Gs (Tigyi et al., 1994), and Gi (Moolenaar, 1995b), which leads to the inhibition of adenylate 
cyclase and the activation of Ras (Van Corven et al., 1993), while it can also activate 
phosphatidylinositol 3-kinase (Moolenaar, 1995b). Furthermore, BK, LPA, and ET-1 can 
activate phospholipase A2 (Bareis et al., 1983; Simonson and Dunn, 1990; Moolenaar, 1995b) 
via a still unknown G protein or indirectly via Gq (Cockcroft, 1992; Mukherjee et al., 1994). 
They all activate phospholipase D (MacNulty et al., 1990; Van Blitterswijk et al., 1991; Van 
der Bend et al., 1992; Ben-Av et al., 1993; Moolenaar, 1995b) also via a still unknown G 
protein or indirectly via Gq (Cockcroft, 1992). Our present results, together with previous 
results from this laboratory (Afink et al., 1994; Van Zoelen et al., 1994), show that also in 
NRK cells these factors induce degradation of inositol-containing phospholipids, release of 
arachidonic acid (AA), and mobilization of Ca2+, all indicative for activation of phospholipase 
C and phospholipase A2, most likely mediated by activation of Gq. However, activation of 
phospholipase A2 can also take place by other mechanisms (for reviews see Cockcroft, 1992; 
Mukherjee et al., 1994), which could explain the present observation that apparently there is 
no correlation between the potency of factors to induce AA-release and to hydrolyze 
PtdIns(4,5)P2.
Our results show that, in spite of their different biological effects on NRK cells, the four 
explored agonists induce the same second messengers, however the absolute levels are 
different. It is possible that the studied signalling pathways are only necessary but not 
sufficient for phenotypic transformation, and that activation of additional pathways is 
essential. Several other reports suggest that in addition to the activation of the (Gq-induced) 
PLC pathway, additional pathways have to be activated to induce a mitogenic response 
(reviewed by Moolenaar, 1991). For example, the mitogenic action of LPA is believed to be 
mediated by activation of Gi (Van Corven et al., 1989; 1993; Koch et al., 1994; Moolenaar, 
1995b), leading to a decrease in cAMP levels. In several other cell types ET-1 also activates 
this G protein (Takuwa et al., 1989; Hilal Dandan et al., 1992; Lin and Chuang, 1993). 
However, we could only detect a decrease in forskolin-stimulated cAMP levels in NRK cells 
upon treatment with LPA, similar to previous results (Afink et al., 1994), but not upon 
stimulation with ET-1, BK of PGF2a. The latter two agents even increased cAMP levels in 
these cells (data not shown). However, in Swiss 3T3 cells ET-1 induces Gi similar to LPA and 
is mitogenic in the absence of other growth factors (Takuwa et al., 1989), suggesting that 
activation of Gi correlates with the direct mitogenic activity of a factor. Furthermore, it has 
been suggested that not the absolute amount of second messengers, but much more the 
kinetics of their induction are important for the biological action of an agonist (Van der Bend 
et al., 1992). The fact that the most factors tested here activate the same pathways but have 
different biological effects supports this notion. In addition, other second messenger systems 
such as phospholipase D activation, sphingomyelin degradation (Michell and Wakelam,
1994), activation of phosphatidylinositol (PI)-3-kinase (Kapeller and Cantley, 1994), and 
enhancement of nitric oxide or cGMP (Schmidt et al., 1993) could also be of relevance to 
understand the biological activity of the factors tested, while it can even not be excluded that 
other, still unknown, pathways activated by G protein-coupled receptors are involved. We
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showed that ET-1 induces a prolonged depolarization of the membrane and prevents Ca2+- 
mobilization by the other ligands of G protein-coupled receptors as a result of heterologous 
desensitization. These observations are in line with previous studies, showing that ET-1 may 
bind its receptor in a quasi-irreversible manner (Hilal Dandan et al., 1994; 1997). This 
phenomenon could explain the fast kinetics by which ET-1 induces phenotypic transformation 
and the strong induction of second messengers.
We have previously postulated (Van Zoelen, 1991) that NRK cells become density- 
arrested as a result of decreased EGF receptor levels and become phenotypically transformed 
by factors that increase EGF receptor levels, thereby enhancing the growth-stimulating 
signals induced by EGF. It has been shown that in NRK cells ET-1 complements EGF to 
induce cell proliferation (Yeh et al., 1991), and that ET-1 upregulates EGF receptor numbers 
(Yumet et al., 1995). Together with our present results, this suggests that the observed 
increase in EGF receptor levels upon ET-1 treatment is essential for induction of phenotypic 
transformation of NRK cells. However, our present results also show that ET-1 induces this 
process with similar fast kinetics as LPA, RA and TGFb, while BK and PGF2a appear to act 
much slower. The fast induction of loss of density-arrest by RA and TGFb can be rationalized 
by their rapid enhancement of EGF receptor levels (Fig. 5), while LPA not only enhances 
EGF receptor levels but is also mitogenic by itself. However, the rate by which ET-1 
enhances EGF receptor levels does not appear to be much different from BK and PGF2a, in 
spite of their different kinetics in inducing transformation. So, although enhancement of EGF 
receptor levels seems essential for induction of phenotypic transformation of NRK cells, no 
direct correlation could be observed between the kinetics of both processes. In this respect it 
should be realized that BK is also known to transiently induce an inhibitor of phenotypic 
transformation (Afink et al., 1994; Lahaye et al., 1994) while under certain conditions PGF2a 
appears to have similar inhibitory activity (not shown). This could explain the delayed 
induction of phenotypic transformation despite the strong induction of second messengers.
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General discussion
1 Model for induction of phenotypic transformation in NRK cells
1.1 Model for (loss of) DDGI of NRK cells
1.2 Model for AIG of NRK cells
1.3 Reflection on model for (loss of) DDGI of NRK cells
1.4 Reflection on model for AIG of NRK cells
1.5 Additional mechanisms describing (loss of) DDGI in NRK cells
1.6 Additional mechanisms describing AIG in NRK cells
2 Inhibitory effect of bradykinin on loss of DDGI of NRK cells
2.1 Introduction
2.2 Specificity of growth-inhibitory effect of BK on quiescent NRK cells
2.3 Role of EGF receptor levels in BK-induced inhibition of cell proliferation
2.4 Role of cyclo-oxygenase product in growth inhibition induced by BK
The studies described in this thesis were focussed on two major differences between 
transformed cells and normal cells: loss of density-dependent growth inhibition (DDGI) and 
anchorage-independent growth (AIG). For these studies we used normal rat kidney (NRK) 
fibroblasts, a widely used model system to study the role of growth factors in phenotypic 
transformation. These cells are immortalised and strictly dependent on externally added 
growth factors for proliferation. When cultured in the presence of epidermal growth factor 
(EGF) as the only growth-stimulating hormone, they have a normal phenotype, are unable to 
proliferate under anchorage-independent conditions and undergo DDGI. In the additional 
presence of specific factors (i.e. TGFb, RA, PDGF, LPA, ET-1, BK, PGF2a) however, these 
cells become phenotypically transformed, overcome density-arrest and are able to proliferate 
under anchorage-independent conditions (Anzano et al., 1982; Van Zoelen et al., 1988; 1991; 
1994; Chapter 4 and 5).
1 Model for induction of phenotypic transformation in NRK cells___________
1.1 Model for (loss of) DDGI of NRK cells
It has been suggested that the modulation of EGF receptor densities is the most appropriate 
mechanism for describing DDGI in the presence of EGF in NRK cells (Van Zoelen, 1991). 
This hypothesis is supported by several observations. First, it has been shown that EGF 
binding decreases with increasing cell density in NRK cells (Rizzino et al., 1988; Rizzino et 
al., 1990). Besides EGF binding, also the PDGF, fibroblast growth factor (FGF) and TGFb 
binding decreases (Rizzino et al., 1988; 1990; Veomett et al., 1989). However, the binding of 
these growth factors is regulated differently: their binding decreases stepwise with increasing 
cell density and there is no sharp reduction of binding at high cell densities, as is seen in the 
case of EGF (Rizzino et al., 1990). Second, both TGFb and RA, which are by themselves not 
mitogenic, are potent inducers of phenotypic transformation in these cells in the presence of 
EGF (Van Zoelen et al., 1988) and both increase EGF receptor gene transcription (Thompson 
et al., 1988; Thompson and Rosner, 1989; Hou et al., 1994) and, in a dose-dependent manner, 
also EGF receptor numbers (Assoian et al., 1984; Roberts et al., 1984; Assoian, 1985). Third, 
the increased EGF binding accompanying RA treatment of NRK cells correlates with 
increased responsiveness of the cells to EGF (Jetten and Goldfarb, 1983; Roberts et al., 1984).
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Fourth, the kinetics by which RA and TGFb induce loss of density-dependent growth 
inhibition show a delay of approximately 4 hours compared to stimulation with PDGF (Van 
Zoelen, 1991), suggesting that the mechanism by which RA and TGFb induce loss of density- 
dependent growth inhibition is different from that induced by PDGF, and most likely involves 
the induction of a crucial gene product.
Our present studies add some new results that support this hypothesis. We showed that 
already in serum-deprived quiescent cells EGF receptor levels are decreased to such a level 
that they limit EGF-induced mitogenesis (Chapter 3). This is predicted from the fact that EGF 
receptor levels are decreased below a critical level in density-arrested cells. Furthermore, in 
these quiescent cells EGF binding correlates with the responsiveness of the cells to EGF, 
showing that EGF receptor numbers control the response of these cells to EGF. As will be 
described below, we showed that modulation of EGF receptor levels also plays an important 
role in AIG.
Our results have led us to suggest the following overall model: In NRK cells EGF receptor 
levels decrease with increasing cell density. In confluent cultures of NRK cells, made 
quiescent by serum-deprivation, EGF receptor levels are decreased to such a level that they 
limit EGF-induced mitogenesis. However, EGF receptor levels are sufficiently high to keep 
the cells responsive to the growth-stimulating activity of EGF and to induce one cell cycle by 
EGF. After this additional cell cycle the EGF receptor levels are decreased further, such that 
they are now below a threshold level which makes these cells unresponsive to stimulation by 
EGF, resulting in DDGI. Growth factors that increase EGF receptor numbers enhance the 
level of growth-stimulating signals induced by EGF, and induce phenotypic transformation 
(loss of DDGI) of the cells in the presence of EGF. Besides by increasing EGF receptor 
levels, phenotypic transformation can also be induced by factors such as PDGF and LPA, 
which are growth stimulating by themselves and are thus able to activate growth-stimulating 
pathways parallel to that of the EGF receptor (Van Zoelen, 1991). This model is summarised 
in figure 1.
In the literature various other mechanisms have been proposed besides a decrease of EGF 
receptor levels to explain why cells stop proliferating above a critical cell density. The role of 
these mechanisms in NRK fibroblasts is discussed in section 1.5.
1.2 Model for AIG of NRK cells
For the regulation of AIG in NRK fibroblasts three mechanisms have been shown to play an 
important role: the expression of extracellular matrix proteins and their receptors, cyclin 
activity and the modulation of EGF receptor densities. These mechanisms will be described 
first and subsequently the correlation between the mechanisms will be discussed
1.2.1 Expression of extracellular matrix proteins and their receptors
The expression of extracellular matrix (ECM) proteins and their receptors has been shown to 
play an important role in the regulation of AIG in NRK cells. The expression of ECM protein 
fibronectin and its receptor a 5fr integrin strongly decreases when NRK fibroblasts are 
cultured under anchorage-independent conditions (Ignotz and Massague, 1986; Thompson et 
al., 1988; Dalton et al., 1992; 1995). The induction of AIG by TGFb is accompanied by an 
increase of fibronectin levels (Ignotz and Massague, 1986; Thompson et al., 1988). As the 
induction of AIG by TGFb can be mimicked by fibronectin in NRK fibroblasts (Ignotz and 
Massague, 1986), it has been proposed that TGFb induces AIG by stimulating the secretion of 
fibronectin, which, in turn, would bind to and activate a 5fr integrin. However, in our group 
we were unable to reproduce these results and could show that fibronectin is unable to replace 
TGFb in inducing AIG of EGF-treated NRK cells in the absence of serum growth factors 
(Allen Hoffmann et al., 1986; E.J.J. van Zoelen, unpublished results). The previous results
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can be explained by the observation that many fibronectin extracts used in the past contained 
TGFß as a contaminant. The hypothesis that fibronectin production plays a direct role in the 
induction of AIG is also not in line with the observation that phenotypic transformation 
inducing factors such as RA do not increase fibronectin gene expression (Thompson et al.,
1988). Furthermore, vanadate (Rijksen et al., 1993b) and TGFß (Dalton et al., 1999) induce 
AIG in the absence of colony formation, showing that that the production of extracellular 
matrix proteins and the subsequent cell-cell interactions via adhesion receptors resulting in 
colony formation are not obligatory for AIG. Moreover, a 5ß1 integrin is not expressed on the 
surface of NRK cells cultured under anchorage-independent conditions (Dalton et al., 1992;
1995). This may explain why in the absence of serum growth factors fibronectin is not able to 
replace TGFß in the induction of AIG: surface a 5ß1 integrin is absent. Together, these results 
show that it is not very likely that fibronectin production does play a direct role in the 
induction of AIG.
Nevertheless, the observation that a peptide that inhibits fibronectin binding to its surface 
receptor can inhibit the TGFß-induced phenotypic transformation of NRK cells suggests that 
fibronectin plays a role in the induction of AIG (Ignotz and Massague, 1986). However, we 
could show that the inhibition by such peptides is non-specific (data not shown).
Figure 1: Model for quiescence, DDGI, 
and growth factor-induced loss of DDGI 
of NRK cells.
A: NRK cells cultured in the presence of 
(excess) EGF and insulin become density- 
arrested at high densities because the EGF- 
induced growth-stimulating signals 
(indicated by the arrow from the EGF 
receptor) are insufficient for induction of cell 
proliferation. In serum-deprived quiescent 
cells EGF receptor levels are limiting but are 
still sufficiently high to keep the cells 
responsive to the growth-stimulating activity 
of EGF.
B: Density-arrested NRK cells can be 
restimulated to proliferate by (1) the addition 
of factors (such as TGFß or RA) that 
increase the EGF receptor number, thereby 
enhancing the level of growth-stimulating 
signals induced by EGF, or alternatively by 
(2) addition of factors (such as PDGF and 
LPA) that act in parallel with EGF, in such 
way that the growth-stimulating signals of 
the two factors combined are sufficient to 
induce proliferation (based on figure 10 in 
Van Zoelen, 1991).
EGF-R: EGF receptor
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Also fibronectin receptors seem to play an important role: a recent study shows that TGFß 
restores the a 5ß1 integrin levels in anchorage-independently cultured NRK fibroblasts and 
thereby overcomes the requirement for cell adhesion (Dalton et al., 1999). The observation 
that fibronectin is able to induce AIG (Ignotz and Massague, 1986) can be explained by the 
fact that the TGFß contaminations in the fibronectin extracts can increase a 5ß1 integrin 
expression, thereby providing a binding site for fibronectin. The increased a 5ß1 integrin 
expression induced by TGFß is necessary for the induction of AIG, since mutants with 
constitutive integrin expression are anchorage-independent in the absence of TGFß, while an 
antisense oligonucleotide to the ß1 integrin subunit and stable expression of an a 5-antisense 
cDNA blocked the TGFß-induced AIG (Dalton et al., 1999). However, a 5ß1 integrin does not 
induce AIG by inducing an extensive fibronectin matrix providing anchoring support for 
growth of daughter cells, since NRK cells do not form multicellular aggregates when they are 
induced to undergo AIG by TGFß in media containing no soft agar or methylcellulose 
(Dalton et al., 1999). This suggests that a 5ß1 integrin plays another, not purely structural role 
in the induction of AIG. Besides its binding to fibronectin, a 5ß1 integrin could have another 
function in the regulation of cell proliferation. Therefore, it would be very interesting to study 
the effect of the AIG-inducing agents used in our studies on a 5ß1 integrin expression in NRK 
fibroblasts. Furthermore, it would be important to repeat the studies of Dalton et al. (1999) 
under our serum-free conditions in order to detect the presence of ligands for a 5ß1 integrin. 
Activation of integrins also leads to reorganisation of the cytoskeleton, which is required for 
cyclin D 1 expression and pRb phosphorylation (Böhmer et al., 1996). Thus, perhaps 
organisation of the cytoskeleton induced by the integrin/ECM interaction may be sufficient to 
induce AIG.
It has recently been shown that connective tissue growth factor (CTGF) is induced by 
TGFß and that this synthesis is necessary although not sufficient for induction of AIG of 
NRK cells by TGFß (Kothapalli et al., 1997). CTGF stimulates the expression of fibronectin, 
collagen and a 5ß1 integrin in adherent NRK cells (Frazier et al., 1996). This suggests that 
CTGF could be responsible for the increase of a 5ß1 integrin levels induced by TGFß in this 
cell system. The observation that addition of CTGF is not sufficient to induce AIG indicates 
that either the increase of a 5ß1 integrin levels is too low or there are other TGFß-induced 
pathways that must be activated to induce AIG. It would be interesting to investigate if CTGF 
increases cyclin A or EGF receptor expression.
1.2.2 Cyclin activity
Expression of cyclin A has also been shown to play an important role in the regulation of AIG 
in NRK fibroblasts. Its expression is suppressed when NRK cells are suspended, ectopic 
expression bypasses the adhesion requirement for proliferation (Guadagno et al., 1993), and 
TGFß increases cyclin A levels only under conditions that NRK fibroblasts undergo AIG, i.e. 
in the presence of EGF (Zhu et al., 2000). The regulation of cyclin A expression by adhesion 
is mediated at the transcriptional level (Krämer et al., 1996), suggesting that proteins that are 
present prior to the appearance of cyclin A during cell cycle progression are targets of the 
adhesion signal. Candidates are two G1 cyclin-cdk complexes: cyclin E-cdk2 and cyclin D- 
cdk4 (Zhu et al., 1996). In contrast to normal human fibroblasts (Böhmer et al., 1996) and 
NIH-3T3 (Zhu et al., 1996), the expression of cyclin D1 in NRK fibroblasts is not regulated 
by adhesion but is constitutively high (Guadagno et al., 1993; Zhu et al., 1996, 2000). Also 
cyclin E-cdk2 activity is only slightly reduced when NRK cells are cultured in suspension 
(Guadagno et al., 1993; Zhu et al., 1996). Cyclin E-cdk2 and cyclin D-cdk4 increase cyclin A 
expression in NIH-3T3 cells by phosphorylating pRb, resulting in a release from E2F which 
subsequently binds to and transcriptionally activates the cyclin A promoter. However,
74
General discussion
although in NRK cells grown in suspension pRb is phosphorylated (Zhu et al., 1996), still 
cyclin A expression remains low (Guadagno et al., 1993). The fact that in NRK cells cyclin D 
and E are present and pRb is phosphorylated in anchorage-independent cultured cells makes it 
very intriguing to understand why these cells do not proliferate. From this can be concluded 
that cyclin A activation plays a crucial role in the induction of AIG of NRK cells and that the 
expression of this gene in NRK cells is probably regulated by an E2F-independent 
mechanism. One possible mechanism is the adhesion-dependent activation of a CCAAT- 
binding protein which induces transcription activation of the cyclin A promoter (Krämer et 
al., 1996). Furthermore, under anchorage-independent conditions E2F could be present in an 
transcription inhibiting p107/E2F complex (Schulze et al., 1995).
1.2.3 Modulation of EGF receptor densities
Another mechanism that plays an important role in the regulation of AIG is the modulation of 
EGF receptor densities. AIG and loss of DDGI are both aspects of phenotypic transformation, 
suggesting that the same mechanisms may play a role. Indeed, there is a strong parallel 
between the growth factor requirements for inducing loss of DDGI and AIG of NRK cells 
(Van Zoelen et al., 1988; Lahaye et al., 1999). Furthermore, by chemical mutagenesis various 
mutant NRK cell lines have been made that are unable to undergo loss of DDGI in the 
presence of transforming factors, such as PDGF or EGF in combination with TGFß. These 
mutants are also unable to proliferate under anchorage-independent conditions in the presence 
of such transforming factors (Masuda et al., 1992). This shows that loss of DDGI and AIG are 
genetically coupled suggesting that most likely the same cellular processes underlie these two 
aspects of phenotypic transformation. On the other hand, several other mutant NRK cell lines 
have been created that are able to proliferate under anchorage-independent conditions in the 
absence of TGFß while they have a normal phenotype when cultured under adherent 
conditions (Han et al., 1993). This shows that in NRK fibroblasts the genes that regulate AIG 
are not necessarily involved in the regulation of DDGI and probably different processes 
underlie these two aspects of phenotypic transformation. This suggests that in NRK 
fibroblasts the regulation of EGF receptor density is not necessarily involved in the regulation 
of AIG.
The studies in this thesis add new data that strongly support the hypothesis that EGF 
receptor levels play an important role in the regulation of AIG in NRK fibroblast. Our studies 
show that also under anchorage-independent conditions EGF receptor levels are strongly 
decreased. Furthermore, there is a parallel between the increase of EGF receptor expression 
and EGF-dependent AIG induced by several transforming factors in NRK cells (Chapter 4). 
This suggests that EGF receptor levels not only control DDGI in NRK cells but also AIG.
This is supported by a recent study in which it is shown that in a NRK mutant in which EGF 
receptor levels are strongly reduced TGFß is not able to induce AIG (Kizaka-Kondoh et al., 
2000). This demonstrates that the ability of TGFß to induce AIG depends on its ability to 
increase EGF receptor levels in NRK fibroblasts. Furthermore, overexpression of the EGF 
receptor gene in these cells results in EGF-induced AIG in the absence of TGFß (Kizaka- 
Kondoh et al., 2000).
1.2.4 Model
When considering the above mentioned mechanisms involved in the induction of AIG, the 
question rises if they act independently from each other or if they can be converted into a 
single model. As mentioned above, the expression of the EGF receptor, cyclin A, and a 5ß1 
integrin decreases when NRK cells are cultured under anchorage-independent conditions. 
Overexpression of the EGF receptor gene in NRK cells results in EGF-induced anchorage- 
independent growth in the absence of TGFß (Kizaka-Kondoh et al., 2000), suggesting that an
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increase of EGF receptor levels is sufficient to induce AIG. However, the same applies to 
overexpression of a 5p1 integrin (Dalton et al., 1999) and Cyclin A (Guadagno et al., 1993). 
Thus, activation of any of these mechanisms seems to be sufficient for induction of AIG. This 
could be explained by a model in which these three mechanisms are all part of the same 
signalling pathway. However, overexpression of a single pathway could also bypass control 
mechanisms, making this conclusion premature. Nevertheless, the fact that inhibition of any 
of these mechanisms prevents the induction of AIG suggests that all these mechanisms are 
necessary for the induction of AIG. This is supported by our results in Chapter 4 which show 
that the increase of EGF receptor numbers alone is probably not sufficient to induce AIG of 
NRK cells and that additional signalling pathways must be involved. In addition, it has been 
shown that increased cyclin A expression is not able to fully rescue normal proliferation 
kinetics in non-adherent NRK cells, suggesting that additional regulatory mechanisms must 
play a role (Guadagno et al., 1993). Thus, most likely the joint activation of the three 
mechanisms is required tot induce AIG of NRK fibroblasts.
The increase of EGF receptor levels induced by transforming factors could probably lead to 
EGF-induced activation of the other two pathways. If the TGFb-induced increase of a 5p1 
integrin level or cyclin A activity is secondary to the increase of EGF receptor levels, this 
would imply that TGFp does not induce a 5p1 integrin expression or cyclin A activity in the 
absence of EGF. Furthermore, in cells that overexpress the EGF receptor (for example the 
NER-1 NRK mutant described in Kizaka-Kondoh et al., 2000) the a 5p1 integrin levels or 
cyclin A activity should be high in the presence of solely EGF. Additionally, in cells with low 
EGF receptor levels (for example the R14 NRK mutant described in Kizaka-Kondoh et al., 
2000) TGFp should be a very poor inducer of a 5p1 integrin expression or cyclin A activity in 
the presence of EGF. In addition, the other AIG-inducing agents used in our studies should 
also be able to induce an increase of a 5p1 integrin levels or cyclin A activity when the cells 
are cultured in the presence of EGF. However, a 5p1 integrin and cyclin A expression could 
also be activated directly by TGFp and in an EGF-dependent way. These mechanisms are 
summarised in a model in figure 2.
Recently it has been shown that the expression of cyclin D1 is necessary for the induction 
of AIG and that TGFp is only able to induce AIG in cells that have anchorage-independent 
expression of cyclin D1 (Zhu et al., 2000) such as NRK fibroblasts (Zhu et al., 1996). This 
suggests that, besides the above mentioned mechanisms, also cyclin D1 expression is required 
tot induce AIG. The induction of cyclin E activity is also not decreased when NRK fibroblasts 
are cultured under anchorage-independent conditions, in contrast to other fibroblast cell lines 
(Zhu et al., 1996), suggesting that this may also be a prerequisite for the induction of AIG in 
NRK fibroblasts. This shows that NRK cells have a reduced number of control pathways that 
normally link adhesion to cell cycle progression.
Figure 2: Model for the induction of AIG in NRK cells by TGFp. ,_~ r" ^
For induction of AIG the joint activation of cyclin A, cyclin D, and 
cyclin E and the increase of a 5p1 integrin and EGF receptor 
expression is needed. In NRK cells cyclin D and E are constituvily 
activated. TGFp increases the EGF receptor and a 5p1 integrin 
expression and the cyclin A activity and as a result induces AIG. It is 
not clear if the a 5p1 integrin expression and the cyclin A activity are 
increased directly by TGFp or that this is secondary to the increase of 
EGF receptor levels.
TGFp
Constitutively 
activated in NRK 
fibroblasts:
Cyclin D
Cyclin E
J
AIG
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1.3 Reflection on model for (loss of) DDGI of NRK cells
1.3.1 Introduction
As stated above in section 1.1, there are numerous arguments that support the hypothesis that 
modulation of EGF receptor densities is the most appropriate mechanism for describing 
DDGI in the presence of EGF in NRK cells. However, we realise that most of the results that 
are mentioned to support this model only suggest a strong correlation between EGF receptor 
levels and cell proliferation, but do not prove a direct causal relation. Another question that 
has not been answered relates to the downstream effectors of the EGF receptor that need to be 
activated to induce loss of DDGI. Some other critical aspects of the model will be discussed 
here.
1.3.2 Decrease of EGF receptor levels at high cell density
First, we did not directly demonstrate the decrease of EGF receptor levels at high cell density 
ourselves but only referred to results of others. In addition, we did not show that EGF 
receptor levels are lower in density-arrested cells than in quiescent cell. These experiments 
are difficult to perform because of the low receptor densities in NRK cells. In fact, we did not 
observe a decrease of EGF receptor promoter activity with increased cell density 
(unpublished results).
1.3.3 Small increase of EGF receptor levels
Furthermore, it remains to be established if the small and delayed increase of EGF receptor 
levels (mRNA levels and 125I-EGF binding) induced by factors such as BK and PGF2a on 
quiescent NRK cells (Chapter 3) really accounts for the increased mitogenic activation of cell 
proliferation induced by EGF, or that other growth-stimulating signalling pathways activated 
by these factors are responsible for this. The same applies to the small and delayed increase of 
125I-EGF binding induced by ET-1, LPA, BK and PGF2a in density-arrested cells, which is in 
contrast to the strong induction of loss of DDGI induced by these factors (Chapter 5).
1.3.4 Is this real DDGI?
It can in fact be disputed if NRK cells that have become growth arrested in the presence of 
EGF because EGF receptor levels drop below a threshold level should really be considered as 
density-inhibited cells. When cultured in the presence of another growth factor, cells may be 
able to proliferate to higher densities than in the case of EGF before a growth-inhibited state 
has been reached. PDGF is not a good candidate to solve this question because when cells are 
cultured in the presence of solely PDGF, which is a strong mitogen for NRK cells (Van 
Zoelen et al., 1988; 1993), they do not undergo DDGI but show phenotypic transformation 
upon restimulation with PDGF (Van Zoelen, unpublished results). This shows that at the 
density at which cells become arrested in the presence of EGF they are still susceptible to 
stimulation by other growth factors. It would be interesting to investigate if EGF receptor 
levels also decrease when cells are grown to high density in the absence of EGF.
1.3.5 Direct causal relation between EGF receptor levels and cell proliferation?
There are only a few reports that suggest a causal relation between EGF receptor levels and 
cell proliferation. However, recently it is shown that in an NRK mutant in which EGF 
receptor levels are strongly reduced, EGF is not able to induce cell proliferation. 
Overexpression of the EGF receptor gene in these cells leads to a restored response to EGF 
(Kizaka-Kondoh et al., 2000). In another study it is shown that constitutive expression of a 
mutant downstream effector of the EGF receptor (CRKII) inhibits phenotypic transformation 
induced by EGF and TGFp in NRK fibroblasts, favouring a causal relation between EGF 
receptor levels and cell proliferation in these cells (Ota et al., 1998). CRKII is an adapter
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protein that binds to the activated EGF receptor and is subsequently phosphorylated by its 
receptor kinase, leading to activation of the c-Jun N-terminal kinase (JNK) signalling 
pathway, actin cytoskeleton organisation and DNA synthesis induced by EGF (Nakashima et 
al., 1999). Mutant CRKII-23 is constitutively bound to the EGF receptor and prevents 
phenotypic transformation of NRK fibroblasts induced by EGF and TGFb (Ota et al., 1998), 
suggesting that this mutant prevents signalling from the EGF receptor. However, the 
prevention of phenotypic transformation by the mutant CRKII-23 can actually also result 
from constitutive activation of a proliferation-inhibiting pathway.
1.3.6 Control of EGF receptor density
The question how cell density controls EGF receptor density has not been answered yet. In 
many cell types EGF itself is able to enhance the EGF receptor mRNA levels (Clark et al., 
1985; Earp et al., 1988; Thompson and Rosner, 1989) and also in NRK cells EGF is able to 
increase expression of its own receptor, although only to a low extent (Thompson and Rosner,
1989). However, in serum-deprived quiescent NRK cells (Chapter 3) and in EGF-induced 
density-arrested NRK cells (Van Zoelen et al., 1994), the presence of EGF is associated with 
low receptor levels, showing that EGF is not able to enhance EGF receptor mRNA levels to a 
sufficiently high level.
In human breast carcinoma cells EGF binding decreases when cell density increases and 
this decrease is parallelled by decreased EGF receptor mRNA expression (Hamburger et al., 
1991). This suggests that also in NRK fibroblasts EGF receptor levels are regulated on 
transcription level. What transcription factors are involved in the density-dependent 
regulation of the EGF receptor transcription is not clear. The human EGF receptor promoter 
has been shown to be stimulated by EGF itself, phorbol 12-myristate 13-acetate (PMA), 
(Bu)2cAMP, dexamethasone (Hudson et al., 1989), and TGFb (Thompson et al., 1988; Hou et 
al., 1994). Retinoic acid (RA) has been shown to have both activating (Hudson et al., 1989) 
and repressing (Zheng et al., 1992) activity on the EGF receptor promoter, while expression 
studies have indicated that agents that induce PtdIns(4,5)P2 hydrolysis in rat liver epithelial 
cells are able to increase EGF receptor mRNA levels in these cells (Earp et al., 1988).
Another factor involved in EGF receptor transcription is p53. This tumour suppressor 
positively transactivates the human EGF receptor promoter (Deb et al., 1994; Ludes-Meyers 
et al., 1996). The levels of p53 are generally strongly decreased in cells at high cell density 
(Deffie et al., 1996). This could explain the observed decrease of EGF receptor numbers in 
cells at high density. However, cells at high density accumulate in a part of G1 during which 
p53 is not active as a transcription factor (Deffie et al., 1996), suggesting that it is not very 
likely that p53 levels regulate EGF receptor transcription in quiescent and density-arrested 
NRK fibroblasts.
We were not able to detect a decrease of EGF receptor promoter activity when cells 
undergo DDGI (data not shown). This suggests that the EGF receptor promoter we used does 
probably not contain all the elements that regulate the density-dependent EGF receptor 
promoter activity. Studies with a larger construct could elucidate this, while instead, mRNA 
levels could be measured directly.
Although PDGF induces loss of DDGI without delayed kinetics, suggesting no role for 
induction of other growth factor receptor genes, we observed a very strong induction of EGF 
receptor promoter activity induced by PDGF-AB in density-arrested NRK cells (unpublished 
results). This is in contrast to studies on EGF receptor mRNA levels where no such effect was 
observed at least during the period of 4 hours after addition (Van Zoelen et al., 1994).
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1.3.7 Is the decrease of EGF-R levels at high cell density a general mechanism?
The decrease of EGF receptor levels at high cell density is not universal. In BSC-1, KB, 
A-549, A-431, NRK-49F, WI-38, and CCD-18LU cells EGF receptor levels are decreased at 
high cell density (Rizzino et al., 1990), but in human glial cells EGF receptor levels have 
been shown to be upregulated at high cell density (Westermark, 1977). Overexpression of 
EGF receptor is a common characteristic in many tumours that have lost the ability to 
undergo DDGI (Merlino et al., 1984; Ozanne et al., 1985; Kamata et al., 1986). EGF receptor 
overexpression could increases the chance for cells to receive mitogenic EGF signals and as a 
consequence it could increase the possibility to accumulate mutations in other genes critical 
for malignant progression.
1.4 Reflection on model for AIG of NRK cells
1.4.1 Small increase of EGF receptor levels
As stated above, EGF itself is able to enhance EGF receptor numbers in many cell types. Our 
results show that also under anchorage-independent growth conditions EGF increases EGF 
receptor promoter activity without induction of AIG (Chapter 4). Factors such as BK, PGF2a, 
ET-1, LPA, and TGFb increase EGF receptor promoter activity only slightly and none of 
these factors exceeds the EGF-induced level (Chapter 4). 125I-EGF binding studies show that 
some of these compounds increase EGF binding more strongly than EGF receptor promoter 
activity, suggesting that promoter activity does not correlate with EGF receptor levels. This 
can be due the fact that the promoter construct is probably not complete or to the fact that 
transcriptional regulation is not the only mechanism to regulate EGF receptor levels. Binding 
studies should confirm whether the small increase of EGF receptor levels induced by factors 
such as BK, PGF2a, ET-1, LPA, and TGFb could be sufficient for the induction of AIG, or 
that other, growth-stimulating signalling pathways activated by these factors are also involved 
in induction of AIG.
1.4.2 Is the decrease of EGF receptor levels under anchorage-independent conditions a 
universal mechanism?
We showed that EGF receptor levels are decreased in anchorage-independent cell cultures 
(Chapter 4). In line with this hypothesis Mansbridge et al. (1994) showed that in A431 cells 
125I-EGF binding strongly decreases when these cell are grown as spheroids. However, this is 
not a universal mechanism because in glioma cell lines EGF receptor mRNA levels are the 
highest when the cells are grown in three-dimensional cultures (Ness et al., 1994). The forced 
expression of cyclin D1 in suspended 3T3 cells renders them susceptible to transformation by 
TGFb, i.e. TGFb induces AIG in the cells (Zhu et al., 2000). If the regulation of EGF receptor 
levels also plays a role in those systems, then the factors that increase EGF receptor levels in 
NRK cells should also be able to induce AIG in such 3T3 cells.
1.4.3 Control of EGF receptor density
The decrease of EGF receptor promoter activity under anchorage-independent conditions is 
not due to a general transcriptional inhibition because the PDGF a-receptor promoter activity 
is not decreased under these conditions (Chapter 4). Because of the reversibility of the 
process upon reattachment, it also does not result from apoptosis of the cells under anchorage- 
independent conditions. High concentrations of PDGF induce AIG in the absence of EGF 
(Van Zoelen et al., 1988; 1993), probably in parallel with enhanced expression of the PDGF 
a-receptor under anchorage-independent conditions (Van Zoelen et al., 1993). However, we 
did not measure an increase of type a  PDGF receptor promoter activity when cells were 
induced to grow under anchorage-independent conditions (Chapter 4).
What transcription factors are involved in the anchorage-dependent regulation of the EGF
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receptor transcription is not clear. As can be seen in Chapter 4, several growth factors 
increase human EGF receptor promoter activity in anchorage-independent NRK cells. A 
factor that is possibly involved in EGF receptor transcription is p53. This tumour suppressor 
transactivates the human EGF receptor promoter (Deb et al., 1994; Ludes-Meyers et al.,
1996). When cells are cultured under anchorage-independent conditions, p53 is rapidly 
activated (Wu and Schonthal, 1997). If EGF receptor transcription is regulated positively by 
p53, this should lead to an increase of EGF receptor transcription, but the opposite is 
observed (Chapter 4). This can be explained by the observation that the p53-binding site 
identified overlaps the binding sites for other, both positive and negative regulators of human 
EGF receptor promoter activity (Ludes-Meyers et al., 1996). This would suggest that p53 
itself does not play a role in the decrease of EGF receptor transcription under anchorage- 
independent conditions.
1.4.4 Anchorage-independent cyclin D1 expression
The increased expression of cyclin D1 under anchorage-independent conditions explains the 
observation that whereas TGFp is growth-inhibiting in the most cells, it potently induces AIG 
in NRK fibroblasts. The physiological importance could be that induction of AIG is a 
specialised function of TGFp under conditions where cyclin D1 expression occurs 
physiologically (e.g. at sites of injury) or pathologically (e.g. in cells that overexpress 
cyclin D1 as described by Zhu et al., 2000).
1.5 Additional mechanisms describing (loss of) DDGI in NRK cells
We showed that in NRK fibroblasts the modulation of EGF receptor levels is the most 
appropriate mechanism for describing DDGI in the presence of EGF in NRK fibroblasts 
(section 1.1). However, various other mechanisms have been proposed in the literature to 
explain why cells stop proliferating above a critical cell density (see Chapter 1). In this 
section the mechanisms that have been investigated in NRK cells will be described briefly. 
Their role in the regulation of DDGI of NRK cells and the correlation with the modulation of 
EGF receptor levels will be discussed.
1.5.1 Production of soluble and membrane bound growth inhibitors
Several studies suggest that autocrine growth inhibitory molecules are secreted in the medium 
of dense cultures which overcome stimulatory effects of growth factors and inhibit cell 
proliferation. However, in the case of NRK fibroblasts no growth-inhibiting activity can be 
detected in medium conditioned by density-inhibited NRK cells (Van Zoelen, 1991). One of 
the best characterised soluble growth inhibitor is an IGF-binding protein (Blat et al., 1989; 
1994), to which NRK fibroblasts are not sensitive, because of the presence of high 
concentrations of insulin in the assay media used. So there is no evidence that secreted 
growth-inhibitory factors are involved in EGF-induced density-arrest.
Furthermore, it has been postulated that the expression of specific cell surface 
glycoproteins called contactinhibins at confluence may regulate density-dependent growth 
inhibition. At present there are no indications, however, that contactinhibin is able to induce 
DDGI in NRK fibroblasts.
1.5.2 Density-dependent control of intracellular second messengers
• Modulation ofthe membrane potential
It has been suggested that modulation of the membrane potential is involved in the regulation 
of DDGI (Binggeli and Weinstein, 1986). In NRK fibroblasts, this seems not to be the case: 
confluent cultures of cells have a more negative membrane potential than single cells or cells 
in subconfluent cultures, but the membrane potential does not differ between exponentially
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growing confluent cells, serum-deprived quiescent cells and density-arrested cells (De Roos 
et al. 1997a; 1997b). This shows that in NRK fibroblasts the density-dependent modulation of 
membrane potential is not involved directly in DDGI. However, it has recently been shown 
that phenotypically transformed NRK fibroblasts have a more depolarised membrane 
potential than density-arrested cells. This depolarisation is induced by a prostaglandin-like 
compound which is secreted by phenotypically transformed NRK cells. This compound is 
able to depolarise quiescent cells but does not induce phenotypic transformation of these 
cells. This shows that a depolarisation as such is not sufficient to overcome DDGI (Harks, de 
Roos, Peters, Van Zoelen, and Theuvenet, unpublished). From this it can be concluded that in 
NRK fibroblasts modulation of the membrane potential does not directly induce DDGI, 
although depolarisation plays a still unidentified role in loss of DDGI.
• Protein-tyrosine phosphatase activity
Tyrosine phosphatase activity is increased in several density-arrested fibroblast cell lines 
(Pallen and Tong, 1991). Inhibition of tyrosine phosphatase activity by vanadate prevents 
NRK cells from undergoing DDGI (Rijksen et al., 1993a; 1993b). Although it has not been 
proven that loss of DDGI is accompanied by a decrease of phosphatase activity in NRK cells, 
this suggests that an increase of phosphatase activity may play a role in DDGI. Such 
phosphatases are supposed to act by dephosphorylating the autophosphorylated EGF receptor 
and receptor substrates, thereby downregulating the EGF signal (Rijksen et al., 1993a). This 
mechanism enhances the effect of decreased EGF receptor levels at high cell density and 
could therefore act in parallel with the above described mechanism. Vanadate has also been 
shown to inhibit loss of DDGI induced by TGFp (Rijksen et al., 1993b), suggesting that there 
are also growth-stimulating phosphatases involved in the loss of DDGI.
• Cyclins and cyclin-dependent kinase inhibitors (CKIs)
In several cell lines the expression of cyclin A and the activity of cyclin D1 are decreased 
during contact inhibition. Furthermore, cyclin E-cdk2 and cyclin D-cdk4 activities are 
decreased as a result of the increased expression of the CKIs p27, p15 and p16, and the 
decreased expression of p21. This decrease of cyclin-cdk activity in dense cell cultures 
prevents phosphorylation of pRb and leads to growth arrest. In NRK fibroblasts cyclin-cdk 
activities have not been studied in relation to DDGI. However, the important role of cyclin A 
in the regulation of AIG (see below) suggests that this mechanism also plays an important 
role in DDGI.
• Modulation o f  Na+/H+ antiporter activity and intracellular p H
The activation of a Na+/H+ antiporter and the resulting rise in intracellular pH (pHi) has been 
shown to play an important role in the induction of cell proliferation by a great number of 
growth factors. Density-arrested NRK cells have a slightly enhanced pHi compared to 
quiescent cells, while the pHi of NRK cells that are phenotypically transformed by TGFp is at 
least 0.2 pH unit higher than that of quiescent cells (Van Zoelen and Tertoolen, 1991). This 
suggests that also in NRK fibroblasts there is a link between pHi and DDGI. A sufficiently 
high pHi seems to be very important for the induction of loss of DDGI in NRK fibroblasts, 
probably because it is required for stimulation of glycolysis. At high cell densities the number 
of EGF receptors is probably too low to induce an elevation of the pHi when the cells are 
treated with EGF.
1.5.3 Cell-cell contact en communication
• The increase o f  intercellular communication via gap junctions (GJ)
It has been hypothesised that the increase of intercellular communication via GJ could be the 
cause of the block in cell proliferation at high cell density (Binggeli and Weinstein, 1986; 
Holder et al., 1993). Intercellular communication can be studied by measuring biochemical or
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electrical coupling. NRK fibroblasts have been shown to be coupled both biochemically 
(Maldonado et al., 1988; Van Zoelen and Tertoolen, 1991; De Roos et al. 1997a) and 
electrically (Maldonado et al., 1988; De Roos et al., 1996). Small clusters of cells, cells in 
confluent, quiescent cultures and also phenotypically transformed cells are well coupled (Van 
Zoelen and Tertoolen, 1991; De Roos et al., 1996; 1997a). This shows that in NRK cells, in 
contrast to most transformed cells (reviewed by Binggeli and Weinstein, 1986; Holder et al.,
1993), uncoupling is not a prerequisite for transformation. Whether cell uncoupling is 
sufficient to induce phenotypic transformation of NRK cells is still unknown.
• Induction o f  extracellular matrix proteins and their receptors
The levels of extracellular matrix (ECM) proteins such as fibronectin, collagen and laminin 
are often decreased in transformed cells (Yamada, 1983; Holder et al., 1993). Also the levels 
of specific types of integrins (receptors for ECM proteins) on transformed cells are 
significantly lower than on normal cells (Plantefaber and Hynes, 1989). In contrast, in NRK 
fibroblasts it has been suggested that an increase of ECM proteins is correlated with 
phenotypic transformation (DDGI). In these cells TGFß increases the levels of the 
extracellular matrix proteins fibronectin (Ignotz and Massague, 1986; Thompson et al., 1988) 
and collagen (Ignotz and Massague, 1986) and in parallel induces loss of DDGI (Van Zoelen 
et al., 1988). It has been proposed that the upregulation of fibronectin plays an important role 
in the induction of AIG by TGFß (Ignotz and Massague, 1986). It is difficult to imagine, 
however, how this mechanism could play a role in the loss of DDGI of NRK cells, since these 
cells are already anchored and form cellular monolayers with high endogenous fibronectin 
levels (Van Zoelen, unpublished results). Furthermore, if the increase of fibronectin 
expression was the mechanism by which TGFß induces AIG, it would lead to the prediction 
that, in the absence of anchorage, progression into S phase would occur after a significant 
time lag since it would take some time before enough ECM proteins are produced. However, 
the S phase progression occurs with an almost identical time course in the presence or 
absence of anchorage (Kume et al., 1992), showing that it is unlikely that the production of 
ECM proteins is required for the induction of AIG. If the increase of fibronectin levels does 
not play an important role in TGFß-induced AIG, a role in the regulation of loss of DDGI is 
very implausible.
• Increase o f  cell adhesion molecules
Cell adhesion molecules are supposed to play an important role in density-dependent growth 
inhibition. However, at present there is no evidence that cell adhesion molecules are involved 
in the regulation of DDGI in NRK fibroblasts.
1.5.4 Reflection
• Other mechanisms
Also for the other mechanisms mentioned in Chapter 1 there are no indications from literature 
that they play a role in density-dependent growth control of NRK fibroblasts. As stated 
before, it is disputable if the density-arrested NRK cells induced by EGF could really be 
considered as density-inhibited cells. This could possibly explain the fact that not all 
mechanisms that have been postulated to play a role in DDGI, are relevant in NRK 
fibroblasts. Besides, one should realise that not all density regulated genes are necessarily 
involved in regulating DDGI.
• Primary and secondary mechanisms in the regulation o f  D DGI
The question remains how cells are able to sensor cell density, because this is the primary 
mechanism leading to DDGI. When growth factors are available at optimal concentrations, 
the only imaginable growth-regulating mechanism seems to be the extent of cell-cell contacts 
and the resulting (secondary) intracellular and extracellular changes triggered by these
82
General discussion
contacts.
This suggests that besides the mechanisms mentioned in section 1.5.3 that involve cell-cell 
contact en communication, all the mechanisms mentioned above are only secondary. Whether 
gap junctions, extracellular matrix proteins and their receptors, as well as cell adhesion 
molecules are the primary regulators of DDGI is presently unknown. All our experiments on 
adherent cells described in this thesis have been performed with confluent cell cultures in 
which the cells make already intensive cell to cell contact. This excludes the possibility that in 
the case of NRK cells cell-cell contact as such is sufficient for induction of DDGI. This 
suggests that the decision between growth and growth inhibition depends on a relatively small 
increase in cell density. The signal which is generated by cell-cell contact, however, remains 
to be elucidated.
1.6 Additional mechanisms describing AIG in NRK cells
Besides the expression of extracellular matrix proteins and their receptors, cyclin activity and 
the modulation of EGF receptor densities which has been described in section 1.2, various 
other mechanisms have been proposed in the literature to play a role in the induction of AIG 
of NRK cells (see Chapter 1). The role of these mechanisms is discussed now.
• Inositol polyphosphate 5-phosphatase
Chronic elevation of Ins(1,4,5)P3, Ins(1,3,4,5)P4, and intracellular calcium concentrations 
leads to the induction of AIG in NRK fibroblasts, suggesting that these second messengers are 
involved in the regulation of AIG (Speed et al., 1996).
• Intracellular p H
As stated in Chapter 1, it is suggested that cells are not able to proliferate under anchorage- 
independent conditions because of a lack of integrin expression, resulting into a decreased 
pHi. The increase of a 5p1 integrin levels induced by TGFb in NRK fibroblasts could result 
into an increase of pHi, leading to AIG. Experimental data should confirm this. However, it is 
not known if an increase of pHi is absolutely necessary to induce AIG. Furthermore, an 
artificially induced increase of pHi is generally not sufficient to induce anchorage- 
independent cell proliferation (Grinstein et al., 1989). On the other hand, a sufficiently high 
intracellular pH seems to be very important for the induction of AIG in NRK fibroblasts 
(Schwartz et al., 1990). It is plausible that the number of EGF receptor under anchorage- 
independent conditions and in cells at high density is too low to induce an elevation of the 
intercellular pH when the cells are treated with EGF.
• Activation o f  protein tyrosine phosphatases (PTPases)
As inhibition of PTPases leads to the induction of AIG in NRK fibroblasts (Rijksen et al., 
1993b), it seems that the activation of PTPases under anchorage-independent conditions plays 
a role in the inhibition of cell proliferation. This suggests that growth factors can only induce 
AIG when they are able to activate PTPases to a sufficiently high level. Direct determination 
of PTPase activity could ascertain this.
2 Inhibitory effect of bradykinin on loss of DDGI of NRK cells______________
2.1 Introduction
In the present study we have shown that BK is able to induce loss of DDGI of NRK cells by 
upregulating the number of EGF receptors (Chapter 5). Previous studies from our laboratory 
indicated, that upon short term incubations BK has in contrast a strong inhibitory effect on the 
RA-, TGFb-, and LPA-induced loss of DDGI of NRK cells (Afink et al., 1994; Van Zoelen et 
al., 1994). Our current results show that this inhibition cannot be correlated to the levels of 
arachidonic acid (AA) release, degradation of inositol-containing phospholipids, Ca2+- 
mobilisation or the duration of the induced membrane depolarisation, since PGF2a, ET-1 and
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LPA induce similar second messengers but do not mimic this growth inhibition (Chapter 5). 
The inhibitory effect of BK appears to be specific for density-arrested cells (Afink et al.,
1994). Several possible mechanisms for the proposed specificity will be discussed below 
(section 2.2). Initially, the short term inhibitory effect of BK had been correlated with the 
repression of the up-regulation of EGF receptor expression induced by RA (Van Zoelen et al.,
1994), suggesting that in NRK fibroblasts BK regulates cell proliferation by regulating EGF 
receptor numbers. In section 2.3 we present some results that make that statement disputable. 
Another mechanism that has been proposed to explain the inhibition of phenotypic 
transformation of NRK fibroblasts by BK is the production of a growth inhibiting cyclo- 
oxygenase product, since inhibition of this enzyme abrogates the inhibitory activity of BK 
(Afink et al., 1994 and Chapter 2 of this thesis). In section 2.4 we present some results of 
experiments to clarify this mechanism of growth inhibition into more detail.
2.2 Specificity of growth-inhibitory effect of BK on quiescent NRK cells
In serum-deprived, quiescent NRK cells BK has no inhibitory activity on cell proliferation, in 
spite of the fact that the cells have functional BK-receptors (Chapter 3). This suggests that BK 
specifically interferes with the process of loss of DDGI. This specific inhibition of density- 
arrested cells could result from different receptor numbers or subtypes present on quiescent 
cells, but this has not been verified yet by direct binding studies. Furthermore, the specificity 
could be caused by the activation of different effector mechanisms after receptor activation. It 
is also possible that, while the same receptors are activated and the same second messengers 
are formed, quiescent cells are insensitive to the growth inhibitor that is induced. However, 
our recent results (Figure 3C) show that BK can have inhibitory activity on quiescent cells as 
well, but only when these cells are stimulated with EGF in combination with RA or TGFp. 
This inhibition is also (partly) abrogated by the addition of a cyclo-oxygenase inhibitor, 
suggesting that the same mechanism underlies this phenomenon. Thus, in the presence of 
EGF in combination with RA or TGFp, the putative growth inhibitor is also produced in 
quiescent cells, showing that in these cells the same receptor mechanisms are activated and 
that the cells are sensitive to the growth inhibitor. It is currently not known how RA and 
TGFp induce this sensitivity. They may increase BK receptor numbers, induce a different 
receptor subtype or make the cells susceptible to the growth inhibitor induced by BK.
A comparison with literature data shows that in human fetal lung fibroblasts BK inhibits 
the EGF-induced cell proliferation in a PKC-dependent way (Newman et al., 1989). PKC was 
inhibited by incubating the cells for 48 hours with PMA to induce down-regulation of its 
activity. Also in NRK fibroblasts such down-regulation of PKC abrogates the inhibitory effect 
of BK on quiescent cells stimulated by EGF and RA (data not shown). This suggests a role 
for PKC in the process of growth inhibition induced by BK, but no further data are available 
to substantiate a direct role of PKC in loss of DDGI by BK.
2.3 Role of EGF receptor levels in BK-induced inhibition of cell proliferation
The BK-induced inhibition of the RA-induced loss of density-dependent growth inhibition of 
NRK cells is parallelled by a repression of the up-regulation of EGF receptor expression (Van 
Zoelen et al., 1994). A similar effect is seen in human breast stromal cells in which BK also 
induces EGF receptor down-modulation (Patel and Schrey, 1992). This suggested that in 
NRK fibroblasts BK regulates cell proliferation by regulating EGF receptor numbers (Van 
Zoelen et al., 1994). However, our current results do not agree with this concept. First, this 
decrease is not exclusive to BK since our results show that the addition of TGFp, RA, PGF2a, 
and PMA to cultures of quiescent NRK cells (Chapter 3) and of TGFp, LPA, PGF2a, and 
PMA to density-arrested NRK cells (data not shown) also results in an initial decrease of the 
125I-EGF binding. Second, there is no clear correlation between the level of 125I-EGF binding
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on the one hand, and mitogenic activation and induction of loss of DDGI induced by TGFb 
and RA in the presence or absence of BK and PGF2a on the other hand (Figure 3 panel A 
through D). Third, BK also inhibits the LPA and PDGF-BB induced loss of DDGI, while 
these factors do not require EGF for their transforming activity (unpublished results). In 
conclusion, these results shows that it is very unlikely that the inhibition of NRK cell 
proliferation by BK can be fully explained by a decrease of EGF receptor numbers.
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Figure 3: Effect of BK and PGF2a on the RA and TGFP-induced enhancement of 125I-EGF binding in 
quiescent (A) and density-arrested (B) NRK cells, in parallel with their effects on mitogenic activation (C) 
and loss of density-dependent growth inhibition (D) of NRK cells.
A and B: Serum-deprived, quiescent NRK cells (A) and density-arrested NRK cells (B) were treated for 8 hours 
with 50 ng/ml RA or 1 ng/ml TGFp, or no addition (Cont) in the additional presence of 1 pM BK or 1 pM 
PG F2a or no addition (Cont). 125I-EGF (4 ng/ml) binding was determined and corrected as described in 
Chapter 5 (figure 5).
C: Serum deprived, quiescent NRK cells were treated for 20 hours with the indicated growth factors at the
same concentration as used for the 125I-EGF binding study, all in the presence of 5 pg/ml insulin. The 
concentration of EGF was 5 ng/ml. When indicated the cells were treated for 3 hours with cyclo- 
oxygenase (Cox) inhibitors (1 pM Indo + 1 pM Flur). Cumulative [3H]-thymidine incorporation was 
measured as described in Chapter 5 (figure 1).
D: Density-arrested NRK cells were restimulated to proliferate by addition of the indicated growth factors
for 19 hours. Cumulative [3H]-thymidine incorporation was measured as described in Chapter 5 
(figure 2).
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2.4 Role of cyclo-oxygenase product in growth inhibition induced by BK
2.4.1 Introduction
BK is thought to inhibit phenotypic transformation of NRK fibroblasts by the production of a 
growth inhibiting cyclo-oxygenase product (Afink et al., 1994). This is based on the 
observation that inhibitors of this enzyme abrogate the inhibitory activity of BK. Inhibitors of 
lipoxygenase or epoxygenase, two other AA converting enzymes, have no effect on BK- 
induced inhibition of phenotypic transformation. The combined addition of these inhibitors 
also prevents the observed growth inhibition, showing that this abrogation is not due to a raise 
of AA concentration, leading to the formation of stimulating AA-metabolites. Also inhibition 
of thromboxane (Tx) synthesis does not abrogate the growth inhibition, showing that this 
cyclo-oxygenase metabolite is not the inhibitor involved (data not shown).
2.4.2 Several possible models
Based on the observation that inhibition of cyclo-oxygenase activity abrogates the BK- 
induced growth inhibition, several models can be postulated. In the most simple model all 
factors induce AA-release and only BK induces the subsequently conversion to (growth- 
inhibiting) prostaglandins (Figure 4, model a). HPLC analysis shows that AA is always 
converted into prostaglandins, indicating that this model is probably incorrect (data not 
shown). In a second model all factors induce AA-release and subsequently production of 
prostaglandins and BK induces in addition one specific, growth-inhibiting prostaglandin 
(model b). In that case, the addition of this specific prostaglandin should completely mimic 
the growth inhibition induced by BK. However, BK could also induce the production of 
another messenger (called "X") which is growth inhibiting only in combination with the 
prostaglandins the factors produce in common (model c). A slightly different situation is 
reflected in model d in which BK induces a target by which a prostaglandin can inhibit cell 
proliferation (model d). In these last two models the growth inhibition of BK cannot be 
simulated by the addition of single prostaglandins.
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Figure 4: Possible models describing BK-induced growth inhibition involving a cyclo-oxygenase product.
See text of section 2.4.2 for explanation.
2.4.3 What is the cyclo-oxygenase product induced by BK?
In several other cell types such as human breast stromal cells (Patel and Schrey, 1992), human 
gingival fibroblasts (McAllister et al., 1993a; 1993b) and vascular smooth muscle cells (Yau 
et al., 1996), BK has been shown to inhibit cell proliferation via a cyclo-oxygenase product.
In all these cases the effect of BK could be mimicked by prostaglandin E2 addition and in 
some cells the BK-induced synthesis of this prostaglandin was demonstrated (McAllister et 
al., 1993a; 1993b). In NRK cells we tested several cyclo-oxygenase products, including 
prostaglandin A2, D2, E1, E2, F2a, I2, J2, and the thromboxane A2 agonist U46619 at
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concentrations up to 10 |iM (Chapter 2), and observed that PGJ2 is the only prostaglandin 
tested with growth-inhibiting activity for NRK cells. The same results were obtained when 
prior to prostaglandin addition the cells were treated with a cyclo-oxygenase inhibitor and 
subsequently stimulated with RA and BK (data not shown). This excludes the possibility that 
BK induces a non-prostaglandin inhibitor that is inhibitory in combination with PGJ2 (model 
c, Figure 4). PGJ2 is a known growth inhibitor of cell proliferation by activation of a nuclear 
hormone receptor (Nakahata et al., 1990; Fukushima, 1992) and could therefore well be the 
BK-induced growth inhibitor in NRK cells. Other cyclo-oxygenase products that have been 
described as potential inhibitors of cell proliferation are prostaglandin A1, A2, D7-A1, B1, E1, 
D2, and D12-J2 (Wiley et al., 1983; Narumiya and Fukushima, 1985; Bhuyan et al., 1986; 
Sasaki and Fukushima, 1994).
One of the precursors of PGJ2 is PGD2 (see figure 5). PGJ2 is synthesised via 
nonenzymatic dehydration of PGD2 (Fukushima, 1992). This suggests that PGD2 may also 
have inhibitory activity on NRK cells. When comparing the effects of PGD2 with those of 
PGJ2, we observed that PGD2 indeed inhibits RA-induced DNA-synthesis, but only at 
concentrations of 15 |iM and higher (data not shown). In the presence of albumin, serum or 
plasma, D12-PGJ2 is the ultimate metabolite of PGD2 (Fukushima, 1992). The observed 
inhibitory activity of PGD2 could therefore also result from this metabolite. It can also not be 
excluded that in the assays where PGJ2 is added to the cells, this prostaglandin is also 
dehydrated to D12-PGJ2, and that this factor is responsible for the observed inhibitory effect.
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Figure 5: Conversion of arachidonic acid 
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The observation that PGJ2 is able to mimic the growth inhibition of BK (Chapter 2) does not 
prove that this is the growth-inhibiting factor induced by BK. Therefore, several different 
approaches were used to test the hypothesis that PGJ2 is indeed the growth-inhibiting factor 
specifically induced by BK. We tried to prevent the formation and activity of PGJ2, compared 
some secondary effects of BK with those of PGJ2 and measured PGJ2 levels directly.
• Prevention ofthe synthesis o f  PGJ2
The synthesis of PGJ2 has been described to be abrogated by glutathion in aortic endothelial 
cells (Koizumi et al., 1992). However, addition of glutathion did not prevent the BK-induced 
inhibition of loss of DDGI induced by RA in NRK cells (data not shown).
• Downstream effectors o f  prostaglandins
Several growth-inhibiting prostaglandins have been shown to induce the expression of the 
heat shock protein (hsp)70 (Santoro et al., 1989; Sasaki and Fukushima, 1994). If BK 
specifically induces a growth-inhibiting prostaglandin when added to density-arrested NRK 
cells while LPA, ET-1 and PGF2a do not, this could probably be reflected in hsp70 induction. 
However, we did not observe an increase of hsp70 levels induced by any of these factors. In 
fact, the hsp70 levels were already at such a high level in density-arrested cells that even a 
heat shock (15 minutes 45°C or 3 h 42°C) was not able to further increase this level. Under 
the same conditions hsp70 was strongly induced in subconfluent NRK cells (unpublished 
results).
As several prostaglandins have been shown to inhibit Ras activity (Han et al., 1991), we 
tested if BK is able to specifically inhibit Ras activation. We tried to demonstrate this by 
measuring inhibition of MAPK activation, which is downstream of activation of Ras. MAPK 
can also be activated by a PKC-dependent pathway which can be prevented by prolonged 
treatment of the cells with TPA. However, after inhibition of this PKC-mediated pathway, 
hardly any MAPK activation could be detected, showing that in NRK cells factors such as 
LPA, BK, and PGF2a activate Ras only to a very low extent in density-arrested cells. This 
makes it difficult to demonstrate a BK-induced inhibition of the Ras activation induced by for 
example LPA. In conclusion, we could not demonstrate that Ras activity is selectively 
inhibited by BK. We also could not find any evidence that the growth inhibition induced by 
BK is related to the induction of nitric oxide (NO) synthase activity and the accompanying 
increase of guanylate cyclase (GC) activity (for review see Schmidt et al., 1993) like in other 
cell types (Fleming et al., 1994; Warren et al., 1994). The inhibition of the production of NO 
or the NO-induced GC activity did not abrogate the growth inhibition induced by BK, while 
the enforced increase of NO or the addition of dbcGMP (an analogue of the GC product) were 
not growth inhibiting in the presence of PGF2a (data not shown).
According to literature data, BK inhibits proliferation of A10 vascular smooth muscle cells 
by inhibiting rRNA synthesis (Yau et al., 1996). In this study RNA synthesis was determined 
by measuring [3H]uridine incorporation in the same way as we assayed [3H]thymidine 
incorporation. We investigated if BK could inhibit the increase of RNA synthesis induced by 
TGFb in density-arrested cells. TGFb strongly increased RNA synthesis (200% basal level) 
while BK and PGF2a slightly decreased RNA synthesis during the first two hours after which 
an increase of up to approximately 150% basal level was observed. BK and PGF2a slightly 
repress the TGF^-induced increase of RNA synthesis during two hours and after 5 hours the 
same level of stimulation was reached as without these factors (unpublished results). Because 
BK and PGF2a both inhibit RNA synthesis, this could not explain the specificity in the 
inhibition of cell proliferation by BK.
2.4.4 Is PGJ2 the growth-inhib iting factor specifically induced by BK?
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• Measuring PG J2 levels
First, we investigated if the putative growth inhibitor induced by BK is secreted into the 
medium. We harvested the medium of density-arrested cells stimulated with BK (referred to 
as conditioned medium) and applied it to quiescent NRK cells which were stimulated by 
EGF. If there was a growth inhibitor present in the conditioned medium, then the proliferation 
of quiescent cells should be inhibited, providing that these cells are susceptible to this 
inhibitor and the secreted amounts are high enough to induce inhibition. Because PGJ2 not 
only inhibits loss of density-dependent growth arrest but also mitogenic activation of NRK 
cells by EGF (unpublished results), the quiescent cells should also be inhibited if this 
prostaglandin is really the BK-induced growth inhibitor. We cultured the cells in the absence 
and presence of cyclo-oxygenase inhibitors but were not able to measure any inhibitory 
activity in the medium of BK-treated cells (data not shown). Supposed that the BK-induced 
growth inhibitor is present under these conditions, this suggests that the concentration in the 
medium is probably too low to detect it in this assay.
We also purified and concentrated the prostaglandins secreted into the medium (for 
method see Powell, 1987). The extraction efficiency was near 100% for PGF2a, as measured 
in an assay in which the prevention of DDGI is measured (see Chapter 5 for 
method). However, we did not see any inhibitory activity in the medium of BK-stimulated 
cells (data not shown). We were also not able to detect directly by HPLC (high pressure 
liquid chromatography) or TLC (thin layer chromatography) the existence of PGJ2 or another 
prostaglandin specifically induced by BK in the medium (data not shown). Due to practical 
problems the extraction efficiency was not constant. However, if PGJ2 is the prostaglandin 
specifically induced by BK, the concentration in the medium based on its inhibitory activity 
should be around 10 |iM, since the half-maximum concentration for inhibition by PGJ2 is 5-7 
|iM (Chapter 2). Such amounts can be easily detected by HPLC, suggesting that in spite of 
possible variations in extraction efficiencies we should have been able to demonstrate its 
presence. Together with the previous results, we conclude from these observations that it is 
unlikely that PGJ2 is the BK-induced growth inhibitor.
Another explanation for the observation that no inhibitory activity can be detected in the 
medium of BK-stimulated cells is that the inhibitor is not secreted into the medium but 
remains in the cell. It has been shown that PGJ2 added to cell cultures is transported to the 
cytoplasm and from there to the nucleus (Narumiya et al., 1987). This suggests that the 
produced PGJ2 should not necessarily be detectable in the medium, but rather in the cell. This 
means that if PGJ2 is produced by the cells, most of the PGJ2 stays in the cell and the amounts 
could be very low. This makes detection difficult. By using several different extraction 
methods we were not able to detect any PGJ2 in BK-stimulated cells. PGD2, PGJ2 and its 
metabolites have been shown to be ligands for the nuclear receptor PPARg (peroxisome 
proliferator-activated receptor) which induces promoter activity by binding to PPARg 
response elements (Forman et al., 1995). A reporter construct containing this PPARg response 
element could probably enable the determination of the levels of this type of prostaglandins, 
provided that PPARg is indeed present in NRK fibroblasts. Otherwise, a PPARg expression 
vector can be cotransfected.
2.4.5 Conclusions
Most of the experiments aimed to detect the growth-inhibiting cyclo-oxygenase product 
induced by BK were based on the expectation that BK induces growth inhibition via a 
mechanism shown in model b (Figure 4), i.e. a specific growth-inhibiting prostaglandin is 
induced by BK and subsequently secreted into the medium. Thus, if BK inhibition takes place 
via model c or d, this approach will not be successful. The inability to isolate a specific 
growth inhibitor suggests that BK could probably be inhibitory by one of these alternative
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models or that the growth-inhibiting prostaglandin induced by BK is not secreted into the 
medium.
The only indication that a prostaglandin is involved in the BK induced growth inhibition 
comes from the observation that cyclo-oxygenase inhibitors are able to block the growth- 
inhibiting effect of BK (Chapter 2). However, the cyclo-oxygenase inhibitors did not always 
fully block the growth-inhibiting effect of BK. In contrast, the secretion of the depolarising 
compound by phenotypically transformed NRK cells (see section 1.5.2) is always inhibited by 
cyclo-oxygenase inhibitors, suggesting that besides prostaglandins also other growth 
inhibitors may be involved in the BK-induced growth inhibition of NRK cells. In some 
experiments these cyclo-oxygenase inhibitors slightly stimulate the loss of density-dependent 
growth inhibition induced by LPA and PGF2a, suggesting that AA-release induced by these 
factors is always parallelled by the formation of growth-inhibiting prostaglandins. Under 
specific conditions PGF2a also shows inhibitory activity; in particular it slightly inhibits the 
ET and LPA-induced loss of DDGI (data not shown). This demonstrates that growth 
inhibitory activity may in fact not be specific for BK. Together, this suggests that all factors 
tested may induce growth-inhibiting prostaglandins although to a different level. The results 
presented here do not clarify if PGJ2 is involved in BK-induced growth inhibition. The use of 
an radioimmunoassay could probably elucidate this question.
In conclusion, the present results do not explain the initial growth inhibitory activity of BK 
on NRK fibroblasts released from density-arrest by the addition of several transforming 
factors. Our results show that it is very difficult to link second messenger levels to effects on 
cell proliferation. This suggests that other, unknown signal transduction pathways exist or that 
the effect on cell proliferation is determined by the balance between the levels of several 
second messengers, the exact time of activation, the duration of activation, etc. This 
complicates the detection and further characterisation of this BK-induced growth inhibitor.
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Summary
Cells are the building blocks for all organisms in nature. Organisms such as bacteria are 
composed of only a single cell, while animals and plants consist of numerous cells that have 
mostly acquired specialised functions by a process named differentiation. Examples of such 
specialised cells are red blood cells, sensory cells, muscle cells, etc. These cells are assembled 
in a variety of different types of tissues such as epithelia, connective tissue, muscle, etc. The 
regulation of cell proliferation and differentiation is of vital importance for the development 
of a multicellular organism. In order to form an adult organism, cells must receive signals that 
instruct them when to divide or to differentiate. However, there must also be signals that 
instruct cells to stop dividing or even to die. In an adult organism, the great majority of cells 
are in a quiescent, i.e. non-proliferating, state, but also proliferation and differentiation play 
an important role. For example, during wound healing cells that in a quiescent state must be 
instructed to initiate multiplication. The importance of this regulation is illustrated by the 
observation that defective regulation of these processes may result in uncontrolled 
proliferation of cells, which can lead to the formation of cancer cells.
A central role in the regulation of cell proliferation and differentiation is played by growth 
factors. These are extracellular signalling molecules that can act locally or throughout the 
body by binding to specific receptors on their target cells. Some of them stimulate cell 
proliferation and are therefore called mitogens and some of them act as inhibitors of cell 
proliferation. Not all cells possess similar growth factor receptors and the effect of a growth 
factor is therefore strongly cell type dependent. This provides a fine-tuned activation 
mechanism by which specific types of cells can be stimulated at a specific time and place in 
the organism.
Ideally cells should be studied under conditions that are as close to their natural 
environment as possible, i.e. within the intact organism. However, the experiments that can be 
carried out under such in vivo conditions are very limited because there are too much 
variables that cannot be controlled. For this reason, biologists often study cells that are grown 
under artificial laboratory conditions. In the presence of specific nutrients most animal cells 
can be grown either suspended in a liquid medium or attached to a solid surface. The 
experiments described in this thesis are carried out on cells called normal rat kidney (NRK) 
49F fibroblasts. These cells were once isolated from the kidney of a rat and can be cultured on 
the plastic surface of culture disks or flasks.
Cells become limited in their growth when high cell densities are reached in cell culture, a 
process called density-dependent growth inhibition (DDGI). This feature is lost upon 
tumourigenic transformation of cells. Another characteristic of normal cells that is lost upon 
tumourigenesis, is the inability to proliferate in the absence of attachment to the surface of a 
culture disk. The molecular mechanisms underlying these processes are poorly understood. 
The production of growth-inhibiting factors, the density of growth factor receptors, the cell 
membrane potential, the activity of intracellular protein tyrosine phosphatases and many other 
factors have been suggested to play a role.
In addition to tumour cells, also certain normal cells including NRK fibroblasts can be 
induced to proliferate under anchorage-independent conditions or to undergo loss of DDGI, 
when treated with specific combinations of growth factors. This reversible process is referred 
to as phenotypic transformation. The investigation of the molecular mechanisms that underlie 
this process could elucidate the mechanisms involved in malignant transformation. Therefore,
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in this thesis these two aspects of phenotypic transformation, i.e. the ability to proliferate 
under anchorage-independent conditions and the loss of DDGI, have been investigated 
extensively in NRK cells. These cells have been the subject of many studies on the role of 
growth factors in (loss of) DDGI and anchorage-independent growth (AIG). They provide an 
excellent model system since all these aspects can be studied in a single cell line: the cells 
become limited in their proliferation at high cell density when cultured in the presence of 
epidermal growth factor (EGF) as the only growth factor, while in the additional presence of 
growth factors such as transforming growth factor b (TGFb) or platelet-derived growth factor 
(PDGF) they undergo loss of density-dependent growth inhibition as a consequence of 
phenotypic transformation. In addition, these factors are also able to induce AIG of these 
cells, which normally only proliferate when attached to a substrate.
In NRK fibroblasts several mechanisms have been proposed to play a role in DDGI. 
However, a density-dependent modulation of EGF receptor levels is currently the most 
appropriate model to describe DDGI of EGF-treated NRK cells. In this model, EGF receptor 
levels decrease with increasing cell density, such that above a critical density the cells 
become unresponsive to the stimulating activity of EGF, resulting in DDGI. The cells can 
undergo phenotypic transformation by an increase of EGF receptor numbers, as induced by 
factors such as retinoic acid (RA) and TGFb, thus enhancing the growth-stimulating signals 
of EGF, or alternatively by the activation of parallel growth-stimulating pathways by factors 
such as PDGF and lysophosphatidic acid (LPA).
Previous reports from our laboratory have shown that bradykinin (BK) has initially a 
strongly inhibiting effect on the RA- and TGFb-induced loss of DDGI of NRK cells. 
Inhibition of cyclo-oxygenase activity abrogates the inhibitory action of BK, suggesting that 
most likely a cyclo-oxygenase product mediates the inhibiting effect of BK. However, the 
identity of this putative inhibitor was still unknown. In this thesis we tried to identify the 
unknown cyclo-oxygenase product. In Chapter 2 we showed that externally added 
prostaglandin (PG)J2 can mimic the inhibiting effect of BK on the RA-induced loss of 
density-arrest, while the prostaglandins A2, D2, Ei, E2, F2a, and I2 were unable to mimic this 
process when added at concentrations of 10 |iM. This suggested that PGJ2 could be the 
bradykinin-induced growth-inhibiting prostaglandin. However, from analysis of the cyclo- 
oxygenase products produced by the treated NRK cells and by studying the downstream 
effectors of PGJ2, no evidence could be obtained for BK-induced production of PGJ2 
(Chapter 6). Furthermore, our results showed that the growth inhibitory activity is probably 
not specific to BK.
As mentioned above, it has been postulated that NRK cells become density-arrested as a 
result of a decrease in EGF receptor levels below a critical threshold, which makes these cells 
unresponsive to stimulation by EGF. Confluent cultures of NRK cells, made quiescent by 
serum-deprivation, can still be induced to undergo one additional cell cycle by treatment with 
EGF, before reaching quiescence as a result of density arrest. Assuming that EGF receptor 
levels are decreased below a critical level in density-arrested cells, we hypothesised that 
already in serum-deprived quiescent cells EGF receptor levels must have been decreased to 
such a level that they limit EGF-induced mitogenesis. In Chapter 3 of this thesis we 
investigated the role of EGF receptor levels in the regulation of mitogenic activation of NRK 
fibroblasts. We showed that NRK cells, made quiescent by serum-deprivation at 
submaximum densities, are mitogenically still responsive to EGF. The additional presence of 
TGFb, RA, PGF2a, or BK prevented NRK cells from undergoing DDGI, suggesting that all 
these factors increase EGF receptor levels. The quiescent cells showed enhanced mitogenic 
stimulation by EGF after 8 hours of pre-treatment with either TGFb or RA, while only slight 
effects were observed upon addition of PGF2a and BK. The same difference was seen when 
measuring the effects of these agents on EGF receptor mRNA levels, 125I-EGF binding to
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NRK cells and EGF-induced MAPK phosphorylation. The low ability of PGF2a and BK to 
enhance EGF receptor numbers appears not in line with the proposed model that factors that 
are able to induce phenotypic transformation of NRK cells in an EGF-dependent manner 
should also increase EGF receptor numbers. However, longer incubations up to 24 hours lead 
to both enhancement of the effects of PGF2a and BK on mitogenic stimulation by EGF and 
125I-EGF binding, showing that they indeed increase EGF receptor levels, although with 
delayed kinetics. The parallel between the increase of EGF receptor levels and EGF-induced 
mitogenic stimulation shows that already in serum-deprived quiescent cells EGF receptor 
levels are decreased to such an extent that they limit EGF-induced mitogenesis. This is in line 
with our hypothesis and provides further evidence for the regulating role of the EGF receptor 
in density-dependent growth control of NRK cells.
The strong parallel between the growth factor requirements for induction of loss of DDGI 
and AIG suggests that probably the same mechanisms underlie these two aspects of 
phenotypic transformation, and raises the possibility that the EGF receptor levels are also 
involved in AIG. In Chapter 4 of this thesis we investigated the role of EGF receptor levels 
in the regulation of AIG of NRK fibroblasts. We showed that EGF receptor levels are also 
decreased in cells cultured under anchorage-independent conditions. Furthermore, we showed 
that RA and EGF increase EGF receptor mRNA levels in NRK cells under anchorage- 
independent conditions, while PGF2a, RA and TGFß increase 125I-EGF binding to non­
adherent NRK cells. In addition, the induction of AIG of NRK cells was paralleled by 
increased EGF receptor promoter activity. This shows that agents that stimulate AIG of NRK 
cells, also upregulate EGF receptor levels. From this we concluded that in NRK cells EGF 
receptor levels do not only regulate DDGI, but also mitogenic activation and induction of 
AIG, again suggesting that the same mechanisms underlie these two aspects of phenotypic 
transformation.
In our studies we often compared the effects of BK with those of other growth factors. 
Intriguingly, we observed that while PGF2a, LPA, and BK are able to induce similar second 
messengers, they exhibit different effects on NRK cell proliferation. We investigated this 
phenomenon in more detail and included endothelin-1 (ET-1), another activator of G-protein- 
coupled receptors, in our studies. The results are presented in Chapter 5. We showed that 
only LPA is mitogenic by itself, while the other three factors tested require the additional 
presence of EGF. All factors slightly increase the EGF-induced mitogenic stimulation 
following pre-treatment for 8 hours. In addition, they are all able to prevent NRK cells from 
undergoing DDGI, suggesting that all these factors increase EGF receptor levels, as was 
confirmed by binding studies. In density-arrested NRK cells, ET-1 and LPA induce 
phenotypic transformation rapidly, with similar kinetics as RA and TGFß, while BK and 
PGF2a only do so with delayed kinetics. ET-1 and PGF2a are strong inducers of AIG, with a 
similar level of induction as TGFß, while LPA, RA and BK have only low activity. When 
investigating second messenger generation, we found that ET-1 is the strongest activator of 
arachidonic acid release and phosphatidyl-inositol diphosphate hydrolysis. All factors induce 
cell depolarization, but only in the case of ET-1 the cell depolarization is not reversible upon 
removal of the factor. Similar, only the ET-1-induced transient enhancement of intracellular 
calcium concentration is parallelled by both homologous and heterologous desensitisation. 
This could be explained by the observation that ET-1 binds to its receptor in a quasi­
irreversible manner, in agreement with literature data, which is probably the explanation for 
the strong induction of second messengers. The fast induction of loss of density-arrest by RA 
and TGFß can be rationalised by their rapid enhancement of EGF receptor levels, while LPA 
does not need enhanced EGF receptor levels for mitogenic activity. The rate by which ET-1 
enhances EGF receptor levels is not much different from that by BK and PGF2a, in spite of 
the fact that their kinetics in inducing transformation are very different. So, although
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enhancement of EGF receptor levels seems essential for induction of phenotypic 
transformation of NRK cells, no direct correlation could be observed between the kinetics of 
both processes. In this respect it should be realised that according to our data BK also 
transiently induces an inhibitor of phenotypic transformation, while under certain conditions 
PGF2a appears to have similar inhibitory activity. This could explain the delayed induction of 
phenotypic transformation despite the strong induction of second messengers.
In Chapter 6 (General discussion) the role of EGF receptor levels in the regulation of cell 
proliferation of NRK cells is discussed. Finally, additional results on the BK-induced 
inhibitor are presented. No evidence for BK-induced production of PGJ2 could be obtained.
In conclusion, the mechanisms involved in the regulation of cell proliferation have been 
investigated using NRK fibroblasts as a model system. The results presented in this thesis 
increase our understanding of the mechanisms that regulate DDGI and AIG in NRK cells.
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Samenvatting
Cellen zijn de bouwstenen voor alle organismen in de natuur. Organismen zoals bacteriën 
bestaan uit een enkele cel, terwijl dieren en planten uit een groot aantal cellen bestaan.
Tijdens het proces dat differentiatie wordt genoemd, krijgen deze cellen een specialistische 
functie. Voorbeelden van zulke gespecialiseerde cellen zijn rode en witte bloedcellen, 
zenuwcellen, spiercellen, enz. Gegroepeerd vormen deze cellen een groot aantal verschillende 
weefsels zoals epitheel, bindweefsel, spierweefsel, enz. De regulatie van celvermeerdering en 
differentiatie is van vitaal belang voor de ontwikkeling van een meercellig organisme. Om 
een volwassen organisme te kunnen vormen, moeten cellen signalen krijgen die aangeven 
wanneer zij moeten delen of moeten differentiëren. Er moeten echter ook signalen zijn die een 
cel instrueren om te stoppen met delen of zelfs om af te sterven. In een volwassen organisme 
zijn de meeste cellen in een toestand die quiescent (rustend) wordt genoemd, d.w.z. zich niet- 
vermeerderend. Toch spelen ook in een volwassen organisme celvermeerdering en 
celdifferentiatie een belangrijke rol. Tijdens wondheling bijvoorbeeld moeten cellen die zich 
op dat moment in een quiescent toestand bevinden geïnstrueerd worden om te delen. Het 
belang van deze regulatie kan worden geïllustreerd met de observatie dat een defect in het 
regulatiemechanisme van deze processen kan leiden tot ongecontroleerde celvermeerdering, 
hetgeen kan leiden tot de vorming van kankercellen.
Een centrale rol in de regulatie van celvermeerdering en differentiatie wordt gespeeld door 
groeifactoren. Dit zijn signaalstoffen die door cellen uitgescheiden worden en locaal of ergens 
anders in het lichaam binden aan receptoren op hun doelwitcellen. Sommige groeifactoren 
stimuleren de celvermeerdering en worden daarom ook wel mitogenen genoemd. Niet alle 
cellen bezitten dezelfde soort receptoren voor groeifactoren en het effect van een groeifactor 
is daardoor sterk afhankelijk van de soort cel. Dit veroorzaakt een verfijnd 
activeringsmechanisme dat het mogelijk maakt om specifieke cellen op een specifiek tijdstip 
en een specifieke plaats in het organisme te stimuleren.
In het ideale geval zouden cellen bestudeerd moeten worden onder omstandigheden die 
zoveel mogelijk op hun natuurlijke omgeving lijken, d.w.z. in een intact organisme. Een 
beperkt aantal experimenten is echter maar geschikt om onder zulke in vivo omstandigheden 
uit te voeren, omdat er meestal te veel variabelen zijn die men niet onder controle heeft. 
Daarom maken biologen vaak gebruik van cellen die onder laboratoriumcondities gekweekt 
worden. In de aanwezigheid van specifieke voedingsstoffen kunnen de meeste dierlijke cellen 
zwevend in een vloeibaar medium of hechtend aan een vast oppervlak gekweekt worden. De 
experimenten zoals die in dit proefschrift beschreven staan, zijn uitgevoerd met cellen met de 
naam "normal rat kidney (NRK) 49F fibroblasts". Dit zijn cellen die ooit uit de nier van een 
rat geïsoleerd zijn en die op de bodem van plastic kweekflessen of -schaaltjes gekweekt 
worden.
Cellen die gekweekt worden stoppen met delen zodra zij een hoge dichtheid bereikt 
hebben. Dit proces wordt dichtheidsafhankelijke groeiremming genoemd. Dit kenmerk 
hebben tumorcellen verloren. Een andere eigenschap van normale cellen die tumorcellen 
verloren hebben, is het feit dat zij zich niet kunnen vermeerderen onder omstandigheden 
waarin zij niet kunnen hechten aan de bodem van een kweekschaal. De moleculaire 
mechanismen die aan dit proces ten grondslag liggen, zijn nog grotendeels onbekend. Er is 
een groot aantal factoren genoemd die mogelijk hierbij een rol spelen zoals de vorming van 
groeiremmers, de dichtheid van groeifactorreceptoren, de celmembraanpotentiaal, de activiteit
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van tyrosine-fosfatases in de cel, enz.
Naast tumorcellen kunnen ook bepaalde normale cellen, waaronder NRK fibroblasten, 
door toevoeging van specifieke combinaties van groeifactoren aangezet worden tot 
celvermeerdering terwijl zij gekweekt worden onder omstandigheden waaronder zij niet 
kunnen hechten, hier hechtings-onafhankelijke groei genoemd. Speciale combinaties 
groeifactoren zijn in deze cellen ook in staat om dichtheidsafhankelijke groeiremming op te 
heffen. Dit proces heet fenotypische transformatie en is omkeerbaar door verwijdering van de 
groeifactoren. Onderzoek naar de moleculaire mechanismen die aan dit proces ten grondslag 
liggen, kan mogelijk de mechanismen die betrokken zijn bij maligne transformatie 
verhelderen. Daarom zijn in dit proefschrift deze twee aspecten van fenotypische 
transformatie, namelijk hechtings-onafhankelijke groei en het verlies van 
dichtheidsafhankelijke groeiremming, uitgebreid onderzocht in NRK cellen. Deze cellen zijn 
onderwerp geweest van vele studies naar de rol van groeifactoren bij (het verlies van) 
dichtheidsafhankelijke groeiremming en hechtings-onafhankelijke groei. Zij vormen een 
uitstekend modelsysteem voor dit soort studies, aangezien al deze aspecten in een enkele 
cellijn bestudeerd kunnen worden: NRK cellen raken geremd in hun groei als zij een hoge 
celdichtheid bereiken indien zij gekweekt worden in de aanwezigheid van epidermal growth 
factor (EGF) als enige groeifactor, terwijl zij in de additionele aanwezigheid van 
groeifactoren zoals transforming growth factor b (TGFb) of platelet-derived growth factor 
(PDGF) deze dichtheidsafhankelijke groeiremming verliezen als gevolg van fenotypische 
transformatie. Daarnaast zijn deze factoren in staat om hechtings-onafhankelijke groei te 
induceren in deze cellen die normaal niet in staat zijn om zich onder niet-hechtende condities 
te vermeerderen.
In NRK fibroblasten is een aantal mechanismen gesuggereerd die een rol zouden spelen in 
dichtheidsafhankelijke groeiremming. Een dichtheidsafhankelijke modulatie van het aantal 
EGF receptoren wordt echter op dit moment als het meest geschikte model beschouwd om 
dichtheidsafhankelijke groeiremming van met EGF behandelde NRK cellen te beschrijven. 
Volgens dit model vermindert het aantal EGF receptoren met toenemende celdichtheid 
dusdanig dat boven een kritische dichtheid de cellen ongevoelig worden voor de stimulerende 
werking van EGF, resulterend in dichtheidsafhankelijke groeiremming. De cellen kunnen 
fenotypische transformatie ondergaan door een toename van het aantal EGF receptoren, zoals 
bijvoorbeeld geïnduceerd door factoren als retinoic acid (RA) and TGFb, waardoor de 
groeistimulerende signalen van EGF versterkt worden, of, als alternatief, door de activering 
van een parallelle groeistimulerende route door factoren zoals PDGF en lysophosphatidic acid 
(LPA).
Voorafgaand onderzoek binnen ons laboratorium heeft aangetoond dat bradykinine (BK) 
aanvankelijk een sterk remmend effect heeft op het door RA en TGFb geïnduceerde verlies 
van dichtheidsafhankelijke groeiremming van NRK cellen. Deze remming vindt niet plaats 
wanneer de cyclooxygenase-activiteit geremd wordt, hetgeen suggereert dat waarschijnlijk 
een cyclooxygenase-product de remming door BK veroorzaakt. De identiteit van deze 
mogelijke remmer was echter nog onbekend. In Hoofdstuk 2 hebben we aangetoond dat de 
toevoeging van prostaglandine (PG)J2 de remmende werking van BK op het door RA 
geïnduceerde verlies van dichtheidsafhankelijke groei kan nabootsen, terwijl de 
prostaglandines A2, D2, E1, E2, F2a, and I2 hiertoe niet in staat zijn. Dit suggereert dat PGJ2 
mogelijk het door BK geïnduceerde groeiremmende prostaglandine is. De analyse van de 
cyclooxygenase-producten die door de behandelde NRK cellen geproduceerd worden en de 
bestudering van processen waarop PGJ2 effect heeft leverde echter geen direct bewijs voor de 
door BK geïnduceerde productie van PGJ2 (Hoofdstuk 6).
Zoals hierboven genoemd, is er gesuggereerd dat in NRK cellen dichtheidsafhankelijke 
groeiremming ontstaat als gevolg van een afname van het aantal EGF receptoren tot onder
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een kritische grens waardoor de cellen ongevoelig worden voor EGF. Wanneer de cellen een 
zodanige dichtheid bereikt hebben dat zij contact met elkaar maken, wordt het medium 
waarin zij groeien vervangen door een medium zonder groeifactoren. Deze cellen kunnen 
door toevoeging van EGF nog een enkele keer tot delen aangezet worden, voordat zij 
dichtheidsafhankelijke groeiremming ondergaan. Er van uit gaande dat het aantal EGF 
receptoren in dichtheidsafhankelijk groeigeremde cellen onder een kritisch niveau is gedaald, 
is door ons gesuggereerd dat al in het stadium waarin wij de groeifactoren verwijderen het 
aantal EGF receptoren al zodanig verminderd moet zijn dat de door EGF geïnduceerde 
celdeling niet meer maximaal is. In Hoofdstuk 3 van dit proefschrift hebben wij aangetoond 
dat deze hypothese correct is: toevoeging van groeifactoren die het aantal EGF receptoren 
verhogen, versterken het effect van EGF. Deze resultaten bewijzen nogmaals dat de EGF 
receptor een regulerende rol in de dichtheidsafhankelijke groeiregulatie van NRK cellen 
speelt.
Er bestaat een sterke overeenkomst tussen de vereisten aan groeifactoren om 
dichtheidsafhankelijke groeiremming teniet te doen en om hechtings-onafhankelijke groei te 
induceren. Dit suggereert dat waarschijnlijk dezelfde mechanismen een rol spelen en dat het 
aantal EGF receptoren ook een rol speelt in hechtings-onafhankelijke groei. In Hoofdstuk 4 
van dit proefschrift hebben wij aangetoond dat dit inderdaad het geval is: onder hechtings- 
onafhankelijke condities is het aantal EGF receptoren verlaagd en factoren die hechtings- 
onafhankelijke groei induceren verhogen ook het aantal EGF receptoren.
In onze studies hebben wij vaak de effecten van BK vergeleken met die van andere 
groeifactoren. Wij zagen dat toevoeging van PGF2a, LPA, en BK vorming van dezelfde 
boodschappermoleculen in de cel veroorzaakt. Toch hebben deze factoren een verschillend 
effect op de celvermeerdering. Omdat deze bevinding ons intrigeerde, besloten wij dit 
fenomeen verder te onderzoeken en hierbij nog een andere soortgelijke groeifactor, namelijk 
endotheline-1 (ET-1), te testen. De resultaten zijn beschreven in Hoofdstuk 5. Kort 
samengevat hebben wij aangetoond dat alle factoren het aantal EGF receptoren verhogen en 
dichtheidsafhankelijke groeiremming kunnen opheffen. ET-1, LPA, RA en TGFß doen dit 
laatste met snelle kinetiek, hetgeen kan worden verklaard doordat RA en TGFß ook heel snel 
het aantal EGF receptoren verhogen en LPA een parallelle groeistimulerende route activeert. 
ET-1 echter verhoogt het aantal EGF receptoren net zo langzaam als BK en PGF2a, hetgeen 
aangeeft dat er geen directe relatie bestaat tussen de snelheid waarmee het aantal EGF 
receptoren verhoogd wordt en de snelheid waarmee celdeling geïnduceerd wordt. Deze 
vertraagde inductie van celdeling zou verklaart kunnen worden door het feit dat BK, en in 
mindere mate ook PGF2a, in staat zijn initieel een groeiremmer te induceren..
In Hoofdstuk 6 (Algemene discussie) is de rol van het EGF receptorniveau in de regulatie 
van celvermeerdering in NRK cellen bediscussieerd. Verder zijn nog aanvullende resultaten 
met betrekking tot de door BK geïnduceerde groeiremmer gepresenteerd. Zoals eerder 
beschreven, kon er geen bewijs geleverd worden voor de hypothese dat toevoeging van BK de 
vorming van PGJ2 zou veroorzaken.
Samenvattend zijn de mechanismen die betrokken zijn bij de regulatie van 
celvermeerdering bestudeerd, gebruik makend van NRK fibroblasten als modelsysteem. De 
resultaten die in dit proefschrift zijn gepresenteerd, vergroten ons begrip van de mechanismen 
die dichtheidsafhankelijke groeiremming en hechtings-onafhankelijke groei reguleren in NRK 
cellen.
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